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Summary 
Increasing pressure mandated by different government policies, for developing sustainable chemical 
processes for the synthesis of optically pure compounds, has resulted in increased considerations of 
biocatalysis as a viable option by many industries. Biocatalysis, with its exquisite selective 
properties and potential ‘green’ attributes, presents it as a sustainable alternative. Today, the role of 
biocatalysis is most evident in the pharmaceutical industry and is currently extending towards fine 
and bulk chemical production as well. The use of hydrolytic enzymes (lipases) is well established in 
several chemical industries, though certain challenges persist in other types of enzymes 
(transferases and ketoreductases), thus limiting their implementation in industry. Inhibition by 
substrate and product as well as low aqueous solubility of substrates has constrained the full 
potential of these enzymes to be harnessed.  
To overcome these challenges, different process strategies are required to obtain high yields. A 
number of different challenges and proposed solutions are discussed in chapter one of this thesis 
and have also been published as a review. In recent years, integrating porous resins as an auxiliary 
phase in enzymatic processes, to non-selectively bind the substrate and product as a means to 
alleviate substrate and product inhibition, has gained considerable recognition.  The resins act as a 
reservoir for the inhibitory substrate and a sink for the inhibitory product and simultaneously attain 
the required high substrate loading to make the process economically feasible. In this way the 
potential benefit of the enzyme can be exploited.  
Porous resins as opposed to other auxiliary phases, for example organic solvents, are non-
bioavailable, biocompatible and offer simpler operational handling (no foaming and emulsification). 
This strategy has been applied effectively to single substrate – single product systems (oxidation, 
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microbial degradation and hydrolysis). However, this concept has not been extended to other 
industrially relevant reactions which are two substrate – two product systems.  
In this thesis, a methodological framework has been successfully developed to aid in implementing 
the strategy of integrating porous resins for multi-component systems. In this manner, a generic 
platform has been established for biocatalytic reactions that require the integration of this strategy. 
The framework identifies the key information about the reaction and the process using a step-wise 
protocol with the required tools. It includes the use of kinetic modelling in characterizing the 
reaction kinetics, a heuristic approach for screening resins and a model based approach for 
evaluating the process. Greater knowledge about the enzymatic processes with integrated porous 
resins can therefore be gained and thus the efficiency of process development with respect to time 
and resources required (reduced number of experiments) could be increased.  
Estimating kinetic model parameters for enzymatic reactions is quite complex and frequently leads 
to identifiability issues. In order to understand the different techniques to estimate the parameters, a 
number of concepts are discussed in chapter four of this thesis. This knowledge has contributed to 
the development of a robust methodology for the estimation of kinetic model parameters for 
biocatalytic reactions, which has also been published in a peer reviewed journal.   
Screening resins for moderately hydrophobic multi-component systems is challenging. Often it is 
found that the capacity of the resin is inversely related with product selectivity. Therefore a trade-
off has to be made between these parameters which can be crucial from an economic point of view. 
A low resin capacity points towards the need for higher resin loading, which in turn determines the 
equilibrium concentration of the substrate in the reactor and the type of reactor that can be used 
(stirred tank reactor or packed bed reactor). Similarly low product selectivity would result in higher 
product concentration in the reactor and thus not aid in alleviating inhibition. Further considerations 
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of resin stability and cost also have to be taken into account in the screening procedure. The 
screening therefore becomes a multi-objective task that has to be solved simultaneously. Such an 
approach has been applied in the method formulated in this framework.  
Process modelling is a very effective tool in evaluating a process. Critical information about the 
process can be gained by means of simulations, which can further be re-used to tune the reaction or 
process conditions to harness the full potential of the enzyme. State-of-the-art mathematical 
techniques for model quality evaluation, such as uncertainty and sensitivity analysis, have been 
included in this analysis in order to identify the key model parameters for better understanding of 
the process.  
Three case studies were used to illustrate the applicability of the methodology to fulfil different 
objective requirements. The case studies were selected for not only being industrially relevant but 
as well as having certain limitations which contributed in developing the tools and strategies to 
overcome them. The asymmetric synthesis of 1-phenylethylamine using Ȧ-transaminse, the 
asymmetric synthesis of 1-methyl-3-phenylpropylamine using Ȧ-transaminse and enantioselective 
synthesis of 2-octanol using alcohol dehydrogenase were selected.  
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Dansk resumé 
Et stigende pres fra offentlig politik med hensyn til udviklingen af bæredygtige kemiske processer 
til syntese af optisk rene forbindelser, har resulteret i øgede overvejelser om biokatalyse som en 
farbar vej af mange brancher. Biokatalyse, med sin udsøgte selektive egenskaber og potentielle 
grønne attributter, præsenterer sig som et bæredygtigt alternativ. Biokatalyse er i dag mest tydelig i 
den farmaceutiske industri og strækker sig i øjeblikket mod fine og bulk kemikalie produktion. 
Brugen af hydrolytiske enzymer (lipaser) er veletableret i flere kemiske industrier, der er dog stadig 
visse udfordringer med andre typer af enzymer (transferaser og ketoreduktaser), hvilket begrænser 
deres gennemførelse i industrien. Inhibering af substrat og produkt samt lav vandopløselighed af 
substrater har begrænset realisering af disse enzymers fulde potentiale. 
For at overvinde disse udfordringer, kræves der forskellige proces strategier for at opnå høje 
udbytter. En række forskellige udfordringer og forslag til løsninger er diskuteret i kapitel ét af denne 
afhandling og er også blevet offentliggjort som et review. I de seneste år er det blevet populært at 
integrere porøse resiner som en ekstra fase i enzymatiske processer. Resinerne vil uden specifik 
selektivitet binde substrat og produkt og virke som et middel til håndtering substrat og produkt 
inhibering, dette har opnået betydelig anerkendelse. Resinerne virker som et reservoir for det 
hæmmende substrat og en vask for det hæmmende produkt.  Her kan der også opnås den 
nødvendige høje koncentration af substrat i resinet som gør processen økonomisk mulig. Potentialet 
som enzymet har kan på denne måde blive udnyttet. 
De porøse resiner er i modsætning til andre hjælpe faser, for eksempel organiske opløsningsmidler,  
ikke-biotilgængelige, biokompatible og kan tilbyde enklere operationel håndtering (ingen 
skumdannelse og emulgering). Denne strategi er blevet anvendt effektivt til enkelt substrat- enkelt 
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produkt-systemer (oxidation, nedbrydning og hydrolyse). Imidlertid har dette koncept ikke blevet 
udvidet til at omfatte andre industrielt relevante reaktioner, som er to substrat- to produkt-systemer. 
I denne afhandling, er der udviklet en metodologisk skelet til at hjælpe med at gennemføre 
strategien til integration af porøse resiner i multi-substrat og multi-produkt-systemer. På denne 
måde, er der blevet fastlagt en generisk platform for biokatalytiske reaktioner, som kræver 
integration af denne strategi. Platformen identificerer de vigtigste oplysninger om reaktionen og 
processen ved hjælp af en trinvis protokol med de nødvendige værktøjer. Den omfatter anvendelse 
af kinetiske modeller til at karakterisere de reaktionskinetiske forhold, en heuristisk metode til 
screening resiner og en modelbaseret fremgangsmåde til vurdering af processen. Større viden om de 
enzymatiske processer med integrerede porøse resiner kan derfor også opnås, dermed bliver 
effektiviteten af procesudviklingen med hensyn til tid og ressourcer øget. 
Estimering kinetiske modelparametre for enzymatiske reaktioner er temmelig kompleks og fører 
ofte til et spørgsmål om identificerbarhed. For at forstå de forskellige teknikker til at estimere de 
parametre, findes der er en række begreber, disse diskuteres i kapitel fire af denne afhandling. 
Denne viden har bidraget til udviklingen af en robust metode til beregning af kinetiske 
modelparametre for biokatalytiske reaktioner, dette er også blevet offentliggjort i et peer-reviewed 
tidsskrift. 
Screening af resiner til moderat hydrofobe flerkomponentsystemer er udfordrende. Ofte er det sådan 
at kapaciteten af resinet er omvendt proportional med produktselektivitet. Der skal derfor foretages 
et trade-off mellem disse parametre, og dette kan være afgørende ud fra et økonomisk synspunkt. 
En lav resin kapacitet peger mod behovet for højere resin kapacitet, som igen bestemmer 
ligevægtskoncentrationen af substratet i reaktoren og den type reaktor, der kan anvendes (Stirred 
Tank Reaktor eller Packed Bed Reaktor). Tilsvarende lav produkt selektivitet ville resultere i højere 
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produktkoncentration i reaktoren og er derfor således ingen hjælp til at lindre inhiberingen. Yderlige 
betragtninger af resiners stabilitet og omkostninger skal også tages i betragtning i 
screeningsproceduren. Screeningen bliver derfor en multi-objektiv opgave, der skal løses samtidig. 
En sådan strategi er blevet anvendt i den metode, som er formuleret i dette skelet. 
Procesmodellering er et meget effektivt værktøj til at vurdere en proces. Kritisk information om 
processen kan opnås ved hjælp af simulationer, som yderligere kan genbruges, til at tune 
reaktionsbetingelserne eller procesbetingelserne til at opnå det fulde enzym potentiale. State-of-the-
art matematiske teknikker til model kvalitetsevaluering, såsom usikkerheds-og følsomhedsanalyse, 
er blevet inkluderet i denne analyse med henblik på at identificere de vigtigste modelparametre til 
en bedre forståelse af processen. 
Tre casestudier blev brugt til at illustrere anvendeligheden af metodens evne at opfylde forskellige 
objektive krav. Casestudierne blev ikke kun udvalgt for at være industrielt relevante, men også for 
at have visse begrænsninger, dette bidrog til udviklingen af de værktøjer og strategier som er 
behøvet for at overvinde dem. Asymmetrisk syntese af 1-SKHQ\OHWK\ODPLQ PHG Ȧ-transaminse, 
asymmetrisk syntese af 1-methyl-3-SKHQ\OSURS\ODPLQ KM OS Ȧ-transaminse og enantioselektiv 
syntese af 2-octanol med alkohol-dehydrogenase blev valgt. 
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Abbreviation 
[A]  Concentration of substrate A (mM) 
[B]  Concentration of substrate B (mM) 
[P]  Concentration of product P (mM) 
[Q]  Concentration of product Q (mM) 
[E0]  Concentration of enzyme (g/L) 
[I]  Concentration of inhibitory compound (mM) 
Kcat  Rate of catalyst turnover (1/min) 
KM  Michaelis constants (mM) 
Ki  Core inhibition constants (mM) 
KSi  Substrate inhibition constants (mM) 
KEQ  Chemical equilibrium constant 
ȖȜ Reaction direction indicator 
y  Model variable 
ı Standard deviation 
Į significance level 
COV  Covariance 
ș Parameter 
J  Jacobian matrix 
N  Number of data points 
p  Number of parameters to be estimated 
TAm  Ȧ–transaminase 
PLP  Pyridoxal-5'-phosphate 
APH Compound acetophenone 
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IPA                   Compound 2-propylamine 
PEA                compound 1-phenylethylamine 
ACE               compound acetone 
PB             compound 4-phenyl-2-butanone 
MPP             compound 1-methyl-3-phenylpropylamine 
NADP nicotinamide adenine dinucleotide phosphate 
NADP+ - NADPH Nicotine amide 
LbADH alcohol dehydrogenase from Lactobacillus brevis 
GDH glucose dehydrogenase from Bacillus spec 
ON Compound 2-octanone 
OL Compound 2-octanol 
Glu Compound Glucose 
Gdl Compound Gluconic acid-į-lactone 
ADA N-(2-acetamido)iminodiacetic acid 
[APH]  Concentration of acetophenone (mM) 
[IPA]  Concentration of 2-propylamine (mM) 
[PEA] Concentration of 1-phenylethylamine (mM) 
[ACE] Concentration of acetone (mM) 
[ON] Concentration of 2-octanone (mM) 
[OL] Concentration of 2-octanol (mM) 
[Glu] Concentration of glucose (mM) 
[Gdl] Concentration of gluconolactone (mM) 
ISSS in-situ substrate supply 
ISPR in-situ product removal 
Aq aqueous phase 
Sol resin phase 
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Eq Equilibrium 
ȖȜ  reaction direction indicator 
SS                  substrate supply 
PR                        product removal 
Q substrate flux (mmol/min) 
V volume of reactor (L) 
R rate of reaction (mM/min) 
Mass mass of resin (g) 
q* reactant adsorbed per gram of resin (mmol/g) 
C concentration (mmol/L) 
T time (mins) 
kLA mass transfer coefficient (m/min) 
A surface area (m2) 
Qmax maximum adsorption capacity (mmol/g) 
P  Langmuir constant (mmol/L) 
N unit less 
V velocity of reaction (U/mg) 
KM Michaelis constant (mM) 
KP core inhibition constant (mM) 
Ki substrate surplus inhibition constant (mM) 
Superscripts  
F Forward 
R Reverse 
A Compound A 
B Compound B 
P Compound P 
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Q Compound Q 
I Inhibitory compound 
APH Compound acetophenone 
IPA Compound 2-propylamine 
PEA Compound 1-phenylethylamine 
ACE Compound acetone 
ON Compound 2-octanone 
OL Compound 2-octanol 
Glu Compound glucose 
Gdl Compound gluconolactone 
Subscripts  
N number of compounds in reaction 
i, j Index 
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Chapter 1  
Introduction           
   
 
1.1 Biocatalysis 
In recent years there is a great societal expectation that chemists and chemical engineers should 
produce greener and more sustainable chemical processes (Dunn, 2012). Part of this awareness 
comes from increasing pressure from different governmental policies (U.S., E.U. and Japan) to 
synthesize optically pure compounds along with reduced waste. (Muñoz Solano et al., 2012). 
Biocatalysis, with its exquisite properties stereo- and regio- selectivity (Turner and Carr, 2007) and 
potential green (mild operating conditions and reactions performed in water) attributes (Jegannathan 
and Nielsen, 2013; Tao and Xu, 2009; Wu and Tao, 2012), presents it as a sustainable alternative 
(Schmid et al., 2001; Schoemaker et al., 2003). The role of biocatalysis is most evident in the 
pharmaceutical industry (Pollard and Woodley, 2007) and its repertoire currently extending towards 
the industrial synthesis of fine chemicals, agrochemical intermediates, food ingredients and bulk 
chemicals (Busacca et al., 2011; Clouthier and Pelletier, 2012; Jackson, 2011; Li et al., 2010; Nestl 
et al., 2011; Nielsen et al., 2008; Patel, 2011). Some examples of industrial biocatalysis include 
hydroxylation of steroids (Znidarsic-Plazl and Plazl, 2010), penicillin G acylase to make 
semisynthetic penicillin (Elander, 2003), lipase-catalysed resolution of chiral precursors for 
synthesis of diltiazem (a blood pressure drug) (Matsumae et al., 1993), hydroxynitrile-lyase-
catalysed synthesis of intermediates for herbicides (Griengl et al., 2000), carbonyl-reductase-
20
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catalysed synthesis of enantiopure alcohols for cholesterol-lowering statin drugs (Liljeblad et al., 
2009), lipase catalysed synthesis of wax esters such as myristyl myristate or cetyl ricinoleate for 
cosmetics (Hills, 2003). Nature has provided several classes of enzymes which can perform 
complex chemistry in a single step (Wohlgemuth, 2010). In this context the protection and de-
protection in chemical synthesis can be avoided resulting frequently in a single step reaction for the 
generation of new chiral centres via asymmetric reactions, such as reduction with dehydrogenases, 
to resolve an existing chiral center, such as kinetic resolution with a lipase, or, C-C bond formation 
by lyases (Woodley, 2008a). From a process perspective this means that biocatalysis has the 
potential in creating new green chemical synthetic processes. 
The different types of enzymes found in nature have been categorized into six groups based on the 
type of chemistry that can be performed (Webb, 1992) as shown in Table 1.1.  
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Table 1.1 Different categories of enzymes (modified from Faber, 2011) 
Category Enzyme 
examples 
Example 
Oxidoreductase 
Alcohol 
dehydrogenase 
(EC 1.1.1.1) 
O
R1 R2
OH
R1 R2 
Ketone reduction 
Transferase Ȧ-transaminase (EC 2.6.1.18) 
O
R1 R2
NH2
R1 R2 
Transfer of amine groups 
Hydrolases Lipase  (EC 3.1.1.3) 
O
R1 OR2
O
R1 OH 
Hydrolysis 
Lyase Aldolase (EC 4.1.2.13) 
O
OH OH
OH
O
P
OOH
OH
OP
OH
O
OH
OHP
O
O
OH
O
OH
OHP
O
O
OH
OH
O
+
 
Cleaves carbon-carbon bond 
Isomerases 
Phosphoglucose 
isomerase 
(EC 5.3.1.9) 
O
OH OH
OH
OH
OP
OH
O
OH O P
OH
O
OH
O
OH OH
OH
OH
 
Structural rearrangement of isomers 
Ligases 
L-glutamine 
synthetase  
(EC 6.3.1.2) 
NH2
H
HOOC COOH
NH2
H
HOOC
NH2
O  
Forms carbon-nitrogen bond 
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1.2 Challenges in biocatalytic reactions 
The opportunity of incorporating a biocatalytic step in chemical synthesis has been exploited by 
several chemical industries (Wohlgemuth, 2007). Companies such as BASF, DSM and Lonza have 
established large scale (> 1000 tons) production facilities which include a biocatalytic step in the 
process (Ghisalba et al., 2010). An effective integration of a biocatalytic step in chemical synthesis 
is indeed paramount because for many complex syntheses only a few steps will be biocatalytic 
while the majority will be chemical (Hailes et al., 2007). It is realized from the companies’ product 
portfolios and filed patents that the industries use mainly hydrolytic enzymes (lipases) in their 
processes. These enzymes are extremely robust (high stability and tolerance to substrates and 
products), and moreover not constrained by equilibrium limitations. On the other hand, certain 
challenges persist in other types of enzymes (transferases and ketoreductases), thus limiting their 
implementation in industry. Some of the major challenges associated with these enzymes are listed 
in Table 1.2.  
Table 1.2 Challenges for biocatalytic reactions 
Limitations Possible solutions Reference 
Substrate is inhibitory, toxic or 
insoluble 
Use of an auxiliary phases or 
fed batch reactor  
(Hilker et al., 2004) 
Product is inhibitory or toxic Use of in-situ product removal  (Woodley et al., 2008b) 
Equilibrium controlled Use of in-situ product removal or excess of substrate 
(Tufvesson et al., 2012) 
From Table 1.2, it can be seen that a number of challenges are posed towards these enzymatic 
reactions for which possible solutions are suggested. The scope of the list has been limited to 
reaction considerations. Process factors, specifically liquid hetrogeneity due to poor mixing, oxygen 
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transfer rate and pH control should be considered during scaling up of a bioprocess (Marques et al., 
2010b; Takors, 2012; Tufvesson et al., 2010). Similarly, further enzyme related limitations such as 
poor enzyme stability and low activity (Ma et al., 2010; Pavlova et al., 2009; Sheldon, 2007) have 
to be taken into account. In the following subsections the challenges encountered in biocatalytic 
reactions will be discussed in more details.  
1.2.1 Substrate concentration 
In many cases, the appropriate substrate feeding technology is dependent on the type of biocatalyst, 
either in the form of isolated enzyme, immobilized enzyme or whole cell. The different biocatalysts 
face different challenges for which tailored solutions have to be provided. For instance, isolated 
enzyme benefits the reaction with an easy control of kinetics (Woodley, 2006). However, the 
enzyme is often denatured in the presence of high concentration of non-natural substrate or organic 
solvents (Kohlmann et al., 2011). The stability of the biocatalyst and tolerance to high substrate 
concentration can be enhanced by means of immobilization, such as adsorption on a porous support 
(Kourkoutas et al., 2004), entrapment inside a polymer (Cardenas-Fernandez et al., 2012) or by 
crosslinking the enzyme (Sheldon, 2011). The stability in many cases is greatly enhanced but it can 
lead to mass transfer limitations, if the reaction is fast. Whole cells are the most economical choice 
with respect to the absolute cost of the catalyst (Tufvesson et al., 2011) but could be challenged 
with increased mass transfer limitations as well as undesired side reactions. Some of the major 
challenges which are characteristic of biocatalytic reactions with regards to substrate concentration 
are highlighted in Table 1.3. 
 
24
6 
 
Table 1.3 Challenges associated with biocatalytic reactions with regard to substrate concentration 
Challenges Problem Reference 
Low enantiomeric  
excess 
High substrate concentration 
could lead to low substrate 
selectivity 
(D'Arrigo et al., 2010; Houng 
and Liau, 2003) 
Substrate inhibition/toxicity 
 
The rate of reaction is 
compromised at high 
concentrations of the substrate  
(Al-Haque et al., 2012; 
Rojanarata et al., 2004) 
Equilibrium limitations Adding excess of substrate in not 
sufficient for KEQ lower than 0.5 
(Tufvesson et al., 2011) 
Downstream processing 
 
Product intensity is low because 
of poor aqueous solubility 
(Baldwin and Woodley, 2006) 
Biocatalyst stability Enzymes are not evolved for 
high substrate concentrations 
(Schmoelzer et al., 2012) 
1.2.2 Product concentration 
For a biocatalytic process to be industrially feasible, high product concentration has to be achieved. 
For instance in the pharmaceutical industry a minimum of 50 – 100 g/L of product concentration is 
required for it to be considered for scaling-up (Pollard and Woodley, 2007), while for fine and bulk 
chemicals the minimum requirements is many fold higher (Panke et al., 2004; Straathof et al., 
2002). Such high concentrations are required to minimise downstream processing cost (Luetz et al., 
2008; Ruinatscha et al., 2006; Straathof et al., 2002; Woodley, 2008b). However, operating a 
reaction at such concentration, in many cases may display inhibitory effects (reversible) or could be 
even toxic (irreversible) (Lye and Woodley, 1999). Similarly, effective product recovery can be 
limited due to low product intensity leading to the requirement of multiple steps for product 
recovery. Furthermore, in some cases product degradation can be a limitation for which additional 
measures have to be taken to remove the product simultaneously as the reaction proceeds (Woodley 
et al., 2008a). Some of the major challenges which are characteristic of biocatalytic reactions with 
regards to product concentration are highlighted in Table 1.4.  
25
7 
 
Table 1.4 Challenges associated with biocatalytic reactions in regards to product concentration 
  Challenges Problem Reference 
Product inhibition/toxicity 
 
The rate of reaction is 
compromised at high 
concentrations of the product  
(Al-Haque et al., 2012; Rojanarata 
et al., 2004) 
Product degradation 
 
High product concentration is 
limited by unstable product 
(Hofstetter et al., 2004) 
Product separation Multi-step separation required 
if product concentration is low 
(Bruggink et al., 2003) 
1.2.3 Equilibrium limitations 
No reaction is truly irreversible. Reactions called irreversible occur very far from the equilibrium or 
the reaction is "pulled" (for example carbon dioxide cleaved off from a substance and then leaving 
the reaction system) so that only reaction in one direction can be observed. Typically in biocatalytic 
processes, as mentioned earlier, hydrolytic enzymes have been studied the most (Straathof et al., 
2002). The concentration of water is 55 M (1000 g/L) providing the necessary push to make the 
reaction irreversible. However for other industrially important enzyme types such as transferases 
and lyases, water is not a substrate. Therefore the maximal conversion is bound by the equilibrium 
constant, KEQ. This parameter is independent of the biocatalyst and therefore protein engineering 
techniques cannot overcome this hurdle. Process strategic solutions are required to drive the 
reaction to product synthesis (Tufvesson et al., 2011). Recent publication illustrated methods to 
quantify the equilibrium constant value experimentally (Tufvesson et al., 2012), using group 
contribution method (Jankowski et al., 2008; Rother et al., 2010) and by calculating it from the 
kinetic model parameters using the Haldane relationship (Al-Haque et al., 2012). It is a powerful 
parameter which can indicate the required effectiveness of the different process strategies to 
displace the equilibrium towards the synthetic direction. Table 1.5 lists the reaction equilibrium 
constant value for different substrate combinations. From Table 1.5 it can be seen that the KEQ value 
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can range from very small to larger than unity, providing indications that some process strategies 
need to be applied to attain yields not limited by equilibrium. 
Table 1.5 Reaction equilibrium value for substrates of different enzyme classes in the synthetic 
direction  
Enzyme Substrate 1 Substrate 2 KEQ* Reference 
alcohol dehydrogenase  
(EC 1.1.1.2) 
1-Phenyl-1-pentanone 2-propanol 0.48 (Tewari et al., 2006) 
Ȧ-transaminase 
(EC 2.6.1.X) 
Cetophenone 2-propylamine 0.03 (Tufvesson et al., 
2012) 
triacylglycerol lipase (EC 
3.1.1.3) 
Butyl decanoate H2O 0.71 (Tewari and Bunk, 
2001) 
carnitine dehydratase 
(EC 4.2.1.89) 
L-carnitine N/A 1.5 (Jung et al., 1989) 
xylose isomerase  
(EC 5.3.1.5) 
D-Glucose  N/A 1.21 (Converti and 
Borghi, 1997)  
isoleucine-tRNA ligase 
(EC 6.1.1.5) 
L-isoleucine ATP + 
tRNAIle 
0.61 (Airas, 2006) 
*value is dependent on the reaction condition. N/A stands for not applicable 
1.3 Proposed strategies to overcome biocatalytic reaction 
bottlenecks 
1.3.1 Substrate feeding 
The substrate feeding strategy for biocatalytic reactions depend on the natural, pre-existing phase of 
the substrate (Kim et al., 2007).  Different methods, such as fed-batch or adding an auxiliary phase, 
can be applied for controlled substrate supply if the substrate has low aqueous solubility or is 
toxic/inhibitory at high concentration towards the biocatalyst.  The various substrate delivery 
techniques are shown in Figure 1.1. Different configurations for substrate supply have its 
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limitations, as listed in Table 1.6. Careful consideration should be taken to select the substrate 
supply technique.  
Batch reactor Fed-batch reactor
Feeding
Batch reactor with 
auxiliary phase
Continuous reactor linked 
with auxiliary phase
Initial feed
 
Figure 1.1 Substrate feeding techniques (shaded area indicates substrate loaded auxiliary phase) 
In a batch reactor, all the substrate is fed at the start. If the substrate is liquid with high aqueous 
solubility and negligible inhibition at required substrate concentration then a batch mode would be 
feasible. However, if the substrate poses inhibitory effects or has low aqueous solubility then it 
should be considered to feed the substrate in a fed-batch mode (Amanullah et al., 2002; Doig et al., 
2002). The complexity arises when the substrate is solid. Dissolution of solid substrates can often 
limit the reaction (Wick et al., 2002) and therefore it would be required to dissolve the substrate in a 
water-miscible co-solvent if a two phase reaction is not desired.  
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The use of an auxiliary phase to supply substrate is an alternative option for substrate feeding as a 
means of controlling the concentrations around a biocatalyst (Dafoe and Daugulis, 2011; Straathof, 
2003). The auxiliary phase can be solid (porous resin), liquid (organic solvent and ionic liquid) or 
gas (Daugulis and Janikowski, 2002; Ferloni et al., 2004; Lilly, 1982; Roberts and Lye, 2002; 
Weuster-Botz, 2007) for which special considerations have to be taken into account. Further details 
about auxiliary phase will be explained in the following chapter. 
Table 1.6 Substrate delivery configurations 
Techniques Methodology Limitations References 
Batch All substrates are fed at 
start-up 
Not possible to supply 
substrate above critical 
concentration 
(Walsgrove et al., 
2002) 
Fed-Batch Substrate/co-substrate is 
fed over a time interval 
Solubility of substrate in 
feed sets limit of 
aqueous concentration in 
reactor  
(Alphand et al., 
2003) 
Organic Solvent Substrate is fed via 
diffusion 
Organic solvent may be 
toxic towards biocatalyst 
and also increases 
complexity of product 
recovery 
(Truppo et al., 
2012) 
Ionic liquid Substrate is fed via 
diffusion 
Ionic liquid has to be 
recycled more than 200 
times to be considered 
economic 
(de los Rios et al., 
2012) 
Resin Substrate is fed by 
desorption and diffusion 
Vigorous stirring may 
damage the resins 
(Held et al., 2000) 
1.3.2 In-situ product removal (ISPR) 
An innovative technique to overcome product inhibition is to remove the product in-situ during 
reaction (Freeman et al., 1993; Stark and von Stockar, 2003; Woodley et al., 2008a). In this way the 
biocatalyst experiences low product concentration and simultaneously leads to higher product 
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yields, because in-situ product removal is applied to minimize product inhibition or degradation, or 
reaction reversibility (Woodley et al., 2008b). The product removal can be carried out internally or 
externally as shown in Figure 1.2. In Figure 1.2 the ISPR is shown as a batch process, however, it is 
possible to continuously extract product out of the removal system eg. pervaporation.  
Direct 
contact
Indirect 
contact
Internal External
 
Figure 1.2 Schematic flow-sheet showing internal and external modes of ISPR operation (shaded 
area indicates the ISPR) 
Implementation of an ISPR technique is of key importance for many reaction systems. Many 
examples can be seen where the indroctuion of an ISPR technique has increased product yields by 
many folds (Bechtold and Panke, 2009; Heerema et al., 2011; Suwannakarn et al., 2009; Vilt and 
Ho, 2011). However, what is more important is the need to understand how to select between them 
confidently and rapidly.  
Lutze et al., 2012 presented a methodology for the selection of processes based on integrating unit 
operations (reaction – separation) (Lutze et al., 2012). Alternatively, the selection can be done based 
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on the physical and chemical properties of the different components (Jaksland et al., 1995; Lye and 
Woodley, 1999). The different techniques applicable to biocatalysis are listed in Table 1.7. 
Table 1.7 In-situ product removal techniques applicable for biocatalysis 
Separation basis Technique Important properties References 
Volatility Reactive distillation 
Evaporation 
Pervaporation 
Boiling point (Etschmann et al., 
2005; Tang et al., 
2005; Yun et al., 
2004) 
Solubility 
 
 
Crystallization 
Precipitation 
Extraction 
Stripping 
Absorbtion  
 
Solubility point 
 
Partition coefficient 
(Buque-Taboada et 
al., 2006) 
(Khan and 
Daugulis, 2011a; 
Lye, 1997; Yun 
and Kim, 2008) 
Molecular weight 
 
Charge/hydrophobicity 
Filtration 
Membrane 
Ion exchange 
Electrodialysis 
Adsorption 
Size, molecular weight 
 
pKa, LogP 
(Heerema et al., 
2011) 
(Dafoe and 
Daugulis, 2011) 
Chemistry Cascade reaction 
 
Gibbs energy of 
formation 
(Karmali and 
Coelho, 2011; Li et 
al., 2012) 
Other Hydrolysis, cyclisation, 
complexation 
 (Liting et al., 2009; 
Truppo et al., 
2010) 
1.3.3 Protein engineering 
Protein engineering can be used to develop enzymes by either modifying the protein structure of the 
enzyme. The development of improved enzymes requires advanced knowledge in protein 
engineering (including directed evolution) (Kazlauskas and Bornscheuer, 2009; Turner, 2009), gene 
synthesis, sequence analysis, bioinformatics tools (Rothlisberger et al., 2008) and computer 
modelling (Bornscheuer et al., 2012). The consequence of this is that new and useful libraries of 
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enzymes can be ‘designed’ which can perform efficient catalysis in conditions that nature did not 
intend it to do. The biocatalyst can be engineered to fit the process conditions (Figure 1.3).  
Non-ideal biocatalyst
Process constraint
Compromised 
process
Engineered 
biocatalyst
Ideal process
Process constraint
Process constraint
Process 
engineering
Protein 
engineering
Ideal process
 
Figure 1.3 The search for the ideal process 
The implications are that the biocatalyst can be designed to withstand high concentrations of 
substrate and product and even to catalyse reactions under elevated temperature and non-
conventional media. Some examples can be seen in the synthesis of Januvia sitagliptin, a drug to 
treat type 2 diabetes, using (R)-transaminase. In that case, the enzyme was improved by directed 
evolution with initial activity 40,000 folds higher than the wild type and moreover was tolerant to 
around 100 g/L of substrate, temperature of around 60 oC and 20% (V/V) co-solvent DMSO (Savile 
et al., 2010). A further example can be seen in the synthesis of (R)-4-cyano-3-hydroxybutyric acid, 
precursor for the cholesterol lowering drug Lipitor, using nitrilase afforded eanantioselectivity of 
only 88%. Through gene site saturation mutagenesis, the enantiomeric excess could be improved to 
98.5% at 3 M substrate loading and a volumetric productivity of 619 g/L-day (DeSantis et al., 
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2003). However, there are also limitations for engineering enzymes and the protocol for finding the 
ideal biocatalyst requires extensive efforts (Wenda et al., 2011) and needless to say the 
thermodynamic limitations cannot be overcome with this strategy. For pharmaceutical industries, 
where the life of the product is governed by the patent lifetime, this results in a narrow window of 
action to define and develop a suitable process (Pollard and Woodley, 2007). It would therefore 
require a synergy between the protein and process engineers to reduce the time for a product to 
reach market (Wohlgemuth, 2011). Protein engineering is a field by itself and is not within the 
scope of this project. For further details please refer to the following publications (Bommarius et al., 
2011; Bornscheuer et al., 2012; Dalby, 2011; Lutz, 2010; Strohmeier et al., 2011; Turner, 2009). 
1.3.4 Process engineering for equilibrium displacement 
Equilibrium displacement for reactions with a KEQ value lower than 81 (in the synthetic direction) is 
required in order to achieve 90% yield (assuming the reaction is two substrate – two product system 
with a stoichiometry of 1 for all components). Process strategies therefore have to be adopted to 
overcome these reactions limited by equilibrium constraints. The effectiveness of the strategy 
required depends on the KEQ value. For example, for the same scenario mentioned above, if the KEQ 
value is close to 1 then adding a 10 fold excess of the substrate or co-substrate would be sufficient 
to shift the equilibrium. Moreover for reactions with unfavourable KEQ value of below 0.5, other 
strategies of selective removal of product or co-product have to be introduced (Truppo et al., 2010; 
Yun and Kim, 2008). In many cases multiple strategies are required including adding an excess of 
substrate and in-situ product or co-product removal (Savile et al., 2010).  Alternatively the choice of 
substrate could be modified such that the product formed goes through a rapid chemical 
modification (hydrolysis or cyclisation). Table 1.8 lists the various process strategies that can be 
used for shifting the equilibrium towards the synthetic direction 
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Table 1.8 Process strategies to shift the equilibrium towards product synthesis 
Basis Comments References 
Excess of substrate Effective for reactions 
with KEQ greater than 0.5 
(Savile et al., 2010) 
In-situ product removal 
physicochemical based 
 
Needs to be highly 
selective. Applicable for 
reactions with KEQ 
greater than 0.04 
 
(Woodley et al., 2008b) 
Enzymatic KEQ of second enzyme 
has to be greater than the 
first one 
(Cassimjee et al., 2010; 
Truppo et al., 2009) 
 
Chemical Second reaction has to be 
thermodynamically 
favourable 
(Li et al., 2012) 
Spontaneous hydrolysis or 
cyclisation or complexation 
Depends on the choice of 
substrate 
(Schroen et al., 2002; 
Truppo et al., 2010) 
Altering reaction condition   
Temperature KEQ increases with 
increasing temperature 
for endothermic reactions 
(Daniel et al., 2008) 
pH The redox potential is 
lower at higher pH 
(Hollmann et al., 2010) 
 
1.4 Integrating porous resins in enzymatic processes 
From the previous section, it could be seen that substrate feeding and in-situ product removal are 
two strategies which when incorporated in biocatalytic reactions can overcome substrate and 
product inhibition respectively. An interesting option to integrate these two strategies is to introduce 
an auxiliary phase into the bioreactor. Generally an organic solvent has been considered as an 
auxiliary phase in the bioreactor to overcome kinetic limitations (Ni and Xu, 2012; Schewe et al., 
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2009; Yang et al., 2009). However, organic solvent exhibits certain operational challenges such as 
biocompatibility (Prpich and Daugulis, 2004), emulsification (Guieysse et al., 2005) and phase 
toxicity (Baldascini and Janssen, 2005). Hydrophobic ionic liquids have also been considered as a 
replacement for organic solvents. However the major drawback being high cost of ionic liquids 
limits its use in industry. Similarly, amorphous polymers have also been applied as an option as it is 
cheap and at the same time the chemistry of the polymer can be modified to fit the requirement of 
the process (Craig and Daugulis, 2013; Dafoe and Daugulis, 2012). Recently, an alternative 
auxiliary phase being porous resins has gained considerable recognition (Brenna et al., 2012; Hilker 
et al., 2008; Lee et al., 2011). Resins are generally inert in the bioconversion, offers simpler 
operational handling and product isolation (filtration).In this thesis the focus therefore has been 
directed towards porous resins as an auxiliary phase.  
Resins have previously been used in combinatorial synthesis for supplying covalently attached 
substrate for catalysis on the surface of the resin (Basso et al., 2006; Humphrey et al., 2003; Laurent 
et al., 2008). Alternatively, the use of resins has also been focused on as a method for in-situ 
product removal (Guo et al., 2010; Liu et al., 2011; Lye and Woodley, 1999; Nielsen and Prather, 
2009). However, selection of a suitable product selective support is difficult and although a few 
processes operate in industry (Burns and Wong, 2002; Johnson et al., 2000), non-selective resins 
have wider potential application (Brenna et al., 2012; Schmoelzer et al., 2012; Shorrock et al., 
2004). Indeed the implementation of this strategy of integrating resins has extended to different 
types of biocatalytic reactions including oxidation (Hilker et al., 2008; Houng and Liau, 2003), 
reduction (Brenna et al., 2012; Schmoelzer et al., 2012) and hydrolysis (Lee et al., 2011). The 
objective of the resin is to act as a carrier for the inhibitory substrate and moreover to achieve high 
substrate loading. An initial equilibrium between the resin and the aqueous substrate concentration 
is displaced with biocatalytic consumption of substrate from the aqueous phase. Additional 
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substrate diffuses from the resin to accomplish in-situ substrate supply (ISSS). Similarly, as the 
product is formed, it partitions back into the resin to accomplish in-situ product removal (ISPR). In 
this way the full potential of the biocatalyst can be harnessed by enabling the biocatalyst to 
experience concentrations beneath the critical concentration, Ccrit (Hilker et al., 2004; Kim et al., 
2007; Vermue et al., 1993). Following synthesis, the resin will be separated by filtration prior to 
elution of the product (Hilker et al., 2005; Rojanarata et al., 2004; Vicenzi et al., 1997). Figure 1.4 
illustrates the general scheme.  
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The rate of supply is a key issue as the substrate supplied should complement the rate of product 
formation. Figure 1.5 illustrates the required rate of supply for a hypothetical case. The rate of 
supply (rate 1) moderated by the transfer constant, kLA, needs to intersect the enzymatic reaction 
rate (rate 2) at a point where the rate is not limited by substrate availability or compromised by 
inhibition. During the time course, the driving force will reduce thus limiting substrate availability. 
Measures have to be taken to increase the mass transfer rate by either replenishing the resin with 
more substrate or alternatively increasing the mechanical stirring speed. 
Figure 1.4 Principal of substrate supply and product removal using resin 
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Figure 1.5 Substrate supply corresponding to rate to reaction 
In many cases this has been applied effectively for overcoming inhibition by both substrate and 
product. An industrial example of such systems can be seen in the Lilly process for the production 
of LY300164 (a drug for improving Parkinson disease symptoms) using resin as the auxiliary phase 
(Vicenzi et al., 1997). The reactor was set up as shown in Figure 1.6 
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filter reactor
agitator
mesh
Step 1 reaction
resin, substrates and 
biocatalyst
Step 2 removal of spent media
resin and 
biocatalyst
Spent media
Step 3 removal of biocatalyst
resin
biocatalyst and water
water
Step 4 product elution
resin
product and acetone
acetone
 
Figure 1.6 Operation of agitated filter for resin-based bioreactor 
In the Lily process, a moderately non polar resin (XAD -7) with roughly equal affinity for both 
substrate and product was selected for the process. The entire process takes place in a single vessel. 
A mesh is used in order to retain the resins in the vessel for re-using. An agitator with low speed is 
used for mixing during the reaction. For separation of the resin from the micro-organism post 
reaction, water is added and the torque of the agitator is increased for washing the resins. The 
agitator is then raised allowing the resin to settle like a packed bed. Acetone is then used for eluting 
the product from the resin.  
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1.5 Overall framework for integrating resins in an enzymatic 
process 
When, how and why? The three basic questions that arise when considering implementing any 
process strategy. Introducing resins is a very interesting option to overcome kinetic limitations, but 
perhaps it is not applicable in all cases. If a resin is required then how can one choose the resin in a 
logical way? Some guidelines need to be in place in order to guide the selection procedure. 
Furthermore the critical question is does integrating resins prove to be beneficial in terms of yield? 
These three fundamental questions need to be addressed in a systematic way. It would be desirable 
to have logical framework which would incorporate a heuristic method of making rule of thumb and 
thus assist in making an educated decision. The framework should be able to state when resins 
would be required based on a quantitative value. An example can be seen in the reduction of o-
chloroacetophenone using whole cells expressed with xylose reductase and formate dehydrogenase. 
The half-life of the enzymes in the cells drastically dropped at concentrations of substrate and 
product exceeding 3 mM (Schmoelzer et al., 2012). In such cases, the presence of 30 % V/V resin 
Amberlite XAD7HP kept the aqueous concentration below toxicity limits and moreover improved 
the bio-reduction yield about 6 folds. In another study of the Baeyer-Villiger oxidation of 
bicyclo[3.3.0]hept-2-en-6-one similar to the previous example was limited by substrate inhibition at 
substrate concentrations above 3 g/L and product inhibition at product concentrations above 4 g/L. 
Integrating the reactor with 100 g/L of resin Optipore-L493 kept the ketone concentration below 1 
g/L and moreover improved the yield from negligible to 83% (Simpson et al., 2001). Both these 
examples provide evidence that a resin was required to improve the synthetic yields. The 
framework should be able to heuristically guide the selection of the resin.  Prior research has 
focused on selecting resin based on affinity (Vicenzi et al., 1997; Rojanarata et al., 2004) and 
working load (gsubstrate/gresin) (Hilker et al., 2004; Bechtold et al., 2012). These kinds of screening 
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worked effectively for single substrate and single product system (reduction and oxidation 
reactions), but for other industrially relevant enzymes such as transferases where it deals with two 
substrate and two product systems (Bornscheuer et al., 2012; Faber and Kroutil, 2005; Woodley, 
2008), selecting a resin based on a single parameter alone would not be adequate. The problem 
becomes multi-objective function where other practical consideration of selectivity and cost has to 
be included into the objective function. Finally the question of why should this strategy be selected? 
The process has to be evaluated in terms of either improved yield (gproduct/gsubstrate) or 
(gproduct/genzyme). A predictive model can provide such information and moreover also help in making 
“what if” analyses i.e. predict output for different process scenarios. “What if” analysis can help in 
identifying the bottlenecks of the strategy (e.g. low capacity of resins) or to help in optimizing the 
process (e.g. improved substrate mass transfer by using polymers with larger surface area 
(Rehmann and Daugulis, 2007). In order to address these questions a methodological framework 
has been developed. It follows  a hierarchical approach where the output of each step becomes the 
input of the subsequent step. Figure 1.7 illustrates the work flow of the framework for integrating 
resins in an enzymatic process. 
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Figure 1.7 Methodological framework for integrating resins in a bioreactor 
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1.6 Description of proposed framework 
1.6.1 Step 1. Select reaction 
A reaction scheme has to be selected which will form the starting point for developing the process. 
The substrates and corresponding products need to be identified. In most cases however, the 
reaction of interest is given based on the project description. The selection can be guided by 
economics, commercial importance, or environmental considerations, substrate and product 
replacements. For example the production of high fructose corn syrup for making sweeteners from 
glucose using immobilized glucose isomerase has completely replaced the chemo-catalytic process 
because of its cost and environmental considerations (Jensen and Rugh, 1987).   
1.6.2 Step 2. Evaluate reaction kinetics 
The key characteristics of the reaction in terms of substrate (Cs,crit) and product (Cp,crit) inhibition 
and the aqueous solubility of substrate (Cs,sat) and product (Cp,sat) can define the process 
constraints. Figure 1.8 illustrates the operability area for operating a reaction. Knowledge of the 
critical concentrations are important information that can set targets for which parameter to 
optimize for protein engineers (Bornscheuer et al., 2012; Martin et al., 2007). Similarly the 
knowledge of the saturation concentration of the substrate and product coupled with the critical 
concentration of the substrate and product can set targets for reactor selection. In most cases the 
search for the ideal process has to be done in synergy between protein and process engineers to 
combat the process constraints  (Savile et al., 2010; Schmoelzer et al., 2012). In order to gather 
information of substrate and product inhibition experimental investigation can be performed. 
Exhaustive numbers of experiments are required to gather this information, alternatively a kinetic 
model can be used not only to optimise the experimental efforts but also be able to predict outputs 
for new conditions (Al-Haque et al., 2012). 
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Figure 1.8 Operability space for substrate and product concentration. (Dashed line indicate the 
limits of substrate and product concentration) 
 Tool 1: Kinetic modelling 
Kinetic models, either mechanistic or empirical, are a powerful tool readily applied in process 
systems engineering for multiple purposes such as process control, design and analysis (Sin et al., 
2009). A validated model is useful for predicting reaction performance under different scenarios.  
Some likely example can be seen in the reactor selection for L-erythrulose synthesis (Vasic-Racki et 
al., 2003a), process optimization for the synthesis of neuraminic acid (Zimmermann et al., 2007). 
Kinetic modelling of a biocatalytic reaction can range from simple Michaelis-Menten kinetic model 
to much more complex model such as ping-pong bi bi. These kinetic models contain a significant 
number of parameters which are often highly correlated leading to issues with parameter 
identifiability (Santacoloma et al., 2010). Nonetheless a number of different methodologies have 
been proposed in order to minimize the experimental effort for estimating kinetic parameters 
(Vasic-Racki et al., 2011). Traditional approaches of using Levenspiel or Hanes plots can be 
considered obsolete because of the large degree of error that is incorporated in the linearization 
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(Nielsen et al., 2003). Methodologies based on non-linear optimization have been applied based on 
sensitivity analysis (Alcazar and Ancheyta, 2007) and assuming negligible inhibition region (Chen 
et al., 2008). Recently, a new and robust methodology has been proposed for estimating kinetic 
model parameters by model decomposition and multiple parameter initializations in a step-wise 
approach. The approach was validated using a Ȧ-transaminase catalysed reaction to prove its 
reliability (Al-Haque et al., 2012).  
Tool 2: Physical property database 
The saturation concentration of the substrate and product are important data that have to be 
collected. Substrate fed beyond this concentration will operate in a two phase (dispersion for liquid 
substrates and slurry for solid substrates). If desired to achieve final product concentration beyond 
saturation point, it would require a substrate feeding and product removal strategies need to be 
implemented. These data can be collected from different physical property databases (e.g. NIST and 
ICAS) or estimated using property modelling (O'Connell, 2009).   
1.6.3 Step 3. Select process options 
Based on the inputs from step 2, different decisions have to be made to select the appropriate 
process configuration. A decision tree as shown in Figure 1.9 has been constructed based on the 
critical concentration for substrates and products coupled with their respective aqueous solubility. 
The goal of this tree is to provide guidance in the type of process that can be selected. When the 
critical concentration of the substrate lies below the solubility limit, substrate feeding strategies 
would be suggested (Schmoelzer et al., 2012). Likewise, a product removal strategy has to be 
considered if the critical concentration of the product is below the solubility limit of the product 
(Stark and von Stockar, 2003). In certain regions where the desired operating point is above the 
critical concentration for both the substrates and products then an integrated substrate feeding and 
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product removal strategy could be considered (Brenna et al., 2012; Hilker et al., 2005). Moreover, if 
it is required to operate in a region beyond the solubility limit then the reactor can be operated in 
two phase system i.e. either as a slurry (if substrate is solid) or dispersion (if substrate is liquid). 
However, in some cases working in slurry system might pose substrate availability limitations 
(Wick et al., 2002) and similarly dispersion might denature the biocatalyst (Kohlmann et al., 2011), 
in such situations a substrate feeding strategy should be considered as well to operate the reactor in 
a single phase. For formulation Figure 1.9, the following assumptions were made: 
x The catalyst is not denatured in a multiphasic system 
x Reaction equilibrium is not considered here 
Based on Figure 1.9, it can be seen that in some cases substrate feeding is required, while in other 
cases ISPR is required and for few cases an integrated approach of substrate feeding and product 
removal would be suggested. In some cases it can be seen that a two phase reactor where either the 
substrate or product concentration is beyond saturation point. In order to design the process, certain 
type of data re required. In cases where a combination of the processes are to be integrated (e.g. 
continuous substrate feed coupled with product precipitation), data is required not only for the 
substrate feeding but as well as product precipitation. Table 1.9 suggests the data that have to be 
collected for the different processes options.  
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Table 1.9 Data collection for different process options 
Process options Data requirements Reference 
Batch reactor 1. Critical concentration of substrate 
2. Critical concentration of product 
(Chin-Joe et al., 2002; Dahl et 
al., 1999) 
Substrate feeding  
(Fed batch reactor) 
1. Feed concentration 
2. Rate of reaction (mM/min) at desired 
aqueous substrate concentration to 
adjust feeding rate 
3. Critical concentration of product 
(Amanullah et al., 2002; d'Anjou 
and Daugulis, 2001; Doig et al., 
2002) 
Packed bed reactor 1. Critical concentration of product to 
adjust length of reactor 
2. Catalyst deactivation profile to adjust 
substrate flow rate 
(Bhattacharya et al., 2004) 
Continuous stirred 
tank reactor (CSTR) 
1. Feed concentration 
2. Critical concentration of substrate 
3. Critical concentration of product 
4. Catalyst deactivation profile to adjust 
substrate flow rate 
(Visser et al., 2010) 
In-situ product 
removal 
1. Volatility (distillation, gas stripping)  
2. Molecular weight (membrane, 
pervaporation, centrifugation) 
3. Solubility (extraction, bi-phasic 
system, precipitation, crystallization) 
4. Charge and hydrophobicity (ion 
exchange, adsorption) 
(Dafoe and Daugulis, 2011; Gao 
and Daugulis, 2009; Liting et al., 
2009; Schmoelzer et al., 2012; 
Steenkamp and Brady, 2008; 
Valadez-Blanco and Livingston, 
2009) 
Integrated substrate 
feeding and product 
removal 
1. Capacity of product 
2. Selectivity of product 
3. Partitioning of components 
4. Mass transfer rate of substrate supply 
and product removal 
(Hagstrom et al., 2011; Heerema 
et al., 2011; Hilker et al., 2004; 
Houng and Liau, 2003)  
Two phase  
(substrate) 
1. Phase toxicity 
2. Rate of dissolution 
3. Substrate solubility 
(Ulijn et al., 2003; Yang et al., 
2009) 
Two phase  
(product) 
1. Phase toxicity 
2. Product solubility 
(Kumar and Bhalla, 2005; 
Schroen et al., 2002) 
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1.6.4 Step 4. Select resin 
The resin has to be loaded with concentration of substrate to match the minimal industrial 
requirements. Subsequently, the substrate must partition from the resin to the aqueous phase at 
concentration within the operability space. The information about the operability space is acquired 
from step 2. Furthermore, with biocatalytic conversion, the formed product must partition back to 
the resin to maintain aqueous product concentration within the operability space. The selected resin 
has to be biocompatible i.e. be inert to the biocatalyst and moreover be cost-effective. In order to 
select the appropriate resin, an experimental guideline for pre-screening of resins has been 
developed.  
Tool 1: Screening resins   
The screening of resin is done in a heuristic approach where the decisions about selecting the resin 
is made based on the fulfilment of certain criterion specific for substrate supply and product 
removal strategy. The criterions include resin capacity, mass transfer rate and cost. More details 
will be discussed in the following chapter.  
In order to compare resins, quantifiable values are required. The objective of this tool is to provide 
guidelines of the type of experiments required and what to expect from each set of experiments. For 
example, the substrate capacity of the resin can be measured by designing an experiment where the 
amount of resin is fixed while a certain concentration of substrate (solubility limit) is added to the 
vial containing the resins. The temperature and pH has to be fixed in accordance with the optimal 
biocatalytic reaction conditions. The concentration the substrate in the resin can be determined by 
mass balance. 
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1.6.5 Step 5. Evaluate process 
With a reactor integrated with resins, it is required to evaluate the process. Key parameters such as 
mass transfer rate and improvement in product yield needs to be evaluated. Furthermore, greater 
understanding about the integration can be made and the bottlenecks can be identified, for example 
the required partitioning coefficient of the product might not be adequate for maintaining product 
concentration within the operability space. Recommendations can be made on how to optimize the 
process by for example predicting optimal resin amount (V/V). These kinds of analyses can be 
made using a model based approach. The validated kinetic model along with an appropriate 
isotherm model and mass transfer model can provide the knowledge required for evaluating an 
integrated resin bioreactor. On the other hand for processes that do not require resins, the process 
model can be used for optimizing the reaction or guiding reactor selection. 
1.7 Objective and motivation 
There is a clear motivation to incorporate a biocatalytic step within many organic synthesis. The 
high enantioselectivity of biocatalysts makes it extremely valuable in the fine chemical sector, and 
in particular in the production of pharmaceutical intermediates. However, there are certain 
limitations to some biocatalysts as was outlined earlier. Henceforth possible solutions have been 
suggested to exploit the full potential of the biocatalyst to aid in achieving the required process 
intensity. Integrating resins is inevitably a strong tool that can be applied to processes to overcome 
the kinetic limitations and enable high substrate loading of poor water soluble substrates. Resins 
have clear advantage over other auxiliary phases such as organic solvents. This strategy has been 
applied effectively to single substrate – single product systems (oxidation, degradation and 
hydrolysis). However, this concept has not been extended to other industrially relevant reactions 
which are two substrate – two product systems.  
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The objective of this Ph.D. thesis is to explore resin based auxiliary phases for multi-component 
systems, both conceptually and practically. In this manner, a generic platform can be established for 
biocatalytic reactions that require the integration of this strategy. It would be desirable to create a 
framework which can identify the key information about the reaction and the process in a 
systematic manner. Specific tools to assist the framework should be developed for characterizing 
the reaction kinetics, screening resins and evaluating the process. In this way greater knowledge 
about the enzymatic process with integrated porous resins can be gained and thus contribute with 
increased efficiency of process development with respect to time and resources. The framework 
should be validated with relevant case studies.  
1.8 Rationale for case studies 
In order to test the methodology three case studies have been selected. The case studies deal with 
the production of chiral molecules which in 2010 accounted for more than 40% of the world drug 
market of 856 bn. USD (Kaspereit et al., 2012). Each of the case studies contribute in gaining 
further understanding of the process and refinement of the framework in making the methodology a 
generic platform for all biocatalytic reactions and not specific for a single biocatalytic process.  
The three case studies are: 
Case study 1: Asymmetric synthesis of 1-phenylethyl amine using Ȧ-transaminase 
Case study 2: Asymmetric synthesis of 4-phenyl -2- butylamine using Ȧ-transaminase 
Case study 3: Enantioselective synthesis of 2-octanol using alcohol dehydrogenase 
The first two case studies deal with the asymmetric synthesis of chiral amines using an isolated 
enzyme transaminase. Many of the challenges encountered with transaminases are common to other 
biocatalytic processes and consequently many parallels can be drawn to other biocatalytic reactions 
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for the production of chiral molecules (e.g. chiral alcohols). Case studies 1 and 3 were selected for 
testing kinetic modelling methodology. Furthermore case studies 1 and 2 present a case in which the 
aqueous solubility of the substrate was low and displayed substrate and product inhibition. 
Consequently, the opportunity of introducing resins to achieve high substrate loading and overcome 
substrate and product inhibition was tested. Finally case study 1 and 3 were used for assessing and 
optimizing the process.  
In order to give an overview of the contribution of the case studies in this thesis, Table 1.10 
summarizes all the case studies, including the type of information that was found in the scientific 
literature and in which steps of the framework did it contribute.  
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Table 1.10 Compilation of the case studies 
 1-phenylethylamine 1-methyl-3-
phenylpropylamine 
2-octanol 
Components 4 4 6 
Substrate Acetophenone 
2-propylamine 
4-phenyl-2-butanone 
2-propylamine 
2-octanone 
Glucose 
Co-factor PLP PLP NADP+ & NADP(H) 
Product 1-phenylethylamine 
Acetone 
1-methyl-3-
phenylpropylamine 
Acetone 
2-octanol 
gluconic acid 
Co-solvent N/A N/A TEGO IL K5 
Enzyme and 
mechanism 
TAm (EC 2.6.1.X):  
Ping-pong bi-bi 
TAm (EC 2.6.1.18): 
Ping-pong bi-bi 
ADH (EC 1.1.1.2): 
Ordered bi-bi 
GDH (EC 1.1.1.47): 
Ordered bi-bi 
Contributions to the thesis: 
Kinetic modelling Performed (Section 4.5) N/A Performed (Section 4.6) 
Resin screening Performed (Section 5.5) Performed (Section 5.6) N/A 
Process evaluation Performed (Section 6.3) N/A Performed (Section 6.4) 
Abbreviations: PLP – Pyridoxial 5’ phosphate; NADP+ – Nicotinamide adenine dinucleotide phosphate; TAm – Ȧ-
transaminase; ADH – alcohol dehydrogenase; GDH – glucose dehydrogenase 
 
1.9 Thesis outline 
Chapter 1 provided an overview of biocatalysis including its advantages and limitations. For 
successful biocatalysis, some of these limitations or hurdles which are mainly related to process 
intensity have to be overcome. Many solutions were proposed to overcome these challenges. One of 
the solutions includes introducing porous resins to operate the reaction in a bi-phasic system. In 
order to systematically decide when and how to choose a resin, a methodological framework was 
developed. Consequently the different steps were described to provide understanding of the 
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backbone of this framework. In the same manner, the motivation and objective and rationale for 
selecting the case studies were stated. Chapter 2 elaborates more on auxiliary phases for bioreactors 
presenting the rationale and process considerations of introducing an auxiliary phase in a bioreactor.  
The methodology is validated using three cases studies as mentioned in the previous section. The 
case studies are introduced in chapter 3 to present the different routes for producing chiral amines 
and chiral alcohols. Chapter 4 presents the results of case studies 1 and 3 for testing the kinetic 
modelling methodology. The kinetic model is further used in a batch reactor model to set targets for 
substrate and product concentration. Chapter 5 presents the results of case studies 1 and 2 for testing 
the resin screening methodology. In chapter 6, the results of chapter 4 are used to build process 
model. The aim of this chapter is to gain further understanding about the process itself and 
moreover use of the model to predict the process performance with new conditions. Chapter 7 
contains an overall discussion about the thesis in general outlining the contribution of the different 
case studies to help to refine and validate the methodology. In chapter 8 a conclusion about the 
thesis in general and specific to the framework developed in this thesis and the case studies are 
outlined. Finally in chapter 9 some future work is proposed to continue the research of integrated 
auxiliary phases in bioreactors. Chapter 10 contains a list of references followed by Appendix 1 
which discusses some of the key concepts about reaction kinetics and the different types of 
inhibition and Appendix 2 containing the publications that have been made through the efforts of 
this PhD.  
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Chapter 2  
Integration of auxiliary phases  
in enzymatic processes 
 
 
2.1 Introduction 
There are several types of auxiliary phase that can be integrated into a bioprocess (Stark and von 
Stockar, 2003). Specific for substrate feed and product removal strategy, three kinds of auxiliary 
phase have received much attention recently. An overview of the different forms is given below: 
1. Liquid – solid: adsorption (auxiliary phase is porous resins) 
2. Liquid – liquid: extraction (auxiliary phases are water-immiscible organic solvent, 
amorphous polymer and ionic liquid) 
3. Liquid – vapour: stripping (auxiliary phase is gas) 
In this chapter the focus will be made on the first two types. Gas has not been considered as an 
auxiliary phase for further discussion as the application is limited only to volatile substrates such as 
flavours or pheromones catalysed by thermo stable enzymes (Ferloni et al., 2004; Lamare and 
Legoy, 1995).  
Searching for an ideal auxiliary phase is in many cases limited to highly hydrophobic or charged 
compounds (Straathof, 2003). Alternative technologies such as fed-batch followed by product 
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recovery based on phase or charge change in some cases would be able to suffice the required 
specific catalyst productivity. Careful consideration has to be made to justify the requirement of an 
auxiliary phase. The selection of the process strategy has to be made based on the reaction 
characteristics, aqueous solubility and level of inhibition. In order for visualization a hypothetical 
case is considered where the catalyst is inhibited by both substrate and product as shown in Figure 
2.1.  
nCs,crit Cs,sat
CP,sat
SF
PR
PR
+S
F
Substrate concentration
P
ro
du
ct
 c
on
ce
nt
ra
tio
n
SF
[S] = [P]
Cp,crit
 
Figure 2.1 Reaction scenarios based on critical concentration and solubility of substrate and product 
(crit is critical concentration; sat is saturation of substrate (s) or product (p); n is >1 or <1; SF is 
substrate feeding and PR is product removal) 
From Figure 2.1 it can be seen that for a feed concentration beyond the substrate critical 
concentration (Cs,crit) would require a substrate feeding strategy to be adopted. Similarly, to 
achieve product concentration beyond the product critical concentration (Cp,crit) a product removal 
technique has to be integrated. To overcome this limitation, an integrated substrate feeding and 
product removal technique can be adapted by means of introducing water-immiscible auxiliary 
phase (Braeutigam et al., 2009; Hilker et al., 2005; Prpich and Daugulis, 2007a; Straathof, 2003; 
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Sun et al., 2012; Ueatrongchit et al., 2009). However, further process considerations have to be 
taken into account when considering using auxiliary phase. Their details will be explained in the 
following section. 
2.2 Process considerations for integrating auxiliary phases in       
enzymatic processes 
2.2.1 Load and selectivity 
Selectivity of the auxiliary phase is a key issue for the process consideration. Generally the 
auxiliary phase is selected based on the physical properties of the components i.e. hydrophobicity or 
ionic form at a specific pH or partition coefficient of the compounds of interest (Lye and Woodley, 
1999). In some cases the properties of the substrate and product of interest have similar chemical 
and physical properties (eg. transaminase reactions) which raise the issue of effectiveness of the 
auxiliary phase (Tufvesson et al., 2011). If the auxiliary phase is overly selective for the substrate 
then it might be too tightly bound to the phase and would not partition into the aqueous phase in a 
desired rate causing the reaction to be substrate limited. On the other hand if the auxiliary phase is 
minimal selective for the substrate then the desired load (gsubstrate/gresin) would be low, thus requiring 
larger ratio of auxiliary phase to substrate (XAP/S). Thus the economics of introducing the auxiliary 
phase has to be evaluated. Alternatively auxiliary phases such as amorphous polymers whose 
architechture can be modified would be highly beneficial for designing a tailored polymer to fit the 
process (Parent et al., 2012). An overview of some of the studies done for different types of 
auxiliary phases is presented in Table 2.1. A clear tendency can be seen in many cases where the 
substrate load is inversely proportional to the selectivity. A general trade-off has to be done between 
selectivity and capacity of the auxiliary phase. 
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2.2.2 Product separation from auxiliary phase 
It is of key importance to be able to select the appropriate separation method in a timely and 
systematic manner (Alvarado-Morales et al., 2010; Jaksland et al., 1995; Siirola, 1996). The 
auxiliary phase can be integrated directly into the reactor thereby allowing reaction and separation 
to take place in the same vessel. However, sometime the auxiliary phase may pose an adverse effect 
to the biocatalyst for which the auxiliary phase can be linked via a recycle loop to the reactor 
(Woodley et al., 2008b). In either case the auxiliary phase has to be regenerated and the complexity 
of the product separation increases with increasing number of components in the reaction media. 
Table 2.2 tabulates the separation scheme from the auxiliary phase for the different reactions in 
biocatalysis. 
Table 2.2 Separation scheme for different types of reaction 
Reaction # Reaction Down stream Type of reaction 
1 $ļ4 Q/A Isomerases 
2 $ļ34 Q/(A+P) Lyase 
3 $%ļ4 Q/(A+B) Lyase* 
4 $%ļ34 Q/(A+B+P) Transferase 
*reverse direction 
In Table 2.2, A is the limiting substrate, Q the target compound while B and P are the co-substrate 
and co-product respectively. It can be seen as the chemistry becomes a little complex, i.e. the 
number of substrates and products increases from one to two, then the separation scheme in the 
downstream process requires high selectivity to generate high separation yields. Moreover, with 
increasing interest in multi-enzymatic processes, the total number of components in the reaction 
media can be greater than four (Santacoloma et al., 2011), thus requiring the separation process to 
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be highly selective otherwise a multi-step separation will be required. Some bioprocesses require 
certain kind of buffer to maintain a certain pH. The salts from the buffer can as well pose an extra 
complication not only to the auxiliary phase but as well as to the separation strategies. Furthermore 
in some bioprocesses it is essential to have co-factors such as nicotine amide to improve the 
viability of the biocatalyst, thus adding more constraints to the separation process (Khan and 
Daugulis, 2011b). For processes (especially the pharmaceutical industry) there is a requirement to 
meet high product specifications of very high product purity. This would result in multiple 
downstream steps to meet the specifications. Novel separation techniques such as chromatographic 
(Bechtold et al., 2006), membrane (Heerema et al., 2011), crystallization (Buque-Taboada et al., 
2006) and tailored solvent (Lek-utaiwan et al., 2008) and polymers methods (Zhang et al., 2006) 
may need to be applied. 
2.2.3  Bio-compatibility 
The compatibility between the auxiliary phase and the biocatalyst is an important issue that has to 
be experimentally determined before introducing it to the process. Resin has an advantage over 
liquid auxiliary phase as it is completely inert to the biocatalyst (Prpich and Daugulis, 2004). In the 
case of liquid auxiliary phases, organic solvent and ionic liquids, a loss in activity is frequently 
noticed for the enzyme. Table 2.3 lists some of the results of different studies done with liquid – 
liquid biocatalysis. A general strategy for selecting solvents for whole cell catalysis is based on the 
log P values of the solvent (Bruce and Daugulis, 1991). The Log P value of the solvent should be 
higher than the Log Pcrit of the microorganism to be biocompatible (Straathof, 2003). A study done 
by Lane et al., (1987) on free and immobilized lipases revealed that solvents with Log P value 
greater than 4 would not strip away the water associated within the enzyme, and hence retain the 
necessary water to remain catalytically active (Laane et al., 1987). However, this is not the case for 
isolated enzymes which are more susceptible to deactivation as they do not have any cellular 
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protection (Shin and Kim, 1997). Therefore the selection process is rather a trial and error in many 
cases. 
Table 2.3 Stability of the different biocatalyst in liquid auxiliary phases 
Auxiliary phase Biocatalyst Residual activity 
(%) 
Reference 
Cyclohexanone Ȧ-transaminase 65 (Shin and Kim, 1997) 
Hexane Carbonyl reductase 59 (Kansal and Banerjee, 
2009) 
Toluene Carbonyl 
reductase 
66 (Wang et al., 2011) 
Bis(2-ethylhexyl)  
sebecate 
Pseudomonas  
putida MC2  
(whole cell) 
100 (Prpich and Daugulis, 
2007b) 
BMIM – PF6 Laccase 8 (Zhou et al., 2008) 
IEMIM – EtSO4 Mycobacterium sp.  
NRRL B-3805  
(whole cell) 
120 (Marques et al., 2010a) 
C4MIM – PF6 Rhodotorula  
Sp. AS2. 2241  
(whole cell) 
98 (Wang et al., 2009) 
BMIM – PF6 Alcohol dehydrogenase 15 (Zhang et al., 2008) 
 
2.2.4 Reactor design 
Once an ideal auxiliary phase is identified, it is necessary to determine the type of reactor that is 
suitable. Selection of a reactor is often determined by economics, reliability, or availability of a 
proven system. The choice of the reactor governs the application of the different auxiliary phases. 
The different types of reactors with different reactor configuration that can be used in biocatalytic 
reactions for batch reactions are shown in Figure 2.2. 
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                                        Recycle 
 
 
   
    
Figure 2.2 Reactor types with different modes of configuration (shaded area indicates auxiliary 
phase) 
To identify the appropriate reactor, the first step is to determine the key characteristics of the 
reaction (Lilly and Woodley, 1996). This requires information, which can be obtained either from 
published literature or by specifically designed experimental work, on: (i) the form of the 
biocatalyst (solubilised, whole cell and immobilized) (Woodley, 2006), (ii) the interaction between 
the biocatalyst with the substrate(s) (the kinetic reaction model used to describe the reaction) 
(Vasic-Racki et al., 2003a) and (iii), the interaction of the biocatalyst with the resin (adverse effect 
of resin on contact with biocatalyst) (Shorrock et al., 2004). The reaction kinetics of the substrate 
                   Batch             CSTR                Packed Bed        Fluidised Bed 
                      Recycle - Filtration 
INTERNAL 
EXTERNAL 
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with the biocatalyst plays a major role in the selection of the reactor (Vasic-Racki et al., 2003b). A 
preliminary guidelines based on the reaction kinetics have been presented in Table 1.9. Specifically 
for auxiliary phase reactors the general mode of operation would be an internal configuration using 
a stirred tank reactor (Schügerl and Hubbuch, 2005). However in some cases the auxiliary phase 
might have an adverse effect on the catalyst and thus can be linked to the reactor by a recycle loop 
(Kim et al., 2007). These precautions should be considered when there is a necessity of pH/phase 
shifting or perhaps the mechanical agitation with resins or emulsions with solvents denatures the 
biocatalyst. Packed bed reactor would generally be used with resins as auxiliary phase for ease of 
handling. However, if the dimensions of the support are too small, it might result in a high pressure 
drop, in such cases a fluidized bed or expanded bed reactors would be the desired option. A further 
point that has to be evaluated is the volumetric requirements of the auxiliary phase (V/V). As a rule 
of thumb a stirred tank reactor incorporates 80 – 90% voidage while a fluidized bed reactor is 
around 70% and a packed bed reactor of 34% (Burton et al., 2002). 
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Chapter 3  
Introduction to  
case studies 
 
 
3.1 Synthesis of optically pure chiral amines 
Enantiomerically pure chiral amines are of increasing commercial value in the fine chemical and 
pharmaceutical areas in view of their application as resolving agents for chiral acids (Palovics et al., 
2007; Schindler et al., 2007), chiral auxiliaries/bases (Liu et al., 2007), catalysts for asymmetric 
synthesis (France et al., 2003; Nagano et al., 2012), intermediates for agrochemicals (Jackson, 
2011) and especially as pharmaceutical intermediates (Patel, 2011). About 80% of the active 
compounds that pharmaceutical companies have in the pipeline are chiral, and it is estimated that 
this fraction will increase, as the development of active compounds continues to be improved 
(Breuer et al., 2004; Fernandez et al., 2008). Some examples of pharmaceutical drugs containing 
chiral amines can be seen in Figure 3.1.  
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Figure 3.1 Pharmaceutical drugs containing chiral amines 
The importance of enantiopure active substances has been driven primarily by the strict regulations 
of the US Food and Drug Administration (FDA) and the European Committee for propriety 
medicinal products to stipulate the physiological action of each enantiomer of a pharmaceutical 
product. The current methods to prepare enantiomerically pure chiral amines are based upon 
resolution of racemates by crystallization of diastereoisomeric salts or by enzyme catalysed kinetic 
resolution of racemic substrates using hydrolases (lipase and accylase) and aminotransferases (Ȧ-
transaminase) (Turner and Truppo, 2010; Turner and Carr, 2007). These strategies have an inherent 
disadvantage of having a theoretical yield of 50%. Apart from resolution, deracemisation of racemic 
mixtures with monoamine oxidase is an attractive alternative, which when coupled with a reducing 
agent can yield close to 100% product in a single pass (Alexeeva et al., 2003). Asymmetric 
syntheses have received much attention as it can theoretically have a yield of 100%. These 
strategies include asymmetric hydrogenation of acetamides and imines, asymmetric addition of 
carbanions, conversion of ketones to amines using transaminases (Breuer et al., 2004). In contrast to 
Codeine 
(Johnson Matthey, pain relief) 
Zoloft 
(Pfizer, depression) 
Repaglinide 
(Novo Nordisk, antidiabetic) 
Rivastigmine 
(Novartis, alzheimers) 
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deracemisation with monoamine oxidase, which requires the prior synthesis of racemic amines, Ȧ-
transaminases can directly use the more readily available ketone. An overview of the different ways 
to produce chiral amines are shown in Figure 3.2  
From Figure 3.2, it can be seen that in total there are 9 different methods for producing chiral 
amines. These methods can be classified into two categories: 
1. Chemical synthesis processes 
2. Biocatalytic processes 
The limitations and challenges of the different routes will be discussed briefly in the following 
sections.  
O
R1 R2
+
NH2
R3 R4
O
R1 R2
+ NADH + NH3
NH2
R1 R2
+ CH3
O
OEt
O
NH2
R1 R2
+ O2
NH2
R1 R2
+
R4
R3 O
OH
2
NH2
R1 R2
+
O
R3 R4
N
R1 H
R3
NHR3
R1 R2
N
R1 R2
R3
NH2
R1 R2R2 X
Asymmetric enzymatic process
+ 100% theoretical yield
- cofactor recycling necessary
Enzymatic kinetic resolution process
+ broad substrate scope
- racemization requires harsh conditions
Enzymatic deracimization process
+ 100% theoretical yield
- product instable
Crystallization of chiral carboxylic acid salts
+ Established process
- 50% theoretical yield
Enzymatic kinetic resolution process
+ Favourable reaction equilibrium
- 50% theoretical yield
Nonenzymatic asymmetric addition process
+ 100% theoretical yield
- Cleavage of auxiliary group is difficult
Enzymatic asymmetric synthesis process
+ 100% theoretical yield
- Unfavourable reaction equilibrium
Nonenzymatic asymmetric hydrogenation
process
+ 100% theoretical yield
- Requires expensive chiral ligands
Nonenzymatic asymmetric
hydrogenation
process
+ 100% theoretical yield
- Difficult to prepare precursor
 
Figure 3.2 Different strategies to produce chiral amines 
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3.1.1 Chemical synthesis of chiral amines 
The classic chemical approach for the production of optically pure chiral amines has been done by 
the crystallization of diastereomic salts of chiral carboxylic acids with racemic amines (Jacques et 
al., 1994). (R) or (S)-1-phenylethylamine can be prepared at industrial scale from the salts of (S)-
malic acid (Loven, 1905) or (R)-mandelic acid (Ingersoll et al., 1933) or (R)-tartaric acid 
(Theilacker and Winkler, 1954) with very high optical purity. This process has in some cases been 
considered inefficient (maximum 50% yield) and may be viewed as uneconomic. Figure 3.3 
illustrates the scheme for the production of enantiomerically pure chiral amines. 
NH2
R1 R2
+ 2
R4
R3 O
OH NH3
+
R1 R2
R4
R3 O
O
-
+
NH3
+
R1 R2
R4
R3 O
O
-
crystalline in solution
 
Figure 3.3 Racemate resolution through fractional crystallization of salts of racemic amines and 
enantiomerically pure carboxylic acids 
This has led to increased efforts towards asymmetric chemical synthesis of chiral amines by 
catalytic asymmetric hydrogenation of imines and amides. These approaches require chiral 
auxiliaries or metal complexes with chiral ligands (Boezio et al., 2003; James, 1997). An extensive 
research effort has resulted in diverse sets of chiral ligands. The use of rhodium, ruthenium, and 
iridium in combination with certain chiral ligands are reported to catalyse the enantioselective 
hydrogenation of amides and imine (Li and Zhang, 2000; Tang and Zhang, 2002; Xiao and Zhang, 
2001). The difficulty in this approach lies with the synthesis of the prochiral imine precursor to give 
the free amine (Breuer et al., 2004). The imine or amide precursor can be made by condensation of 
ketones with appropriate amines. This therefore presents a multistep process (Tararov and Börner, 
2005). Moreover the chiral ligands and metal precursors are usually expensive and not easily 
available (Li and Zhang, 2000). Figure 3.4 illustrates the asymmetric hydrogenation processes. 
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Figure 3.4 Asymmetric hydrogenation for the synthesis of chiral amines 
An alternative approach is the asymmetric addition of carbanions to aldimines. Figure 3.5 illustrates 
the scheme for asymmetric addition process. Similar to the previous approach, it is a multi-step 
approach where the cleavage of the auxiliary group X can be difficult (Breuer et al., 2004). 
R1 H
O
R1 H
N
R3
R1 R2
NH
X
R1 R2
NH2N source deprotectionR2X
  
Figure 3.5 Asymmetric addition for the synthesis of chiral amines 
 
3.1.2 Biocatalytic processes 
Kinetic resolution using hydrolytic enzymes 
The kinetic resolution of racemic amines can be accomplished by hydrolytic enzymes such as the 
subtilisin Carlsberg (protease), lipases (EC 3.1.1.3) and penicillin acylase (Breuer et al., 2004). A 
likely example can be seen in the patented BASF process at a multiton scale for the production of 
chiral amines using Burkholderia plantarii lipase in combination with an acylating agent to yield 
enantiomerically pure (S)-1-phenylethylamine and the corresponding amide (Funke et al., 2003). 
The versatility of the process with regard to possible substrates, the ability to recycle undesired 
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enantiomers by racemization and the recovery of the acylating agent are the main advantages of the 
process. Figure 3.6 illustrates the scheme used by BASF. 
NH2
+ R'O
OR
O
NH2
+
NH
O
OR'
NH2
NaOH/H2O
Lipase
 
Figure 3.6 Lipase catalysed enantioselective amide formation (BASF). 
Kinetic resolution using Ȧ-transaminases 
Ȧ-Transaminases (TAm, EC 2.6.1.18) are capable of selectively producing chiral amines. The 
enzyme transfers an amino group from an amino donor to a ketone utilizing the cofactor pyridoxyl-
5-phosphate (PLP) (Cho et al., 2008). This process has been industrially scaled up to 2.5 cubic 
meter scale by Celgene technology (Matcham and Bowen, 1996). In the Celgene process, a racemic 
mixture of amines can be resolved to form a ketone. Figure 3.7 illustrates the scheme.  
NH2
R
+ O +
NH2
R
O
R + NH2
 
Figure 3.7 Kinetic resolution using Ȧ-transaminase (Celgene) 
However a general challenge to the kinetic resolution strategy using Ȧ-transaminase has been the 
inhibition caused by both substrate and product leading to low product concentrations. Moreover 
the product mixtures can only be separated by cumbersome methods. 
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Deracemisation 
Turner and collaborators at GlaxoSmithKline developed an alternative to kinetic resolution using an 
(S)-selective monoamine oxidase (MAO, EC 1.4.3.4) from Aspergillus niger. The enzyme can 
deracemise a racemic mixture of amines with a theoretical yield of 100% in the presence of a 
reducing agent for the (R)-enantiomer (Victorovna et al., 2003). The (S) selective monoamine 
oxidase selectively oxidises the (S)-amine enantiomer from a racemic (R, S) amine mixtures to the 
corresponding imine while leaving the other enantiomer intact (Alexeeva et al., 2003). The formed 
imine in the presence of a borane based reducing agents subsequently converts the imine to a (R)-
amine. In this way the final product left in solution would be pure (R)-amine in high yield 
(Dunsmore et al., 2006). The major challenge for this reaction is in the selection of the reducing 
agent, which determines the efficiency of the process and furthermore has to be compatible with the 
enzyme and aqueous reaction media (Alexandre et al., 2002). Moreover, in some cases the imine 
formed can hydrolyse to ketones resulting in an undesired reaction, especially if the substrate is a 
primary amine (Alexeeva et al., 2012). Figure 3.8 illustrates the reaction scheme for the 
deracemisation process. 
NH2
R1 R2
NH
R1 R2
NH2
R1 R2
MAO
[H]
 
Figure 3.8 Deracemisation of primary amines using MAO and a non-specific imine reductant 
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Asymmetric synthesis with amine dehydrogenase 
Amine dehydrogenases (EC 1.4.99.3) oxidises amines to ketones and ammonia. The enzyme 
requires redox cofactors such as NADH which has to be regenerated. Unfortunately very few highly 
enantioselective variants have been created of which only one enzyme extracted from Streptomyces 
virginiae can be found in the literature (Itoh et al., 2000). The reaction scheme is illustrated in 
Figure 3.9.  
R2
O
R1 R2
NH2
R1
 NH3 
NADH + H+
 H2O 
NAD+
 
Figure 3.9 Asymmetric synthesis with amine dehydrogenase 
 
Asymmetric synthesis using Ȧ-transaminases  
In a recent publication it was stated the benefits of the asymmetric synthesis of chiral amines 
namely the potential to achieve a 100% yield at mild operating conditions by the enzyme 
transaminases (TAm, EC. 2.6.1.18) (Tufvesson et al., 2011). The published review is focused on the 
considerations for developing industrial transamination processes at large scale, summarizing the 
challenges and strategies to meet a number of proposed success criteria for an efficient and 
economic process. Transaminases catalyse the transfer of an amine (-NH2) group from an amine 
donor, usually an amino acid or a simple amine such as 2-propyl amine, to a pro-chiral acceptor 
ketone, yielding a chiral amine as well as a co-product ketone or alpha-keto acid (Figure 3.10). 
Transaminase requires cofactor pyridoxal phosphate (PLP) to act as a shuttle to transfer the amine 
group. This cofactor is fully regenerated within the same two substrate reactions on the same 
enzyme, and hence does not pose the cofactor regeneration problems encountered in 
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oxidation/reduction reactions (Hwang et al., 2005).  The general scheme for asymmetric synthesis 
of chiral amines is illustrated in Figure 3.10.  
R2
O
R1
+ NH2
R2
NH2
R1
+ O
 
Figure 3.10 Asymmetric synthesis of chiral amines using transaminase 
In spite of the many attractive features of asymmetric synthesis using transaminase catalysed 
reactions, there are still a number of challenges that need to be dealt with in order to make 
transaminase processes feasible for the production of a wider range of amines.  
The major challenges to this approach are: 
1. The thermodynamic equilibrium favours the ketone starting material 
2. Transaminases typically challenged with substrate and product inhibition at industrially 
relevant concentrations 
3. Hydrophobic substrates at high concentration denature the enzyme 
Many of the challenges encountered with transaminases are common to other biocatalytic processes 
and consequently many parallels can be drawn to other biocatalytic reactions for the production of 
chiral molecules (e.g. chiral alcohols). Therefore the objective of selecting these model reactions 
would be the ability to assess the feasibility of using these kinds of enzyme to systematically make 
process evaluations for scale-up considerations and also to further validate the usefulness of using 
resin as an auxiliary phase. At the same time many conclusions can be drawn from the analyses 
which will help gain further understanding and develop process strategies for the asymmetric 
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synthesis of chiral molecules. The study of this section about transaminases formed the basis for a 
peer reviewed journal publication as seen on Appendix 2. 
3.2 Synthesis of optically pure chiral alcohols 
The stereoselective reduction of inexpensive prochiral ketones to their corresponding alcohols is 
one of the most useful ways of introducing chirality in a molecule. Chiral alcohols can then be 
transformed into various functional groups (halides, thiols, amines, azides etc.) without 
racemization and concurrent loss of chirality of the product (Nakamura et al., 2003).It is supposed 
that 40% of all chiral centres in drugs are secondary or tertiary hydroxyl groups (Meyer et al., 
1997). 
Chiral alcohols can be synthesized by three approaches as listed below: 
1. Chemical synthesis  
2. Kinetic resolution of racemic alcohols 
3. Asymmetric synthesis by biocatalysis 
The limitations and challenges of the different approaches will be discussed briefly in the following 
sections of this chapter.  
3.2.1 Chemical synthesis of chiral alcohols 
The common techniques that have been applied for producing chiral alcohols are asymmetric 
hydrogenation and reduction using enantioselective chemical catalysts (Breuer et al., 2004). The 
asymmetric transfer hydrogenation of ketones to chiral alcohols has been demonstrated using a 
variety of chiral catalysts generally including phosphine ligands (Akutagawa, 1995; Blaser et al., 
2003; Ikariya and Blacker, 2007; Noyori et al., 1995; Saito et al., 2001). In contrast, 
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enantioselective ketone reductions have been demonstrated successfully using CBS borane catalysts 
(Hett et al., 1998; Hirao et al., 1981). While these asymmetric chemical synthesis of chiral alcohols 
have been extremely useful in the production of pharmaceutically important intermediates (Blaser 
and Studer, 1999; O'Shea et al., 2005), the challenges set forth by the chemo-catalytic route are the 
demand for transition metals, high pressure and temperature and moreover the use of hazardous 
substances resulting in their application getting limited. Figure 3.11 illustrates the production of 
chiral alcohol by hydrogenation of reduction systems. 
R
COOR
O [RuI2(cymene)]
(R)-tol-binap R
COOR
OH
O
HalR
BH3 SMe2
(S)-prolinol
OH
HalR
 
Figure 3.11 Asymmetric hydrogenation or CBS Borane reductions for alcohol production  
3.2.2 Kinetic resolution  
Enantioselective hydrolysis of racemic epoxides using cobalt complexes to catalyse the reaction can 
result in highly selective ring opening reactions. Water is generally used as the nucleophile but 
alternatively phenols can be used to provide the high selectivity required. The catalysis requires a 
complex metal catalyst which can be considered expensive if not recycled. While there have been 
chemo-catalytic methods developed for the enantioselective acylation of alcohols, industrial 
examples of these reactions are rare (Birman and Jiang, 2005). Figure 3.12 illustrates the scheme. 
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Figure 3.12 Enantioselective hydrolysis of racemic epoxides 
Alternatively lipase mediated resolution can be carried out in the presence of an acylating agent. 
This concept has been applied by BASF for the synthesis of styrene oxides. Racemic chloroalcohols 
in the presence of succinic anhydride produce styrene oxide in two steps. The unconverted 
enantiomer is separated from the acylated enantiomer by means of distillation. Figure 3.13 
illustrates the reaction scheme. 
OH
Cl
R
O OO
lipase OH
Cl
R
+
O
Cl
O
OH
O
R
NaOH O
R
 
Figure 3.13 The enantioselective synthesis of styrene oxides through enzymatic acylation 
A major drawback of resolutions is a maximum theoretical yield of 50 %. Typically the undesired 
product is either disposed or different strategies have to be taken to deracemise the undesired 
enantiomer back to racemic starting materials for another round of resolution.  
Dynamic kinetic resolution allows conversion greater than the theoretical 50% conversion. 
However, additional steps have to be taken for such method. The majority of these processes use a 
combination enzyme/metal-catalysis (Kamal et al., 2008). Typically, a lipase is used to acylate one 
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enantiomer of the alcohol, while a metal catalyst continuously racemises the remaining enantiomer. 
Figure 3.14 illustrates the racemization catalysts. The key in making this system successful was the 
development of efficient racemization catalysts that were capable of working under the mild 
reaction conditions necessary for the lipase (Ahn et al., 2008). Most racemization catalysts are 
ruthenium based (Martin-Matute et al., 2005; Turner, 2003), and capable of operating at room 
temperature to facilitate the dynamic kinetic resolution. 
 
Figure 3.14 Alcohol racemization catalysts 
 
3.2.3 Asymmetric synthesis of chiral alcohols 
The use of enzymes for the reduction of ketones contributes with good yields and excellent 
enantioselectivity (> 99 % ee). Biocatalytic reductions can be run using whole cell systems, but 
these systems are frequently hampered by by-product formation from endogenous enzymes inside 
the cell (Pollard et al., 2006). Isolated ketoreductase on the other hand are simpler to handle and any 
undesired side reaction can be avoided. Moreover, with the use of genetic and protein engineering, a 
large range of ketoreductases are available with a broad spectrum of substrates with corresponding 
high enantioselectivity and activity (Kaluzna et al., 2005; Leuchs and Greiner, 2011; Zhu et al., 
2005). Figure 3.15 illustrates this reaction. 
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O
R2 R1
OH
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NAD(P)H NAD(P)+
 
Figure 3.15 Ketone reduction using ketoreductase enzymes 
A limitation of using isolated ketoreductase is the requirement of expensive cofactors. Therefore, 
co-factor recycling options have to be considered. Several methods are available including 
enzymatic coupling, chemical addition and substrate coupling. A recent publication from Huisman 
et al., 2010 summarized the different options with the advantages and disadvantages of each option 
(Huisman et al., 2010). The scalability of the strategy is also mentioned. Table 3.1 displays a 
summary of the different cofactor recycling options that are applicable for NADP dependent 
ketoreductases. The major challenges for asymmetric synthesis of chiral alcohols using isolated 
enzymes are: 
i) Expensive co-factor NADP is required 
ii) Hydrophobic substrates reduces the catalytic activity of the enzyme 
Many of the challenges encountered with ketoreductase are common to other biocatalytic processes 
that require co-factors. Therefore the objective of selecting these model reactions would be to 
evaluate the possibility of determining the optimal reaction concentrations and at the same time to 
evaluate process feasibility for scale up considerations. 
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Table 3.1 Considerations for cofactor recycling (Huisman et al., 2010) 
Technology Reductant Product Advantages Disadvantages 
Whole cells Glucose Gluconic 
acid 
Irreversible 
reaction 
Potential for by-products 
from endogenous enzymes  
Glucose 
dehydrogenase 
Glucose Gluconic 
acid 
Irreversible 
reaction  
Highly active  
Causes pH of reaction to 
drop, requiring pH control 
system 
Ketoreductase Isopropanol Acetone Same enzyme can 
be used for desired 
conversion and co-
factor recycling 
May require acetone removal 
to shift equilibrium towards 
desired product 
Phosphite 
dehydrogenase 
Sodium 
phosphite 
Sodium 
phosphate 
Irreversible 
reaction 
 
High ionic strength of 
reaction medium 
Phosphate waste stream 
Phosphate destabilizes 
cofactor at low pH 
 
Hydrogenase H2  Irreversible 
reaction 
Hazardous 
Electro 
chemical 
Rhodium 
complex 
 Clean and 
sustainable 
Low productivity 
 
Photochemical Photosynthetic 
microorganism 
 Sustainable Low productivity 
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Chapter 4  
Kinetic modelling of 
 enzymatic reactions 
 
 
4.1 Introduction 
Detailed knowledge of the reaction kinetics is essential for effective implementation and operation 
of enzymatic processes. Furthermore, the kinetic parameters provide an insight into the biocatalytic 
reaction mechanisms (such as inhibition) (Straathof et al., 1992). Often, the ratio of f A0 cat ME K /K   is 
used to describe the biocatalyst performance (Koshland, 2002). However, for more complex 
biocatalytic reactions it is important to include also the inhibition parameters of the substrate(s) and 
product(s) to accurately quantify the catalyst effectiveness and to provide guidance for biocatalyst 
improvement (Fox and Clay, 2009). The kinetic model can also be used in a process model to 
describe the dynamic behaviour of the reaction and in this way be used to evaluate opportunities for 
process integration (e.g. in-situ product removal) (Sin et al., 2009), process control and operational 
optimization (Findrik et al., 2005). Furthermore, the reaction equilibrium can be derived from the 
kinetic parameters, which is essential in selecting suitable process operating strategies for 
biocatalytic processes (Tufvesson et al., 2011).  
Biocatalytic reactions obey mixed order (between 0 and 1) kinetics similar to the Langmuir-
Hinshelwood model denoted as the Michaelis-Menten kinetics (Michaelis and Menten, 1913). The 
principals of the Michaelis-Menten kinetics have been further expanded to describe multi-substrate 
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reactions with complex reaction behaviour. For example, a generic equilibrium controlled bi-
substrate reaction can be formulated as follows: 
A B    P Q U                                                                                    [4.1] 
The kinetic model (full) for  reaction 4.1 which follows a ping pong bi-bi mechanism in which 
substrate (A) is bound first, while the co-product (P) is released before the second substrate (B) and 
the final product (Q) leaves the enzyme last (Walsh, 1998), can be formulated as (Leskovac, 2003): 
 
 
 
 
 
                                                                                   [4.2] 
The dynamic equation consists of 9 parameters including terms such as the catalytic turnover of the 
reaction  f rcat catK , K , Michaelis parameters  A B P QM M M MK , K , K , K , inhibition parameters  A Qi iK ,K  
that are derived from the core mechanism, un-competitive substrate inhibition parameter  ISiK due 
to formation of non-SURGXFWLYHFRPSOH[HVDQGWKHELQDU\UHDFWLRQGLUHFWLRQLQGLFDWRUȜDQGȖWKXV 
forming a complex model.  
The chemical equilibrium can be represented with a constitutive equation using the Haldane 
relationship. The relationship is shown in Equation 4.3: 
2f P Q f Q P f P Q P Q
cat M M cat M i cat M i i i
EQ r A B r B A r A B A B
cat M M cat M i cat M i i i
K K K K K K K K K K KK  = = = =
K K K K K K K K K K K
§ · § · § ·  ¨ ¸ ¨ ¸ ¨ ¸© ¹ © ¹ © ¹
 [4.3] 
While enzymes have evolved to operate very effectively at low concentrations of substrates in a 
natural environment, for industrial applications, high concentrations of substrates are required to 
ensure that the downstream processing costs are manageable. For this reason the effects of higher 
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concentrations of substrate (and product) on the enzyme kinetics are critically important. In fact, 
under industrial conditions it is normally the case that the enzyme is inhibited by the substrate and 
the product or even other components present in the reaction medium. These excess inhibition 
effects are introduced into the kinetic expression through an inhibition relationship 
I
Si
[I]1+
K
§ ·¨ ¸© ¹
factored into Equation 4.2 either in the velocity term or the Michaelis constant term or 
both, depending upon whether the reaction exhibits uncompetitive, competitive or non-competitive 
inhibition, respectively (for details please refer to Appendix 1). For example, a reaction exhibiting 
uncompetitive inhibition with compound I, would result in the inhibition relationship factored into 
the numerator as shown in Equation 4.2. When attempting to estimate the parameters in Equation 
4.2 it is often realized that the parameters may be strongly correlated, thereby compromising the 
uniqueness of the parameter values (Santacoloma et al., 2010). This means that the physical 
meaning of the parameters is lost and that many different sets of parameter values can fulfil the 
requirements of the given equations. For instance, different initial guesses for the parameters will 
result in completely different values of the parameters. There is therefore a need to address the 
problem of determining the kinetic parameters for biocatalytic reactions in a systematic and 
efficient manner. 
To reduce the number of parameters to be estimated simultaneously, it is therefore suggested to 
decompose the full model to the initial rate model by designing experiments where samples are 
taken at the initial period of the experiment. During this initial time, it can be assumed that the 
influence of product and reversibility of the reaction is negligible. Therefore, the terms related to 
product accumulation and the equilibrium relationships can be omitted. For equilibrium controlled 
reactions, in the absence of products, Equation 4.2 can be decomposed into Equations 4.4a and 4.4b 
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E\ FRQVLGHULQJ Ȗ    DQG Ȝ    WR JHW HTXDWLRQ IRU -rA DQG FRQVLGHULQJ Ȝ    DQG Ȗ    WR JHW
equation for -rQ: 
Forward direction: 
f
0 cat
Q A A B I
M M Si
E K [A][B] [I]r =-r = 1+
K [B]+K [A]+[A][B] K
§ ·¨ ¸© ¹
                                                                                 [4.4a] 
Reverse direction: 
r
0 cat
A Q P Q I
M M Si
E K [P][Q] [I]r =-r = 1+
K [Q]+K [P]+[P][Q] K
§ ·¨ ¸© ¹
                       [4.4b] 
Where Equation 4.4a represents the consumption of substrate A for the forward direction, while 
Equation 4.4b represents the consumption of substrate Q when running the reaction in the reverse 
direction. The most commonly used methodologies to estimate the parameters for enzymatic 
reactions are the graphical plotting (GP) method and non-linear regression (NLR) method. The 
former requires a linearization of the kinetic expression at different initial rate conditions in order to 
obtain linear plots from which the kinetic parameters can be determined. Some of the commonly 
used plots are the Lineweaver-Burke, Hanes and Dixon plots (Ranaldi et al., 1999). Although 
simple to use, these methods introduce inaccuracy in the parameter estimation as the errors increase 
significantly at low concentrations of the substrate (Nielsen et al., 2003). Furthermore, where there 
is significant inhibition of the substrates, the plots are no longer linear and therefore assumptions of 
linear regions are not valid.  
The non-linear regression method, on the other hand, relies on minimizing the margin of error 
between the model outputs or model predictions and the corresponding experimentally measured 
values. Often, this procedure is carried out using an optimisation routine such as the least squares 
method. This is clearly an improvement on the GP method since no model linearization is required, 
although mathematical software with curve fitting or an optimisation toolbox is needed. The major 
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advantage of the NLR method is that it can be applied for both initial rate data (as the GP method) 
and a set of reaction progress curves. However, a difficulty in using the NLR method is the 
necessity of good initial guesses for the kinetic parameters. A local minimum of the objective 
function is frequently found if the initial guesses are poor and the kinetic model is complex (Zavrel 
et al., 2010).  
An alternative approach developed by Chen and co-workers (Chen et al., 2008) proposed a 
methodology, which simplifies the kinetic expression into regions of negligible and non-negligible 
inhibition. However, the assumption of including a region of negligible inhibition is rather 
subjective, leading to an inherent weakness in this approach. For reaction systems with severe 
inhibition, using data from the low concentration range (where inhibition is assumed to be 
negligible) is likely to result in erroneous estimations and may result in overestimation of the 
Michaelis parameters. Furthermore, the method was validated for an irreversible biocatalytic 
reaction with the assumption that the co-product was completely removed in-situ. On the other 
hand, many industrially relevant biocatalytic reactions (e.g. reactions catalysed by transaminases, 
transketolases and transaldolases) are equilibrium controlled reactions involving two substrates 
being converted into its corresponding products for which the optimization of the parameters have 
to be treated differently.  
In this chapter a systematic methodology to estimate the kinetic parameters of enzymatic systems 
which exhibit substrate/product inhibition is presented. The methodology incorporates the 
advantages of each of the different approaches, thus enabling estimation of the parameters with the 
highest reliability. Likewise, the methodology avoids the assumptions made by Chen and co-
workers (Chen et al., 2008) to construct a negligible inhibition region. An experimental framework 
is presented to provide guidelines for the type of experiments required to acquire the kinetic 
parameters according to the model selected. The outcome of the new approach will provide a 
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platform for good practice for estimating kinetic parameters of biocatalytic reactions. In this 
chapter, the methodology is exemplifiHG VWHSZLVH XVLQJ WKH Ȧ-transaminase catalysed reaction 
between acetophenone and 2-propylamine for the asymmetric synthesis of (S)-1-phenylethylamine 
and a multi-enzymatic process using alcohol dehydrogenase for the synthesis of 2-octanol. 
4.2 Proposed Methodology for kinetic model parameter estimation 
In order to deal with the problems discussed earlier, a robust systematic methodology for kinetic 
parameter estimation has been developed. This is built upon the previously documented 
methodology of Chen and co-workers (Chen et al., 2008). The parameter estimation problem is 
decomposed into five hierarchical steps where the solution of each of the steps becomes the input 
for the subsequent step.  The available data is broken down into 6 sub-sets to match the different 
steps of the estimation. Figure 4.1 illustrates the proposed methodology. 
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4.3 Description of the methodology 
In step 1, data set 1 contains the results of experiments where the initial rate of reaction is measured 
as a function of enzyme concentration. Often, the rate of reaction increases linearly with enzyme 
Figure 4.1 Proposed methodology for kinetic model parameter estimation 
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concentration until a saturation limit is reached where mass-transfer limitations begin to influence 
the overall reaction rate. Subsequent addition of enzyme will increase the overall rate of reaction in 
a non-linear manner. The objective is therefore to determine this linear region to guide the 
experiments such that all subsequent experiments for parameter estimation must be carried out with 
enzyme concentrations within the enzyme linear region, as the non-linear effect of the enzyme 
concentration is not considered in this study.  
In step 2 the kinetic model (full model) (Equation 4.2) is decomposed into two initial rate models 
for the forward and reverse reactions (Equation 4.4a and 4.4b) to represent the initial period of the 
experiment. In this way the numbers of parameters to be estimated simultaneously are reduced. 
Data collected from initial rate experiments (data sets 2 and 3) at different substrate concentrations 
in both directions are used to regress the parameters  f r A B P Qcat cat M M M M SiK , K , K , K , K , K , K in the 
decomposed models (Equation 4.4a and 4.4b). The objective function (Equation 4.5a and 4.5b) for 
both forward and reverse  reactions, which is calculated as the sum of the squares of the deviations 
between model prediction and experimental result (least squares), is minimized for both the forward 
DQGUHYHUVHUHDFWLRQVXEMHFWWRWKDWSDUDPHWHUYDOXHVDUHJUHDWHUWKDQș!ZKHUHșUHSUHVHQWVD
vector of parameters).  
 exp 21 , ,
1
( ) ½ ( )
N
A j A j
j
J r rT T
 
 ¦                                                                                                                  [4.5a] 
 exp 22 , ,
1
( ) ½ ( )
N
Q j Q j
j
J r rT T
 
 ¦                            [4.5b] 
A common challenge in kinetic parameter estimation for biocatalytic reactions is the high degree of 
correlation between parameters, which often results in a local minimum in the objective function. 
Therefore it is required to solve the optimization problem for different initial parameter values to 
increase the probability of finding a global minimum in the objective function. The optimization is 
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solved within a given range in order to obtain the local minimum for each evaluated set. The final 
estimated parameters correspond to the minimal of the local optimization.  These parameters can be 
considered to the global optimal solution.   
In step 3 the additional core inhibition parameters  A Qi iK , K from the full kinetic model (Equation 
4.2) are regressed using data set 4 (dynamic experiments where the product accumulation and 
substrate depletion is followed over time) keeping all the other parameters fixed at the values 
obtained in step 2. Similar to step 2, the optimization problem is solved several times with different 
initial values. Equation 4.2 represents the reaction rate which is used to formulate the mass balances 
for each of the reactants in the process. Consequently, the process model is expressed as a set of 
ordinary differential equations (ODEs), which must be solved in order to obtain the prediction for 
the substrate and product concentrations as a function of time. The expressions for product 
formation and substrate consumption have the same form only differing in a plus sign for product 
formation and minus sign for substrate consumption. The objective function (Equation 4.6) is 
formulated by the least squares method as the sum of squared error between the model prediction 
and experimental data of the different compound concentrations yn. Furthermore, the optimization is 
VXEMHFWHG WR WKH FRQVWUDLQW WKDW SDUDPHWHU YDOXHV DUH JUHDWHU WKDQ  ș !  ș QRZ UHSUHVHQWV WKH
additional parameters).  
 2,exp ,model
1
( ) ½ [ ] [ ] ( )
N
n j n j
j
J y yT T
 
 ¦   [4.6] 
Where, n represents the number of different compounds present in the reaction. 
In step 4 the parameters that have been estimated in steps 2 and 3 are used as initial estimates and 
using the full data set (sets 2, 3, 4 and 5), they are regressed to obtain the final model (Equation 
4.2). The final model with the regressed parameters is able to describe the initial rate data sets as 
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well as the progress curve data sets.  The knowledge of the equilibrium constant, if available, can be 
included into the full model to reduce the search space for the estimation. The value of the 
equilibrium constant (KEQ) may be obtained experimentally (Tewari et al., 2000; Tufvesson et al., 
2012) or by using group contribution methods (Jankowski et al., 2008). However, this data is 
generally not available for enzymes exhibiting slow reaction rates because performing equilibrium 
experiments would require a lot of enzymes which is relatively expensive. KEQ can then be 
calculated using the estimated parameters by following Equation 4.3. Two parameters 
 B Pi iK , K which are not included in the full model (Equation 4.2) are calculated using the 
relationship shown in Equation 4.3, the estimated parameters and the value of the equilibrium 
constant, KEQ.  
Once the final model with the corresponding parameters is obtained, it is verified with new data and 
analysed before making it ready for different applications. In step 5a, verification of performance is 
made through data set 6 (progress curves and initial rate data with different initial conditions). In 
step 5b, the objective is to understand the correlation between parameters, thereby identifying the 
relationship between the parameters. A linear approximation of the covariance matrix of parameter 
estimators, CO9ș ZDV XVHG WR HVWLPDWH WKH FRUUHODWLRQ PDWUL[ 7KH FRYDULDQFH PDWUL[ RI WKH
estimated parameters was formulated in Equation 4.7(Omlin and Reichert, 1999): 
    > @ > @
1
2
min 1
T
d y d yJ
Cov
N P d d
TT T V T
ª º§ · § ·« » ¨ ¸ ¨ ¸ « »© ¹ © ¹¬ ¼
  [4.7] 
where min Jș corresponds to the minimum value obtained from the objective function (Equation 
4.6), N is the number of data points and P is the number of estimated parameters, and > @d y
dT
§ ·¨ ¸© ¹
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corresponds to the Jacobian matrix which is also the local sensitivity of model variable y to 
parameters ș.   
The importance of the covariance matrix is to calculate both the confidence intervals of the 
parameters and the correlation matrix of the estimated values.  
7KH FRQILGHQFH LQWHUYDO RI SDUDPHWHUV LV GHWHUPLQHG ZLWK D FRQILGHQFH OHYHO RI  ņ Į
corresponding to the 95th percentile of the t-GLVWULEXWLRQYDOXHFDOFXODWHGDWWKHĮ/2 percentile with N 
ņ p degrees of freedom, as described in Equation 4.8.    
1 ( ( )) , 2
diag Cov t N pD
DT T T § · r  ¨ ¸© ¹                                                                                    [4.8] 
In Equation 4.8, the diag(Cov(ș)) takes into account only the diagonal values of the covariance 
matrix of parameters (see Equation 4.7) for this calculation. 
The linear relationship between the parameters is analysed with the correlation matUL[&25șișj) 
as shown in Equation 4.9 (Sin et al., 2008). 
      
,
,
, ,
i j
i j
i i j j
Cov
Cor
Cov Cov
T TT T T T T T      [4.9] 
Here, correlation coefficients are calculated: a negative coefficient between two parameters 
indicates that as one parameter value increases, the other decreases. While a positive coefficient 
indicates that both parameter values increase or decrease simultaneously. A value of zero denotes a 
lack of correlation. Even though it is preferable that correlation between parameters does not exist, 
this is usually not the case since the parameters in multi-substrate enzymatic reactions are generally 
correlated with each other. At the end of step 5, the model is ready for use in different applications.    
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4.4 Data collection 
The experiments required to collect the six data sets can be summarized in Table 4.1 as follows: 
Table 4.1 Collected data sets for the proposed methodology 
 Initial ratea Initial rateb Progress curvec 
Variables Enzyme concentration Substrate concentration  Substrate or product 
concentration over time 
Data set 1 3   
Data sets 2 and 3  3  
Data sets 4 and 5   3 
Data set 6*  3 3 
aInitial rate of reaction is measured for varying enzyme concentration at a fixed substrate concentration 
bInitial rate of reaction is measured for varying substrate concentration for forward and reverse direction at a fixed 
enzyme concentration  
cConcentration of substrates and products are measured as a function of time (until it approaches equilibrium) at a fixed 
enzyme concentration 
*Independent data set which is not used for parameter estimation 
4.5 Case study: asymmetric synthesis of 1-phenylethylamine 
In order to illustrate the application of the systematic methodology for kinetic model parameter 
estimation, the synthesis of 1-phenylethylamine (PEA) and co-product acetone (ACE) from 
acetophenone (APH) and 2-SURS\ODPLQH,3$LQWKHSUHVHQFHRIWKHȦ-transaminase (EC 2.6.1.X) 
(TAm, ATA – 040, C-Lecta) has been studied. In the synthesis of optically pure chiral amines using  
TAm, the reaction is catalysed by the transfer of an amine (-NH2) group from an amine donor, to a 
pro-chiral acceptor ketone, yielding a chiral amine as well as a co-product ketone (Leskovac, 2003) 
(see Figure 4.2). The enzyme requires pyridoxal phosphate (PLP) as a cofactor to act as a shuttle to 
transfer the amine moiety between the molecules (Hwang et al., 2005). 
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+ NH2 + O
O NH2
TAm
PLP
acetophenone 2-propylamine (S)-1-phenylethylamine acetone
 
Figure 4.2 7UDQVDPLQDWLRQ FDWDO\VHG E\ Ȧ-transaminase illustrating the synthesis of 1-
phenylethylamine (PEA) and co-product acetone (ACE) from the substrates acetophenone (APH) 
and 2-propylamine (IPA) in the presence of the enzyme TAm 
4.5.1 Reaction kinetic modelling 
7KH Ȧ-transaminase-catalyzed reaction is known to follow the so-called “ping-pong bi-bi” 
mechanism (Höhne and Bornscheuer, 2009; Segel, 1975). For details about the mechanism please 
refer to Appendix 1. The reaction is heavily influenced by (competitive) inhibition of the substrate 
acetophenone (APH) (Shin and Kim, 2002) and product 1-phenylethylamine (PEA) (Shin and Kim, 
1999a; Shin et al., 2001), as well as having unfavourable reaction equilibrium in the synthetic 
direction (Shin and Kim, 1998; Tufvesson et al., 2012). Consequently, there is a strong motivation 
to go forward with the formulation and analysis of a kinetic model in order to predict reaction 
behaviour under different process conditions.  
The kinetic model to describe the reaction mechanism includes the formation of four non-
productive complexes, which are characterised by a substrate surplus inhibition constant 
 APH IPASi SiK , K in the forward direction and  PEA ACESi SiK , K in the reverse direction. The derived rate 
equation is as follows (Equation 4.10Ȝ Ȗ  
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                                                  [4.10] 
The constitutive equation of the chemical equilibrium is formulated using the Haldane relationship 
in Equation 4.11:  
ACE ACEPEA PEA
APH IPA IPA APH
2f f PEA f ACE PEA ACE
cat M M cat M i cat M i i i
EQ r r APH r IPA APH IPA
cat M M cat M i cat M i i i
K K K K K K K K K K KK  = = = =
K K K K K K K K K K K
§ · § · § ·¨ ¸ ¨ ¸ ¨ ¸© ¹ © ¹ © ¹
                                 [4.11] 
Equation 4.10 is further decomposed into Equation 4.12a and 4.12b by considering the initial period 
of the experiment. In the present case study, the time interval for initial rate was considered to be 
the first 5 minutes of reaction time. During this period, it was assumed that the concentration of 
product was extremely small and thus the terms related to product and equilibrium in Equation 4.10 
could be neglected. In this way, the rate equation in the absence of products for both forward, -
r[APH] Ȗ  Ȝ  DQG UHYHUVHGLUHFWLRQ -r[PEA] Ȗ  Ȝ ZDVGHFRPSRVHG LQWR(TXDWLRQ
4.12a and 4.12b. 
Forward direction: 
 
> @  f0 cat
[PEA] [APH]
APH
M IPAIPA APH
Si Si
E K [APH][IPA]
r =-r =
[IPA] [APH]K [IPA] 1+ +K [APH] 1+ +[IPA][APH]
K K
 
§ · § ·¨ ¸ ¨ ¸© ¹ © ¹
                              [4.12a] 
 
> @ > @
> @ f r0 cat cat
EQ
PEA APH
r APH r IPA
cat M cat MPEA IPA APH ACE
Si Si Si Si
PEA
f M
cat APH ACE
EQ Si Si
[ACE][PEA]E K K [IPA][APH] - 
K
r =-r =
[PEA] [IPA] [APH] [ACE]K K [IPA] 1+ + +K K [APH] 1+ + +
K K K K
K [ACE] [APH] [ACE]K 1+ +
K K K
§ ·¨ ¸¨ ¸© ¹
§ · § ·¨ ¸ ¨ ¸© ¹ © ¹
§ ·¨ ¸© ¹
ACE
f M
cat PEA IPA
EQ Si Si
PEA
r f fM
cat cat catIPA
EQ i EQ
IPA
r M
cat PEA
i
K [PEA] [PEA] [IPA]+K 1+ + +
K K K
K [IPA][ACE] [ACE][PEA]K [IPA][APH]+K +K +
K K K
K [APH][PEA]K
K
§ ·¨ ¸© ¹
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Reverse direction: 
> @  r0 cat
[APH] [PEA]
PEA ACE
M MACE PEA
Si Si
E K [PEA][ACE]
r =-r =
[ACE] [PEA]K [ACE] 1+ +K [PEA] 1+ +[PEA][ACE]
K K
§ · § ·¨ ¸ ¨ ¸© ¹ © ¹
                                [4.12b] 
Unlike the methodology of Chen and co-workers (Chen et al., 2008), the simplified model used here 
takes into account substrate inhibition for all components involved in the reaction removing the risk 
of assuming a negligible inhibition region. 
4.5.2 Experimentation 
Analytical methods 
Samples were measured on an Ultimate 3000 HPLC (Dionex, Sunnyvale, CA, USA), equipped with 
a UV detector and a photodiRGHDUUD\GHWHFWRU7KH FRPSRXQGVZHUH VHSDUDWHGRQ D/XQDȝP
C18(2) 100 Å (50 x 4.6 mm) column (Phenomenex, Torrance, CA, USA) at a flow rate of 2 mL/min 
using a multi-step gradient flow of aqueous 0.1% v/v trifluoruacetic acid and acetonitrile, with the 
following gradient of acetonitrile: 0 min (0%), 1 min (10%), 2.5 min (10%), 5.9 min (60%), 6 min 
(0%), 7  min (0%). The compounds were quantified at the following wavelengths: acetophenone 
(280 nm) and 1-phenylethylamine (210 nm), with retention times of 5 and 2.1 minutes respectively. 
Experimental methods 
Unless otherwise mentioned, all reactions were carried out in 4 mL vials with an operating volume 
of 3 mL. The experiments were performed in a thermoshaker (Model 11, HLC Biotech, Bovenden, 
Germany) at Û&ZLWKRUELWDODJLWDWLRQRIDSSUR[LPDWHO\USP7KHS+ZDVPDLQWDLQHGDWE\
addition of 100 mM of potassium phosphate buffer (pH 7). The concentration of co-factor PLP in 
the vial was 2 mM. Samples of 200 L were taken at the specified time intervals and added to a 
centrifuge tube containing 800 L of 1 N HCL in order to stop the reaction. The samples were 
centrifuged for 5 minutes at 14100 rpm (MiniSpin plus, Eppendorf AG, Germany) and analysed by 
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HPLC with a final dilution of 50 fold. The experiments required to collect the six data sets are 
summarized in Table 4.2 as follows: 
Table 4.2 Data collection for the application of the proposed methodology 
Data set [Enzyme]  
(g*/L) 
[IPA] 
(mM) 
[APH] 
(mM) 
[MBA] 
(mM) 
[ACE] 
(mM) 
Sampling time  
(minutes) 
1 0 – 10 1000 5 - - 1, 3, 5 
2 1.8 100, 300, 
500 
1 – 10 - - 1, 3, 5 
3 1.8 - - 1- 30 50, 100, 
500 
1, 3, 5 
4 1.8 1000 1.8 0.8 - Intervals of 30 minutes until equilibrium 
5 1.8 1000 1.7 0.5 - Intervals of 30 minutes until equilibrium 
6a 3.6 - - 5 1000 Intervals of 30 minutes until equilibrium 
6b 1.8 - - 1 – 30 1000 1, 3, 5 
Parity plot 1.8 1000 2 - - Intervals of 30 minutes until equilibrium 
*g represents lyophilized powder 
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4.5.3 Application of the proposed methodology 
Step 1: Determine linear region for increasing enzyme concentration 
Plotting the initial rate of reaction versus the concentration of the enzyme from data set 1 (see 
Figure 4.3), shows that the rate of reaction loses its linearity after an enzyme concentration of 
around 5 g/L. Further addition of the enzyme increases the rate of reaction but not in a linear 
manner with respect to enzyme concentration and therefore also the model predictions were limited 
to rates of reactions carried out with enzyme concentration of up to 5 g/L.  
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Figure 4.3 Enzyme linear region 
Reaction condition: 1000 m M IPA, 5 mM APH, 2 mM PLP, 100 mM phosphate buffer 
Step 2: Perform non-linear curve fitting for decomposed model 
The kinetic model (Equation 4.10) was decomposed into two initial rate models as shown in 
Equation 4.12a and 4.12b. The objective function was formulated as shown in Equation 4.5a and 
4.5b. The objective function was evaluated for different initial parameter values within the range of 
0 – 1000. The new estimated parameters are selected as established in the methodology and listed in 
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Table 4.3 along with the 95% confidence interval (CI) calculated for each of the estimated 
parameters. The optimization was solved in Matlab® (The Mathworks, Natick, MA) using the built-
in least square function with a tolerance of 1.0E-06. Figure 4.4 displays the performance of the 
model predictions with the estimated parameters compared to the experimental data (data sets 2 and 
3). From Table 4.3 it could be seen that the parameters  IPA ACESi SiK , K , which lie in the denominator 
of the fraction in Equation 4.10, were extremely large compared to the operating concentration of 
the reactants. The significance of these terms could thus be considered negligible and were omitted 
from the kinetic model (Equation 4.10). It can be seen visually that a very good fit of the 
experimental data has been achieved. 
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Figure 4.4 Experimental data (symbol) and model prediction (solid line) using estimated parameters 
from step 2.  
Reaction conditions: (a) Forward direction – E0 is 1.8 g/L, concentration of IPA is fixed at 500 mM 
[square], 300 mM [circle] and 100 mM [triangle], 2 mM PLP, 100 mM phosphate buffer (b) 
Reverse direction – E0 is 1.8 g/L, concentration of ACE is fixed at 500 mM [square], 100 mM 
[circle] and 50 mM [triangle], 2 mM PLP, 100 mM phosphate buffer 
 
(a) 
(b) 
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Table 4.3 Estimated parameter values from step 2 using the proposed approach 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameters Estimated 
Values  
95% CI  
Rate Constants 
[min-1] 
  
f
catK  0.0025 ±7E-5 
r
catK  0.023 ±4E-4 
Michaelis Constants  
[mM] 
APH
MK  1.50 ±0.10 
IPA
MK  89.77 ±10.93 
ACE
MK  240.62 ±9.41 
PEA
MK  2.41 ±0.14 
Substrate Surplus Inhibition Constants  
[mM] 
APH
SiK  1.23 ±0.16 
PEA
SiK  6.01 ±0.21 
IPA
SiK  7.2E4 ±7E5 
ACE
SiK  1.1E4 ±1E4 
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Step 3: Perform non-linear regression for full model 
The previously determined parameters  f r APH IPA PEA ACE APH PEAcat cat M M M M Si SiK ,  K ,  K , K ,  K , K ,  K , K were fixed 
and the additional parameters  IPA PEAi iK , K were regressed with data set 4 using the full kinetic 
model (Equation 4.10). The objective function was formulated as shown in Equation 4.6. The full 
dynamic process model represented by the set of ordinary differential equations was solved in 
Matlab® (The Mathworks, Natick, MA) using the ODE45 solver which was based on the Runge-
Kutta algorithm for solving ordinary differential equations. Additionally, integration accuracy was 
set to 1.0E-06 in order to maintain accuracy in the application of the solver.  
Table 4.4 gives the parameter values obtained by minimization of Equation 4.6. Using initial rate 
experiments is not advised in this step as it does not include the effect of the reaction equilibrium 
and may compromise the value of core inhibition parameters. In a report by Shin and Kim (Shin and 
Kim, 1998) LQLWLDOUDWHGDWDZDVXVHGWRHVWLPDWHWKHNLQHWLFSDUDPHWHUVIRUȦ-transaminase (from 
the source Bacillus thuringiensis JS64) catalyzed resolution of 1-phenylethylamine. However, when 
the estimated parameters were analysed, it was evident that the predictions were erroneous. This 
could be confirmed from the significantly deviated predictions of the equilibrium constant when 
compared to literature (Tufvesson et al., 2012).  
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Table 4.4 Estimated parameters values from steps 3 and 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parameters Estimated 
Values  
95% CI  Estimated 
Values  
95% CI  
 Step 3 Step 4 
Rate Constants [min-1]    
f
catK  0.0025 ±7E-5 0.0078 ±7E-5 
r
catK  0.023 ±4E-4 0.013 ±0.007 
Michaelis Constants [mM]   
APH
MK  1.50 ±0.10 1.85 ±4.78 
IPA
MK  89.77 ±10.93 101.28 ±38.23 
ACE
MK  240.62 ±9.41 148.99 ±2.91 
PEA
MK  2.41 ±0.14 0.12 ±0.01 
Substrate Surplus Inhibition Constants [mM]   
APH
SiK  1.23 ±0.16 4.15 ±3E-4 
PEA
SiK  6.01 ±0.21 10.38 ±3E-4 
Core Inhibition Constants [mM]    
APH
iK  - - 0.09 - 
IPA
iK  4281 ±0.03 4281 ±0.63 
PEA
iK  1.55 ±0.01 0.11 ±0.01 
ACE
iK  - - 1E5 - 
Equilibrium Constant    
 KEQ -  0.033  
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Step 4: Perform non-linear regression for full model for re-calibrating all parameters 
The final model and fitted parameters were obtained by regressing all the parameters from steps 2 
and 3 using data sets 2, 3, 4 and 5.  In this case study, the knowledge of the equilibrium constant 
was acquired from literature (Tufvesson et al., 2012). The remaining parameters 
 APH ACEi iK ,  K which were not included in the model (Equation 4.10) were then additionally 
calculated using Equation 4.11.  
The final estimates of the parameters are listed in Table 4.4 and Figure 4.5 illustrates the model 
predictions using the estimated parameters. From Figure 4.5 it can be seen that the model 
predictions fitted very well the experimental data for the progress curve and the initial rate data sets. 
From Table 4.4, it can be seen that the parameter value fcatK which is the catalytic turnover of the 
reaction in the forward direction is much smaller than the parameter value rcatK which is the 
catalytic turnover of the reaction in the reverse direction. This was not surprising as this parameter 
describes the rate of catalyst turnover and from experimental observations the reverse reaction is 
more favourable which is reflected by the difference in fcatK and 
r
catK  values. This is also consistent 
with a study reported by Shin and Kim (Shin and Kim, 1998). The Michaelis constant of the co-
substrates  IPA ACEM MK ,  K  is higher than the corresponding reactants, which reflects the need to add 
an excess of the co-substrate in the reaction media in order to drive the reaction forward, which is 
consistent with other studies reported on transaminases (Kuramitsu et al., 1990). Further it can be 
seen from the substrate inhibition constant of APH, APHSiK  and PEA, 
PEA
SiK  that inhibition 
contributes significantly to the reduction of the rate of reaction which implies the need for a feeding 
strategy to alleviate the substrate inhibition problem. The core inhibition constant for IPA and ACE 
 IPA ACEi iK ,  K are extremely high which was expected since they did not pose any inhibitory affect 
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towards the rate of reaction. However the value of the core inhibition constant of PEA, PEAiK  was 
significantly low which also is consistent with studies reported by other researchers. This confirms, 
what is experimentally observed, that the rate of reaction is significantly reduced with the build-up 
of the product PEA when running the reaction in the forward direction (Shin and Kim, 1997; 
Truppo et al., 2010). The relatively low value of the core inhibition constant indicates the necessity 
of an effective in-situ product removal technique to run the reaction to achieve high levels of 
conversion.   
 
Figure 4.5 Model predictions using the estimated parameters of the model (solid line) and 
experimental data (symbols).  
Reaction conditions; (a) E0 = 1.8 g/L, CIPA = 1000 mM, CAPH=1.70 mM, CPEA= 0.50 mM, 2 mM 
PLP, 100 mM phosphate buffer (b) E0 = 1.8 g/L, CIPA is fixed at 500 mM [square] and CAPH is 
varied from 1 – 10 mM, 2 mM PLP and buffer 100 mM. CACE is fixed at 100 mM (triangle) and 
CPEA is varied from 1 – 30 mM, 2 mM PLP and buffer 100 mM 
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Step 5a: Model validation 
In order to further confirm the validity of the methodology, the estimated parameters used in the 
model were checked against new data (data set 6) of progress curve and initial rate experiments, 
carried out using different initial conditions as shown in Figure 4.6.  
 
Figure 4.6 Model prediction using the estimated parameters (solid line) and experimental data 
(symbols).  
Reaction conditions: (a) E0 = 3.6 g/L, CAPH = 0 mM, CPEA = 5 mM , CACE=1000 mM, 2 mM PLP, 
100 mM phosphate buffer. (b) E0 = 1.8 g/L, concentration of ACE is fixed at 1000 mM, 2 mM PLP, 
100 mM phosphate buffer 
Figure 4.6 shows the comparison of model predictions and experimental data for a different set of 
reaction conditions. As it can be seen, the agreement between the simulated data (solid line) and 
experimental data (symbols) is very good. 
Step 5b: Model analysis 
In this study, the standard deviation of measurements V was assumed to be 5% of the average 
measured concentration during the batch. The standard deviation of measurements was assumed to 
be identical at each time instant. The correlation matrix for the case described here is shown in 
Figure 4.7. As expected (for these type of systems), parameters are significantly correlated. It can 
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be especially seen in the parameters and  displayed strong correlation of around 0.99 
which is reflecting the high confidence interval of the estimated parameters. The true kinetic 
parameter values are strongly influenced by the initial values used in the parameter estimation step. 
That is the reason why the proposed methodology reduces the possibility of accumulating errors in 
the parameter estimation and at the same time provides accurate estimates.  
f IPA APH APH r PEA ACE PEA IPA PEA
cat M M Si cat M M Si i i
f
cat
IPA
M
APH
M
APH
Si
                K           K      K K K K       K K K K
K
K
K
K
                     
         1                
      -0.67     1
      0.26    -0.59     1
 
r
cat
PEA
M
ACE
M
K
K  
K
    0.02     0.34    -0.02     1
      -0.52     0.35    -0.42     0.09     1
    -0.27     0.39     0.03     0.23     0.18     1 
    -0.47     0.84    -0.85     0.41     0.41     0.08  
IPA
i
PEA
i
PPEA
K
K
K
   1 
     -0.19     0.26    -0.12    -0.44     0.01     0.01     0.01     1
     -0.65     0.99    -0.59     0.34     0.34     0.39     0.84     0.26      1
    -0.29     0.62    -0.99     0.05     0.43     0.01     0.87     0.12     0.62     1
§ ·¨ ¸¨ ¸¨ ¸¨ ¸¨ ¸¨ ¸¨ ¸¨ ¸¨ ¸¨ ¸¨ ¸¨ ¸¨ ¸¨ ¸¨ ¸© ¹
 
Figure 4.7 Correlation matrix of the estimated parameters. Negative coefficient between two 
parameters indicates that as one parameter value increases, the other decreases. Positive coefficient 
indicates that both parameter values increase and decrease simultaneously. Zero denotes a lack of 
correlation 
 
4.5.4 Simulations of asymmetric synthesis of 1-phenylethylamine 
The objective of performing simulations is to understand the effect of the concentrations of each of 
the components towards the enzyme productivity. From the results of the parameter estimation it 
was found out that the inhibition by the product 1-phenylethylamine and substrate acetophenone 
was contributing to the reduced activity of the catalyst. Moreover, it was estimated that the reaction 
is extremely unfavourable for asymmetric synthesis.  
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Inhibition by acetophenone and 1-phenylethylamine  
The kinetic model was therefore used to identify an operability space to illustrate the influence of 
the substrate and product as shown in Figure 4.8. Figure 4.8A shows the effect of product and 
substrate concentration on the catalyst activity. The reaction is inhibited at rather low substrate 
concentrations (approximately 5 mM) as reflected on the kinetic parameters, namely the substrate 
inhibition constant of APH. The figure motivates in-situ substrate supply as at high concentration of 
acetophenone the catalyst is strongly inhibited, while at low substrate concentration the reaction rate 
is affected due to low substrate feeding. Therefore it is necessary to accurately compensate substrate 
feeding flow with the desired reaction rate (i.e. the rate of substrate consumption).  
On Figure 4.8B the effect of co-product (acetone) and product (PEA) concentration in solution on 
the catalyst activity can be observed. As observed before, catalyst activity is highly decreased even 
at rather low PEA concentration due to product inhibition. Further, the catalyst activity is also 
affected by the concentration in solution of acetone and therefore acetone removal should be put in 
place, not only to enable equilibrium shifting, but also to increase catalyst activity, as at acetone 
concentrations higher than 30 mM the catalyst activity drops significantly. 
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Figure 4.8 Catalyst activity synthesis of PEA using IPA as amine donor. A) Modelled catalyst 
activity at different product and substrate concentration. B) Modelled catalyst activity at different 
product and co-product concentration (acetophenone concentration is kept constant at 5 mM 
applying a substrate feeding strategy) 
In-situ product removal of products 
The product inhibition constant of 1-phenylethylamine, PEA, is very low suggesting that the 
reaction is strongly inhibited by PEA. This was also the conclusion reached from Figure 4.8. The 
removal of PEA would therefore greatly enhance the reaction rate. The addition of resin as an 
auxiliary phase would help to overcome the inhibition caused by PEA and would thus improve the 
productivity of PEA. 50% (V/V) resin Lewatit AF5 can keep the product concentration of PEA 
below 30 mM and at the same time maintaining a substrate concentration of around 5 mM. Though 
the resin is not highly selective for PEA but it can still help overcome the inhibition problem. A 
second strategy must be applied to remove the co-product acetone in-situ. Physical methods such as 
vacuum evaporation or enzymatic routes of adding an acetone selective alcohol dehydrogenase can 
be couple to remove the co-product very effectively. Figure 4.9 illustrates the impact on conversion 
the introduction of such process strategies.  
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Figure 4.9 Improvement in process with different process strategies shown by means of simulation 
Initial conditions: E0 = 3.6 g/L, CAPH = 300 mM, CIPA=1000 mM. Substrate feeding: F = 0.4 mL/h, 
Co = 1.6 M, Vreactor = 1 L; Substrate feeding – Product removal: Resin = 50% (V/V); SFPR – 
coproduct removal: Acetone removal = 99% of rrxn 
4.6 Case study: enantioselective synthesis of 2-octanol 
Enantiomerically pure 2-octanol (OL) is synthesised from 2-octanone (ON) using the enzyme 
alcohol dehydrogenase from the organism Lactobacillus brevis (LbADH, EC 1.1.1.2). The enzyme 
catalyses the reduction of the ketone to its corresponding alcohol. The enzyme requires 
stoichiometric amounts of co-factor nicotinamide adenine dinucleotide phosphate (NADPH) 
(Leuchs and Greiner, 2011). The co-factor is expensive and therefore recycling it has to be 
considered (Huisman et al., 2010). An enzyme coupled approach was selected based on the high 
selectivity and catalytic efficiency using the enzyme glucose dehydrogenase (GDH, EC 1.1.1.47). 
Co-substrate glucose (Glu) is used as a substrate for the GDH enzyme to yield gluconolactone 
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(GDL) which spontaneously hydrolyses to gluconic acid (Glu). The schematic of the reaction is 
shown in Figure 4.10. 
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Figure 4.10 Reaction system for the enantioselective reduction of 2-octanone 
4.6.1 Reaction kinetic modelling 
The kinetic model to describe the reaction was acquired from a recent publication by Leuchs et al., 
2013. Surplus inhibition by glucose and gluconolactone was included. The kinetic model is an 
ordered bi-bi equation as shown below in Equation 4.13 and 4.14. For details about the mechanism 
please refer to Appendix 1. 
Forward direction:  
,
[ ] [ ]
[ ][ ] [ ] [ ] [ ] 1 [ ]1 [ ] 1 1 1
 § ·§ ·§ · § ·§ ·      ¨ ¸¨ ¸¨ ¸ ¨ ¸¨ ¸ © ¹© ¹ © ¹© ¹© ¹
LbDH f f
NADPHON
MM NADPOL ON Glu Gdl
PP i i i
ON NADPHr V
NADPOL ON Glu Gdl K NADPHK ON
KK K K K
                          [4.13] 
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Reverse direction: 
,
[ ] [ ]
[ ][ ] [ ] [ ] [ ] 1 [ ]1 [ ] 1 1 1
 § ·§ ·§ · § ·§ ·      ¨ ¸¨ ¸¨ ¸ ¨ ¸¨ ¸ © ¹© ¹ © ¹© ¹© ¹
LbDH r r
NADPOL
MM NADPHON OL Glu Gdl
PP i i i
OL NADPr V
NADPHON OL Glu Gdl K NADPK OL
KK K K K
                                               [4.14] 
A similar model was used for the GDH reaction. However, for this reaction the co-product 
gluconolactone formed spontaneously hydrolyses to gluconic acid and therefore can be considered 
irreversible. Equation 4.15 presents the kinetic model to describe the GDH reaction. A substrate 
surplus inhibition of glucose was also considered in the model.  
[ ] [ ]
[ ][ ] 1 [ ][ ] 1
GDH
NADPGlu
MM NADPHGlu
Pi
Glu NADPr V
NADPHGlu K NADPK Glu
KK
 § · § ·  ¨ ¸ ¨ ¸© ¹© ¹
                                           [4.15] 
4.6.2 Experimentation 
Kinetic measurements were carried out in a Biotek Powerwave HT multiplate fluorescence 
spectrometer in black 96-well-plates (nunc immuno modules). The total reaction volume was 200 
L. The pH was maintained at 7 by the addition of 100 mM of ADA (pH 7) buffer while the 
temperature was controlled at 30oC. Ionic liquid, TEGO IL K5 of 0 or 100 g/L was used to increase 
solubility of the substrate. The experimental types and conditions are shown in Table 4.5.  
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Table 4.5 List of experiments for estimating kinetic model parameters 
Data 
set 
Type of 
experiment 
[Enzyme]  
(mg/L) 
[NADPH] 
(mM) 
[2-on] 
(mM) 
[NADP+] 
(mM) 
[2-ol] 
(mM) 
[Glu] 
(mM) 
[Gdl] 
(mM) 
1* Initial rate 1.25 0 – 0.20 0 – 54 0 – 0.05 0 – 10 0 - 675 0 – 450 
2** Initial rate 10 0 – 0.05 0 0.002 – 
0.05 
0 0.5 - 
1350 
0 – 450 
3* Progress 
curve 
0.31 0.05 3.4 - 54 0 0      0 0 
4** Progress 
curve 
1.25 0 0 0.08 0 84 - 675 0 
5 Progress 
curve 
50 (ADH) 
280 (GDH) 
0 60 0.10 0      200 0 
*LbADH measurements 
**GDH measurements 
 
4.6.3 Application of proposed methodology 
The kinetic models to describe the LbADH and GDH reaction were initial rate models and therefore 
there was no possibility to decompose the models further. The estimation routine therefore 
commenced from step 4.  
Step 4: Perform non-linear regression for full model for re-calibrating all parameters  
The calibration of the parameters was performed by using both the initial rate and progress curve 
data sets (data sets 1 and 3 or 2 and 4) simultaneously. Table 4.6 displays the estimated parameters 
for LbADH system while Table 4.7 tabulates the results of the estimation for the GDH system. The 
95% confidence intervals of the estimates are calculated for the estimation as well.  
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Table 4.6 Parameter estimates for LbADH model 
Parameters Estimated value 95% CI 
Velocity (mM/s)   
Vf 0.0003 2E-6 
Vr 0.0002 3E-6 
Michaelis Constant (mM)   
ON
MK  0.21 0.02 
OL
MK  0.03 0.001 
NADPH
MK  0.04 0.001 
NADP
MK  0.83 0.05 
Core Inhibition constant (mM)   
ON
PK  0.01 0.002 
OL
PK  0.21 0.02 
NADPH
PK  0.36 0.03 
NADP
PK  0.21 0.02 
Substrate Surplus Inhibition constant (mM)  
ON
iK  163.05 10 
OL
iK  6065 4040 
Glu
iK  2985 739 
Gdl
iK  3818 1563 
From Table 4.6 it can be seen that the parameter value Vf which is the velocity of the reaction in the 
forward direction is larger than the parameter value Vr which is the velocity of the reaction in the 
reverse direction, thereby indicating that the forward reaction is more favourable. This is also 
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consistent with a study reported by Leuchs et al., 2012. The Michaelis constant of the co-substrate, 
NADPH, NADPHMK is much smaller than for the co-product, NADP, 
NADP
MK providing indication that 
the enzyme is more selective for NADPH than NADP. Further it can be seen from the substrate 
surplus inhibition constants, OLiK , 
Glu
iK  and 
Gdl
iK of the components 2-octanol, glucose and 
gluconolactone respectively are extremely large. These parameters therefore do not significantly 
affect the rate of reaction and could be eliminated from the model.  
Table 4.7 Parameter estimated for GDH model 
Parameters Estimated  
value 
95% CI 
Velocity (mM/s)   
V 0.0001 9E-7 
Michaelis Constant (mM)   
Glu
MK  2.72 0.22 
NADP
MK  0.02 0.001 
Core Inhibition constant (mM)   
NADPH
PK  0.03 0.02 
Surplus Inhibition constant (mM)  
Glu
iK  3783 278 
From Table 4.7 it can be seen that the velocity parameter, V, is relatively smaller as compared to Vf 
for the LbADH reaction thus indicating the necessity of adding the GDH enzyme in excess to match 
the LbADH rate of reaction. Furthermore, it can be seen that the Michaelis constant, NADPMK , is 
much smaller as compared to NADPHMK for the LbADH reaction. This therefore indicates that the 
GDH enzyme is quite selective for NADP used and thus would be effective in regenerating the co-
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factor. The substrate surplus inhibition of glucose, GluiK  is extremely large as compared to the 
operating concentration of glucose in the experimental condition. It could therefore be suggested 
that this parameter could be eliminated from the model.  
Step 5a: Model validation 
An independent data set, data set 5, was used for validating the model predictions. The models for 
LbADH and GDH are combined in sequence and are used in a batch reactor model.  
In order to further confirm the validity of the models, the estimated parameters used in the model 
were checked against new data (data set 5) of progress curve carried out using different initial 
conditions as shown in Figure 4.11. The experiment was carried out in a batch reactor where both 
enzymes were introduced simultaneously. The models were also formulated to mimic the 
experimental conditions. Figure 4.11 illustrates the model predictions. 
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Figure 4.11 Model prediction using the estimated parameters (solid line) and experimental data 
(symbols). Reaction conditions are shown in Table 4.5, data set 5. 
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Figure 4.11 shows the comparison of model predictions and experimental data using data set 5 
which was not used in parameter estimation. As can be seen, the agreement between the simulated 
data (solid line) and experimental data (symbols) is very good. However, the model tends to 
underestimate at higher conversions. Nevertheless, the model can predict the overall tendency of the 
progress of the reaction.  
Step 5b: Model analysis 
From the parameter estimation, it was found that there were many parameters for each model. 
However, some of the parameters resulted in extremely large values with a big confidence interval. 
In order to minimize the simulation time, it would be desirable to eliminate redundant parameters 
that do not influence the model predictions. Based on the estimates of Table 4.6, it was envisaged 
that removing the three substrate surplus inhibition constants of 2-octanol, glucose and 
gluconolactone would be appropriate. Furthermore from Table 4.7, it was envisaged to eliminate the 
substrate surplus inhibition constant of glucose. Moreover, the parameter NADPHPK  also displayed a 
large confidence interval relative to the estimated value. Consequently, this parameter could also be 
eliminated. The model structures were modified by eliminating the parameters. In order to identify 
each model modification, the model structures are named as presented in Table 4.8.  
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Table 4.8 Parameters that are eliminated for each model structure 
Model # Eliminated parameter 
Model 1 OLiK
Glu
iK
Gdl
iK (from ADH model) 
Model 2 
OL
iK
Glu
iK
Gdl
iK (from ADH model) 
Glu
iK (from GDH model) 
Model 3 
OL
iK
Glu
iK
Gdl
iK (from ADH model) 
Glu
iK
NADPH
PK  (from GDH model) 
The modified models were then implemented in Matlab® in order to analyse the effects of the 
model simplification both graphically and numerically in comparison with the original model. 
Table 4.9 Output model comparison between original model and simplified model 
Model Eliminated 
parameters 
Deviation (%) 
Model 1 3 0.001 
Model 2 4 0.5 
Model 3 5 7.5 
The deviation is calculated as the average value of the errors between the modified and the original 
models, presented as a percentage. Table 4.9 shows that even though maximum five parameters are 
removed from the original model, the simplified models show differences of less than 10%. It 
demonstrates that the insignificant parameters in this case can be removed from the model without 
producing big differences in the model prediction accuracy. 
For the graphical comparison, the concentration of the desired product 2-octanol is taken as model 
output. Figure 4.12 shows the plots obtained from the dynamic simulation of each modified model. 
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It shows that all simplified models can well follow the dynamics of the original process. 
Furthermore the deviation between different model predictions is again really small. 
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Figure 4.12 Comparison between dynamic simulations of the modified models 
 
4.6.4 Simulations for the production of 2-octanol 
Inhibition by 2-octanone and 2-octanol 
The kinetic model was used to identify an operability space to illustrate the influence of the 
substrate and product as shown in Figure 4.13. Figure 4.13 shows the effect of product and substrate 
concentration on the catalyst activity. The reaction is very inhibited at rather low substrate 
concentrations as reflected on the kinetic parameters, namely the substrate surplus inhibition 
constant of 2-octanone. However, the reaction was not inhibited by the product. The figure 
therefore motivates a substrate feeding strategy. Alternatively a continuous stirred tank reactor 
would be suggested which would maintain low substrate concentration in the reactor and at the 
same time achieve high catalyst yield (gproduct/genzyme).  
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Figure 4.13 Operability space for 2-octanol production 
4.7 Discussions about kinetic modelling 
In the proposed methodology for kinetic model parameter estimation, model decomposition along 
with non-linear regression of both initial rate data and progress curves has been incorporated. 
Although, non-linear regression is a quicker method which utilizes all the information from the 
experiments, it rarely results in a global optimum because of the existence of the strong correlation 
between the parameters which results in erroneous predictions. Thus a step-wise estimation is used 
in the current approach which assists in increasing the probability of finding the global optimum. 
The final model with the fitted parameters is able to describe both types of experiments (initial rate 
and dynamic experiments). The methodology is approached in a systematic and step-wise manner 
such that the parameters are reconciled at every step in order to minimize the estimation errors.  
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The kinetic model was further useful for outlining the operability space of each of the case studies. 
It was evident from the first case study that the substrate (APH) and product (PEA) reduced the 
activity of the catalyst. It would therefore suggest that using an auxiliary phase such as porous 
resins can greatly enhance the productivity of the catalyst. However, this strategy alone cannot 
overcome the challenges of the reaction. The unfavourable thermodynamic challenge has to be met 
by by incorporating a strategy to remove the co-product, acetone. Different strategies such as 
evaporation (Martin et al., 2007; Savile et al., 2010), gas stripping (Zanfir et al., 2008) and 
enzymatic cascade (Ricca et al., 2011) are possible options which have to be evaluated before its 
applications in the process.  
The kinetic study of synthesis of 2-octanol using a cascade of enzymes LbADH and GDH revealed 
that the kinetic model contained several parameters which were redundant for accurate model 
predictions. The structure of the model was simplified based on a step by step model analysis. The 
original model was over parameterized and a feasible simplification could be performed without 
losing reliability of the model. It was also found that the simplified models still showed a good 
performance with a deviation of less than 10% from the original model. The results of simulations 
using the kinetic model suggested that a continuous stirred tank reactor (CSTR) would be beneficial 
to overcome substrate inhibition (Leuchs et al., 2013; Vasic-Racki et al., 2003a). However, for a 
CSTR the conversion is measured based on the leaving concentration and therefore more than one 
CSTR would be required to achieve a high final conversion.  
4.8 Conclusions 
A methodology to estimate the kinetic model parameters of complex biocatalytic reactions has been 
GHYHORSHG 7KHPHWKRGRORJ\ LV H[HPSOLILHG ZLWK WKH FDVH VWXG\ RI DQ Ȧ-transaminase-catalysed 
reaction which displays severe substrate and product inhibition and enantioselective production of 
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2-octanol which is limited by substrate inhibition. The methodology takes into account the 
advantages of previously developed methodologies and aims to avoid assumptions which lead to 
erroneous estimates. The methodology decomposes the kinetic model into initial rate models in 
order to reduce the number of parameters to be estimated simultaneously. The optimization is 
solved for different initial values of the catalytic turnover, Michaelis parameters and substrate 
inhibition parameters to increase the probability that the final regressed parameters correspond to 
global optimal solution.  The parameters are then fixed and the remaining core inhibition 
parameters are determined by non-linear regression using progress curves on the full model. 
Finally, all the parameters are reconciled (re-estimated) using all the data sets (initial rate and 
progress curve) to obtain the final kinetic model with the corresponding fitted parameters. The final 
model with the regressed parameters is able to describe initial rate and progress curve data sets. The 
methodology is highly reliable which is further validated by comparing predicted values of product 
concentration with different sets of experimental results. The usefulness of building the kinetic 
models was shown by building operability spaces for the different reactions. The model simulations 
suggested different process strategies based on the characteristics of the reactions. Moreover, 
quantitative values were able to be calculated which would be extremely important when selecting 
process strategies. 
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Chapter 5  
Screening porous resins for  
integrating in enzymatic processes 
 
 
5.1 Introduction 
Of the different types of auxiliary phases discussed in Chapter 3, porous resins are the selected type 
used for this thesis. The resins are comprised of porous polymeric matrix varying in particle size, 
pore size, hydrophobicity and functional groups. In this study, the resins that are considered are 
neutral (non-ionic) that work primarily on hydrophobicity based on adsorption. Generally 
separation based on hydrophobicity has low capacity (Woodley, 2012). It is therefore of particular 
importance to identify a resin that has high capacity for the inhibitory substrate and product to 
reduce resin loading. Such an example can be seen in the screening of resins for a microbial Baeyer-
Villiger oxidation (Hilker et al., 2004). The selected resin had the highest capacity (gsubstrate/gresin) of 
0.3 (10 g substrate on 30 g of resin) among the tested resins thus enabling the opportunity to 
integrate with an internal configuration in a batch reactor (Hilker et al., 2005). Similar studies where 
the resin loading was the primary selection criteria can be seen in the synthesis of Ethyl (S)-2-
Ethoxy-3-(p-methoxyphenyl) propanoatethe (Bechtold et al., 2011) and in the synthesis of (S)-1-(2-
chlorophenyl)ethanol (Schmolzer et al., 2012). In other cases, the affinity of the resin for the either 
the substrate or product was the key parameter for selecting the resin. Such a study was done in the 
synthesis of D-Phenylglycine (Rojanarata et al., 2004). The resin Amberlite IRA-400 could 
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maintain the substrate concentration at a level where the reaction rate was not impeded and 
simultaneously had an affinity for the co-product enabling to shift the reaction towards the synthetic 
direction.   In the study done by Vicenzi et al., 1997 resin Amberlite XAD-7 was selected as it had 
intermediate resin polarity and at the same time moderate affinity for the substrate and product thus 
enabling to overcome substrate and product inhibition simultaneously.  
Prior studies using porous resins as an auxiliary phase as a means for in-situ substrate feeding and 
product removal were done for single substrate – single product system.  For multi 
substrate/product systems such as transferases or aldolases, selectivity (affinity) and capacity are 
key parameters which have to be evaluated simultaneously in the screening procedure. The selected 
resin should preferably display high affinity for the “inhibitory” compounds and simultaneously hav 
low affinity for the “non-inhibitory” compounds as it would compromise the resin capacity. 
Similarly the resin should preferably have a higher partitioning for the inhibitory product over the 
inhibitory substrate in order to drive the reaction in the synthetic direction. When considering 
UHDFWLRQV ZKLFK GLVSOD\ VXEVWUDWH DQG SURGXFW LQKLELWLRQ VXFK DV WKH Ȧ-transaminase catalysed 
reactions with components having similar chemical properties, a compromise has to be made 
between capacity and selectivity. 
  
The substrate to resin ratio (load) plays an essential role in determining the equilibrium aqueous 
concentration of the substrate in the reactor. On the other hand, the rate of in-situ product removal 
increases with increasing amount of resin. Therefore, an optimal amount of resin has to be 
experimentally evaluated which would facilitate the required mass transfer of the substrate from the 
resin to the aqueous phase and product from aqueous phase to the resin (Woodley, 2012). Moreover 
the amount of resin plays a role in determining the type of reactor that can be used (Burton et al., 
120
102 
 
2002).  Finally the cost of the resin has to be evaluated. For the process to be economic, the resin 
has to be recyclable and easily regenerated. Table 5.1 tabulates the essential criteria for the resins. 
Table 5.1 Criteria for selection of resin 
High resin capacity for product ( 0.12) 
Low selectivity for non-inhibitory substrate and 
product to bind with the resin (S § 
Moderate selectivity for inhibitory substrate and 
product to bind with the resin (S  1) 
Greater partitioning for inhibitory product over 
inhibitory substrate (PP/PS  1) 
Negligible affinity to enzyme (if soluble) (S § 
Re-usable (Multiple times) 
Durable in reactor (non-brittle) 
Biocompatible ( no effect on enzyme – denaturation) 
 
5.2 Proposed methodology for screening resins 
A rational methodology for screening resins based on the criteria mentioned in Table 5.1 is shown 
below in Figure 5.1. The screening is decomposed into three hierarchical steps where the result of 
each of the steps becomes the input for the subsequent step. The experimental data is broken down 
into four sub sets to match the different steps of the screening. Two types of database are used here, 
the first provides physical properties of the reactants and the second is a database containing 
information about commercially available resins. 
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No
No Continue To Reactor Design
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Experiment to measure:
1. Capacity of product
2. Selectivity of components
3. Partioning of target 
components
Re-usability of 
resins
DATABASE STEPS EXPERIMENTS
Dataset 1
Dataset 2 and 3
Dataset 4
 
Figure 5.1 Proposed methodology for selecting resin 
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5.3 Description of proposed methodology 
Step 1: Characterize reaction 
Step 1 is performed to characterize the reaction using dataset 1 and a physical property database. 
Dataset 1 is used to determine the critical concentration of the different components. The 
components which display inhibition will be considered for adsorption on the porous resin. To 
adequately explore the type of resin required for the process, the important parameters of the 
different components, Log P and water solubility values, are identified from commercially available 
physical property databases. These parameters provide a measure of the hydrophobicity of the 
components (Jaksland et al., 1995).  
Step 2: Screen resin 
In step 2 different types of resins were selected from a resin catalouge obtained from the different 
company sites (www.sigmaaldrich.com). The screening of these resins was first done using data set 
2 where the capacity of the target compound was measured experimentally. The resins which 
displayed the highest capacity (mol/kgresin) for target compound were selected for further screening.  
The second screening is done based on the selectivity of the target compound over the other 
reactants. This parameter provides an indication of which compound it has a higher affinity for. The 
information is obtained from data set 2 where the adsorption capacity for all the reactants is 
measured. The selectivity is calculated using Equation 5.1. 
i%C  adsorbedSelectivity,  
%product adsorbed
 S   [5.1] 
where Ci are the other components 
The resin which displays selectivity lower than 1 indicate the resin has less affinity for the 
compound with respect to target product. A selectivity of higher than 1 indicates the resin has 
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higher affinity for the compound rather than target product while 1 indicates the resin displays equal 
selectivity for both compound and target product. Resins displaying selectivity of lower or equal to 
1 is selected for further screening. 
The third screening is done using data set 3 where the partitioning of the inhibitory product and 
inhibitory substrate are experimentally measured by fixing the amount of resin and varying the 
concentration of those components. For the resin to be the best candidate, it has to display 
favourable adsorption isotherm to provide evidence of its affinity for binding to the given reactant.  
Step 3: Evaluate cost of introducing resin 
The added value of introducing the resin as the second phase is evaluated based on the cost of the 
resin. The resin should be relatively cheap. Otherwise it has to be able to be re-used several times to 
minimize this cost effect.  
5.4 Data collection 
The type of data that has to be collected for the proposed approach is summarized as follows: 
Data set 1: initial rate of reaction was measured for varying substrate concentration at a fixed 
enzyme concentration.  
Data set 2: the corresponding equilibrium concentration of the different reactants at fixed initial 
concentrations was measured in the reactor in the presence of fixed amount of resin. The 
concentration in the resin is calculated based on mass balance. The resins were always used as wet. 
Data set 3: the adsorption isotherms are measured with varying concentration of the target 
components at a fixed amount of resin.  
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Data set 4: the repeated performance of the resin was measured by evaluating the capacity of the 
resin for the target product. The resin was packed in a column with product flowing top-down at a 
flow rate of 2 bed volumes per hour. After the product was loaded on the resin, acetonitrile was 
used to elute the product in a reverse flow at 2 bed volume per hour.  This process was repeated 
several times to measure the resins ability to be re-used.  
Physical property database: commercially available databases such as EPISuite , can be used for 
obtaining properties of the different components 
Resin database: databases from resin distributor companies such as Sigma-Aldrich can be used for 
getting information about the different types of resins (surface area, bead size, pore diameter and 
chemistry) and the cost of the resin. 
5.5 Case study: asymmetric synthesis of 1-phenylethylamine 
The synthesis of optically pure 1-phenylethylamine XVLQJȦ-transaminase (EC 2.6.1.X, ATA - 040, 
C-Lecta) (TAm) was selected for illustration of the methodology. The reaction is catalysed by the 
transfer of an amine (-NH2) group from an amine donor to a pro-chiral acceptor ketone, yielding a 
chiral amine as well as a co-product ketone (Koszelewski et al., 2010). These enzymes require 
pyridoxal phosphate (PLP) as a cofactor to act as a shuttle to transfer the amine moiety between the 
molecules (Hwang et al., 2005). The following reaction was selected for the synthesis of 1-
phenylethylamine (PEA) as shown in Figure 5.2.  
+ NH2 + O
O NH2
TAm
PLP
acetophenone 2-propylamine (S)-1-phenylethylamine acetone
 
 Figure 5.2 Reaction pathway for the synthesis of 1-phenylethylamine 
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The specific challenges that have to be addressed in this system include substrate and product 
inhibition and low aqueous solubility of the substrate (Chapter 4.5). Consequently, there is a strong 
motivation to introduce resins to overcome these challenges. 
5.5.1 Experimentation 
Material 
 Reagents and solvents of highest purity were purchased from Sigma-Aldrich (Buchs, Switzerland) 
DQG XVHG ZLWKRXW IXUWKHU SXULILFDWLRQ 7KH XQSXULILHG HQ]\PH Ȧ-transaminase (ATA-044) which 
came as lyophilized powder was kindly supplied by c-LEcta Gmbh (Leipzig, Germany). In all 
experiments enzyme amount refer to gram of lyophilized powder. All resins were kindly provided 
by Sigma Aldrich (Buchs, Switzerland). The moisture content of the resins was measured by 
calculating the loss of weight after drying for 12 hours at 100oC. 
Methods 
Analytical methods:  
HPLC 
Samples were measured on an Ultimate 3000 HPLC (Dionex, Sunnyvale, CA, USA), equipped with 
a UV detector and a photodiode array detector. The compounds were separDWHGRQD/XQDȝP
C18(2) 100 Å (50 x 4.6 mm) column (Phenomenex, Torrance, CA, USA) at a flow rate of 2 mL/min 
using a multi-step gradient flow of aqueous 0.1% v/v trifluoruacetic acid and acetonitrile, with the 
following gradient of acetonitrile: 0 min (0%), 1 min (10%), 2.5 min (10%), 5.9 min (60%), 6 min 
(0%), 7  min (0%). The compounds were quantified at the following wavelengths: acetophenone 
(280 nm) and 1-phenylethylamine (210 nm), with retention times of 5 and 2.1 minutes respectively.  
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Spectrophotometer 
The concentration of 2-propylamine was measured ex-situ on an UV 1800 Spectrophotometer 
(Shimdzu, Kyoto, Japan) quantified at wavelength of 590 nm with fixed temperature of 30oC using 
protocols developed by Rahman and co-workers (Rahman et al., 2003). The concentration of 
acetone was measured ex-situ on an UV 1800 Spectrophotometer (Shimdzu, Kyoto, Japan) 
quantified at wavelength of 280 nm with fixed temperature of 30oC using an internal standard. Note 
that these compounds can be only measured independently and not in a mixture.  
GC 
The concentration of APH and 1-phenylethylamine were determined using an internal standard (20 
mM 1-octanol in ethanol) with an autosampler TriPlus, Thermo Scientific, Dreieich, Germany 
automatically from a flow cell in the product stream with 0.5 L sample mixed with 1 L of 
standard solution (20 mM of 1-octanol in ethanol) and injected into a Focus or Trace GC from 
Thermo Scientific, Dreieich, Germany (carrier gas: H2, 80 kPa) with a temperature setting of 100°C 
(5 min), 10°C/min to 140°C (0 min) and 40°C/min to 180°C (1 min) to measure APH (5.3 min), 
PEA (5.8 min) and 1-octanol (7.1 min).  
Experimental methods:  
Data set 1: Inhibition studies 
Initial rate experiment was performed with fixed concentration of IPA at 1000 mM while the 
concentration of the co-substrate was varied from 0 – 30 mM. To observe the product inhibition of 
PEA, initial rate experiment was performed with fixed concentration of IPA at 1000 mM and APH 
at 10 mM. PEA was added at a range varying from 0 – 10 mM. The pH was maintained at 7 by 
addition of 100 mM of potassium phosphate buffer (pH 7) to each vial. To a final reaction volume 
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of 3 mL, concentration of crude enzyme was fixed at 2.1 g/L. Samples were withdrawn at 1, 3 and 5 
minutes and diluted 5 times with 6 N HCl to end the reaction. The concentration of APH and PEA 
were measured using the HPLC. 
Data set 2: Adsorption capacity of reactants 
50 mg of each resin was added to four 3 mL vials. Each vial contained 50 mM of APH or 300 mM 
PEA or 2 M IPA or 2 M ACE. The vials were agitated at 300 rpm at 30oC for 24 hours. A sample of 
the aqueous solution was drawn from the vial to determine the concentration of the reactants in the 
vial. The concentration in the resins was calculated based on mass balance. Samples were analysed 
by either HPLC (for APH and PEA) or spectrophotometer (for ACE and IPA). Note the resin was 
wetted with de-ionized water prior to use. 
Data set 3: Adsorption isotherms between resin and components 
50 mg of each resin was added to five 3 mL vials consisting of a range of component concentrations 
(0 till solubility limit of limiting substrate).  The vials were agitated at 300 rpm at 30oC for 24 
hours. A sample of the aqueous solution was drawn from the vial to determine the aqueous 
concentration of the reactants in equilibrium in the vial. The concentration of the reactants in the 
resins was calculated by mass balance. Samples were analysed by using HPLC. 
Data set 4: Re-usability of resins 
The micro reactor which was constructed from a polymer of acrylonitrile butadiene styrene (ABS) 
was at first tested for adsorbing capacity for the reactant PEA. The polymer was cut into different 
sizes and incubated in 300 mM PEA solution. Samples were withdrawn after 24 hours to confirm 
that there was no significant evidence to support that PEA adsorbed on to ABS. The resin was 
packed in a column (1 mL volume) to a bed volume of 0.5 mL to test the performance of the resin 
(adsorption capacity). 300 mM of PEA was flowed through the column at a flow rate 0.05 mL/min 
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for 2 hours. Samples were taken every 10 minutes at the outlet for analysis by HPLC. Afterwards, 
the PEA was extracted from the resin with acetonitrile flowed through the column at 0.05 mL/min. 
This procedure was performed for repeated batches.  
Synthesis of 1-phenylethylamine 
The process was set up in a batch mode where an external resin packed column was connected to a 
membrane reactor. Prior to the experiments, the reactor was flushed with ethanol and water. A 10 
kDA cut-off polyethersulfone membrane from Sartorius Stedim (ø= 63 mm) was wetted in water 
and then carefully placed into the reactor avoiding air-inclusions. The reaction mixture was then 
pumped into the membrane reactor and through the substrate loaded column (210 mM APH) to 
initiate the reaction. After the column the flow went through a flow cell and back to the membrane 
reactor. The reaction mixture contained 1.8 g/L of crude ATA-44 enzyme, 1000 mM 2-propyl 
amine, 2 mM PLP. Conversion was determined by automatically taking samples of 0.5 L with an 
autosampler from a flow cell and directly injecting the sample together with 1 mL of an internal 
standard (20 mM of 1-octano1 in ethanol) into a Focus GC (Thermo Scientific, Dreieich, Germany) 
for GC analysis. The samples were used for determining APH and PEA.  
Product elution from the resin packed column 
The product from the column was eluted using n-heptane with a flow rate of 30 mL/h. 200 L of 
sample was collected every two hours at the outlet and diluted with 800 L of standard solution (20 
mM of 1-octanol in ethanol).  The concentration of PEA and unreacted APH content was 
determined via GC.  
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5.5.2 Application of the proposed methodology 
Step 1: Characterize reaction 
Plotting the activity of the enzyme versus concentrations of the different components from data set 
1 (see Figure 5.3) shows that APH and PEA were causing inhibition. Increasing concentration of 
these compounds in the reactor resulted in decreased activity of the enzyme. The other reactants, 
IPA and ACE, did not show any inhibitory effect within the experimental conditions (data not 
shown).   
5.5.3   
 
 
 
 
 
 
Figure 5.3 Inhibition by substrate acetophenone (open squares) and product 1-phenylethylamine 
(filled squares) 
Reaction condition: E0 = 2.1 g/L, CIPA = 1000 mM, Phosphate buffer = 100 mM (pH 7) 
To further explore the properties of the reactants, a database (EPI) was used to obtain information 
for selecting the type of resin. Table 5.2 tabulates the properties of the reactants involved in the 
desired reaction scheme (Figure 5.2). The Log P value along with the solubility of the reactant 
expresses the hydrophobicity or hydrophilicity of the components. Based on these parameters it can 
be seen that the reactants PEA and APH are both hydrophobic while the others are hydrophilic. It 
will be thus beneficial to carry out the reaction in a two phase reactor using neutral resins to exploit 
the hydrophobicity of the reactants by selectively supplying APH and removing PEA in situ in 
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order to optimize the productivity of the catalyst (mass of product per mass of catalyst) which is 
required in order for the process to be feasible (Tufvesson et al., 2011b).    
Table 5.2 Physical properties of the reactants 
Component Molecular 
weight 
g/mol 
Water 
solubility 
[g/L] 
Log P 
APH 120.15 6.13 1.58 
IPA 57.09 1000 0.26 
PEA 121.18 42 1.49 
ACE 58.08 1000 -0.24 
Step 2: Screen resin 
In this study the resins were looked up in the Sigma Aldrich catalogue as listed in Table 5.3 and 
were tested for their potential to be the resin that fulfilled the selection criteria. The resins were 
selected on the basis that they are commercially available at relatively low cost and neutral charged. 
The resins differed in surface area, pore diameter and matrix of the resin. The moisture content was 
also measured to correlate the dry weight of the resins. 
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Table 5.3 Resin properties 
Adsorbent Type Matrix Surface Area  
[m2/g] 
Pore Diameter 
[Å] 
Moisture content 
[%] 
MCI gel  CHP20P SDB 500 400-600 58.1 
Diaion  HP-20SS SDB 500 260 49.6 
Amberchrom CG300C SDB 700 300 72.3 
Lewatit  VPOC1064 SDB 800 50 68.4 
Sepabeads  SP850 SDB 1000 38 65.8 
Optipore  L493 SDB 1100 46 49.7 
Amberlite  XAD7HP SA 450 90 51.9 
Lewatit  VPOC1600 SAM 130 150 64.2 
Co-polymer Poly ESDB ESDB 650 100 52.6 
Lewatit AF5 Carbon 1200 80 46.4 
Note: SDB – styrene divinyl benzene; SA – styrene acrylate; SAM – styrene methyl-acrylate; ESDB – 
ethylstyrene divinyl benzene 
Capacity for 1-phenylethylamine  
The capacity for PEA (mol/kgresin) was measured experimentally for each of the resins using data 
set 2. The capacity is tabulated in Table 5.4. As it can be seen that the resins with the larger surface 
area displayed a higher capacity for PEA. This result indicates that the matrix of the resin plays 
little role for dictating the affinity of the components. It should be specifically noted that resins 
L493 and AF5 had the highest capacity for PEA.  
Selectivity of 1-phenylethylamine  
The selectivity of PEA over the other components was calculated using data set 3 and presented in 
Table 5.4. From Table 5.4, it can be seen that none of the resins were more selective for PEA with 
respect to APH. The selectivity ratio was always greater than 1 for APH indicating that the resins 
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were non-selective for PEA and thus could be effective for only overcoming the kinetic limitations 
(inhibition) and not for shifting the reaction towards product side. The resin L493 displayed the 
highest selectivity of APH/PEA. Moreover, the resin showed selectivity of almost unity or lower for 
the other reactants. On the other hand, resin AF5 displayed selectivity much lower than unity for 
IPA/PEA and co-product ACE/PEA. Resin CG300C displayed commendable selectivity for PEA 
over IPA and ACE but the capacity for PEA was nominal. Therefore, resins AF5 and L493 were 
selected for further investigation. 
Table 5.4 Capacity and selectivity of target molecule  
 
 
Adsorption Isotherms between resin and components  
The distribution of the different compounds between the resin phase and the aqueous phase was 
tested with the two candidates selected from previous screening. The isotherms for the different 
resins are shown in Figure 5.4. It can be seen that the resins either follow L shaped or S shaped 
Adsorbent Capacity Selectivity 
 [mol/kg] [g/g] [APH/PEA] [IPA/PEA] [ACE/PEA] 
CHP20P 1.7 0.21 5.55 2.42 0.60 
HP-20SS 1.8 0.22 4.34 1.14 0.27 
CG300C 1.9 0.23 2.56 0.10 0.77 
VPOC1064 1.8 0.22 4.76 6.25 0.07 
SP850 2.0 0.24 5.00 2.85 0 
L493 2.3 0.28 2.56 1.06 0.37 
XAD7HP 1.7 0.20 4.00 1.72 0.29 
VPOC1600 1.2 0.14 4.16 0.23 1.05 
Poly ESDB 2.2 0.26 4.54 2.27 0.21 
AF5 4.3 0.52 3.57 0.34 0.51 
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curve which is in accordance with adsorptions studies done previously for ketones (Hilker et al., 
2004) and amino acids (Grzegorczyk and Carta, 1996). In Figure 5.4 it can be seen that the resin 
AF5 has a much stronger affinity for both APH and PEA as compared to resin L493. The 
distribution coefficient of APH between the resin and the aqueous phase for AF5 and L493 was 
determined to be 5112 and 450 L/kg respectively. The distribution of PEA between the resin and 
aqueous phase for AF5 and L493 was determined to be 69 and 43 L/kg respectively. These values 
were calculated with the assumption that the isotherms follow Langmuir adsorption isotherm. These 
values will be determined in a reliable and systematic way in a following chapter. These values can 
be used to provide the partitioning tendency of the resins. The partitioning of acetophenone in 
various aqueous-organic phase systems was measured in a study done by Shin and Kim, 1997 (Shin 
and Kim, 1997). The highest partitioning coefficient of 191.9  was achieved using a 20% v/v 
mixture of toluene. In the same study, the partitioning of PEA in 20% v/v of cyclohexanone in 
phosphate buffer at pH 7 was measured to be 14.45. Consequently it can be suggested that resins 
have higher distribution coefficients than solvents (Straathof, 2003). Based on the attributes of the 
resin AF5, high capacity for PEA, relatively high selectivity of target compound PEA over IPA and 
possibility of high loading of substrate, it was selected to for the final screening of step 3. 
 
  
 
 
 
Figure 5.4 Adsorption isotherms of the different components in the reaction media. left: 
acetophenone, right: 1-phenylethylamine. (Legend – AF5 (square), L493 (triangle)) 
134
116 
 
The cost of resins if assumed for bulk purchase, are relatively low. The cost of resin Optipore L493 
can be assumed to cost around $2.2/kg based on the cost as quoted in Sigma-Aldrich website. 
Similarly, activated carbon costs around $0.60/kg (Sherman, 2012). The costs are relatively lower 
when compared to typical solvents used as a water-immiscible auxiliary phase such as toluene 
($3/kg). However, to be more attractive than solvents as an immiscible auxiliary phase and as well 
as to reduce the impact on downstream operating cost, it is necessary to be able to re-cycle the 
resins.  
The performance of the resin (adsorption capacity) was experimentally measured for five batches 
using data set 5 as shown in Figure 5.5. It can be noted that there is a slight deviation in the 
experimental results. The deviations could be explained through experimental errors and sample 
handling. However, the data provides evidence that the resin was quite durable and resistant to the 
different solvents and in principle can be used many times without compromising its performance.  
 
Figure 5.5 Recyclability and re-usability of the resin. Solid line represents the average capacity of 
the resin 
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5.5.4 Synthesis of 1-phenylethylamine: proof of concept 
The resin AF5 was used for the asymmetric synthesis of PEA. The design of the appropriate reactor 
using solid resins will primarily depend upon the following criteria: first, the interaction of the 
biocatalyst with the resin (adverse effect on resin contact with biocatalyst), second, the interaction 
of the reactants with the resin (stability), third, the working volume of the resin.  For this reaction, it 
was noticed that the enzyme was as well getting adsorbed to the resin. Therefore to overcome this 
bottleneck, it was envisaged using a membrane reactor with cut-off point less than the size of the 
enzyme to be used. A resin packed column would be externally connected thus operating as a 
recycle reactor (Figure 5.7). The stability of the resin in the presence of reactants and solvent was 
quite good as could be seen in the re-usability experiments. The working volume (phase ratio) of 
resins required was calculated using a kinetic model that was derived in a previous study (Al-Haque 
et al., 2012). A kinetic model was used for simulating different scenarios by varying the volume 
ratio of resin (calculated by using the grams of resin and the resin density) to reactor volume. It was 
assumed that the distribution of the substrate and product with the resin relies only on the 
distribution coefficient which was determined from data set 3. Further it was assumed that mass 
transfer rate of substrate release and product removal was instantaneous (Brenna et al., 2012). 
Figure 5.6 illustrates the process overview for the supply of substrate and removal of product in the 
presence of the resin AF5. 
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Figure 5.6 Optimal ratio of resins.  
Reaction condition: Ei = 1.8 g/L, CIPA = 1000 mM, CAPH = 210 mM 
From Figure 5.6 it can be seen that with increasing resin volume ratio, the yield increased until it 
crossed a certain peak after which it dropped. This phenomenon can be explained by the rationale 
that with increasing resin volume ratio, the equilibrium concentration of acetophenone and 1-
phenylethylamine is lower. Hence the kinetic limitation is overcome and the yield correlates to the 
maximum yield based on the equilibrium constant. Further increase in resin volume ratio decreases 
the substrate availability causing the reaction to be substrate limited and hence, the decrease in 
yield. Therefore the optimal resin volume in this case should correspond to around 30% (V/V), 
preferably in a packed bed reactor. It was then possible to carry out the reaction in the reactor 
configuration as shown in Figure 5.7. Two sets of experiments were carried out, the first was 
control (without any resin to act as a benchmark) and second with resin to illustrate the 
improvement in the system. The reaction conditions were identical to each other. 
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Figure 5.7 Process flow sheet for the synthesis of chiral amines using resin. Step 1) Substrate 
loading on resins (solid line) Step 2) Integrated substrate feeding – product removal with a 
membrane reactor (dash dot line Step 3) Elution of product (dash line). AS is auto sampler.  
The resin column was loaded with the specified volume of resin. Substrate solution was pumped 
through the column for 24 hours at a flow rate of 2 bed volume per hour (Step 1). After which the 
pump was stopped and an enzyme membrane reactor was linked externally to the column (Step 2). 
The corresponding amount of enzyme, co-factor and co-substrate was added to the reactor and the 
membrane was enclosed on the top to restrain any enzyme from leaving the reactor. The reaction 
commenced by restarting the pump to allow the reaction media to circulate through the membrane, 
the resin column and the reactor. The reaction was monitored for 48 hours. Biocatalytic conversion 
of substrate from the aqueous phase caused additional substrate to partition from the carrier phase to 
accomplish in-situ substrate supply (ISSS). Similarly, as 1-phenylethyl amine was formed, it 
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partitioned back into the carrier phase to accomplish in-situ product removal (ISPR). After 48 
hours, the pump was stopped. The membrane reactor was removed and replaced with a solvent tank 
(step 3). The results of the experiment are shown in Figure 5.8. 
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Figure 5.8 Yield achieved with the auxiliary phase reactor using the selected resin 
Reaction conditions: Eo = 1.8 g/L, CIPA = 1000 mM, CAPH = 210 mM, CPLP = 2 mM, phosphate 
buffer = 100 mM (PH 7)  
From Figure 5.8, it can be seen that with the introduction of resin as an auxiliary phase there was a 
substantial improvement in the yield as compared to the control column. To make a further 
comparison, the theoretical yield was calculated based on the knowledge on the equilibrium 
constant value (Tufvesson et al., 2012). It can be noted that the accomplished experimental yield is 
quite comparable to the theoretical yield. 
5.5.5 Discussion 
Integration of porous resins provided significant benefits to the reaction. However selecting resins 
for multi-component systems requires the screening protocol to take into account further 
considerations. Emphasis has to be made at the capacity of the resin, selectivity of the product and 
the partitioning ratio of the key components for a multi-component system. The screening protocol 
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developed is systematic and effective in selecting a resin from a pool of resins which fulfilled all the 
criteria mentioned in Table 5.1. Resin AF5 was found to be the best candidate from the available 
list of resins. The resin had relatively high capacity which allowed a working load of around 4 
mmol/g of resin. The resin was more selective for the key product over the non-inhibitory 
compounds and the resin was cheap and moreover showed the tendency to be re-usable several 
times. However, the partitioning coefficient for acetophenone was much higher than 1-
phenylethylamine, which resulted in an accumulation of the 1-phenylethylamine in the reactor and 
inhibited the enzyme. Therefore, efforts have to be placed in engineering the resin to have higher or 
similar partition of PEA/APH.   
A further aspect that was not possible for testing was to evaluate if the reaction was substrate 
limited. Dynamic data that follows the progress of the reaction is required in order to evaluate that. 
Generally, enzymatic reactions are relatively slow and it can be assumed that the reaction was not 
limited by substrate transfer from the resin to the aqueous phase. Alternatively, measures can be 
taken to increase the mass transfer rate by increasing the surface area (using smaller particles) or by 
reducing the pump flow rate to increase the residence time of the reaction media in the column.  
From Figure 5.8, it can be seen that the yield achieved did not exceed equilibrium constraints. 
Therefore, this indicates that this strategy would assist in increasing synthetic yield. Alternative, the 
formed acetone can be selectively removed.  Different strategies such as stripping/sweeping with an 
inert gas like nitrogen (Zanfir et al., 2008) or adding an enzymatic cascade to selectively remove 
acetone (Cassimjee et al., 2010) can be applied. 
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5.6 Case study: asymmetric synthesis of 1-methyl-3-
phenylpropylamine 
For the second case study, the asymmetric synthesis of 4-phenyl-butylamine with 2-propylamine as 
amine donor using Ȧ-transaminases (EC 2.6.1.18) has been selected. The product is of industrial 
relevance and is currently produced by companies such as Cambrex (Martin et al., 2007). The 
process is operated at high temperatures (above 60oC) and amine donor concentration of 1500 mM 
to displace the unfavourable reaction equilibrium towards product synthesis (Tufvesson et al., 
2011). Based on a simplified cost calculation, it was found that the process cost was relatively high 
and was suggested to be reduced by immobilizing and re-using the enzyme and implementing 
alternative unit operations for product separation. In order to address these issues, it was envisaged 
that using resins would be an effective way of separating the product from the reaction media in-situ 
(Shorrock et al., 2004). Moreover the resin introduced would enable a high load of substrate 
concentration and simultaneously maintain low aqueous substrate and product concentration to 
overcome kinetic limitations (Hilker et al., 2005). The cost of the enzymes can be reduced by re-
using them. Such an approach can be implemented by immobilizing the enzymes to increase 
operational stability and simpler for recovery (Sheldon, 2007). Cross-linked enzyme aggregates 
(CLEAs) were considered applicable for this purpose because of its advantages of improved 
operational stability towards denaturation by heat and organic solvents and furthermore the minimal 
diffusional limitation (Sheldon, 2011). 2-propylamine was selected as amine donor as opposed to 
typically used alanine because the reaction is favoured with 10 fold higher rate of reaction 
(Cardenas-Fernandez et al., 2012). Moreover 2-propylamine is highly volatile meaning it can be 
easily distilled and re-used. However, the problem with unfavourable reaction equilibrium cannot 
be overcome with using resins. The resins are non-selective and will bind with both the substrate 
and product. Additional strategies have to be considered to remove the co-product in order to shift 
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the reaction towards product synthesis. A number of different approaches such as operating at high 
temperature (60oC) (Savile et al., 2010), stripping with nitrogen (Zanfir et al., 2008) and selective 
enzymatic cascade reactions (Cassimjee et al., 2010) can be applied. The latter two approaches were 
considered for testing in this study. Operating the reaction at 60oC was not opted as it would result 
in a significant loss in working media and furthermore be ineffective for evaporating off diluted 
acetone (Tufvesson et al., 2011).  Figure 5.9 illustrates the overall reaction scheme was used for 
testing the integration of resin. 
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 Alcohol dehydrogenase
Glucose dehydrogenase
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Figure 5.9 Overview of the reaction scheme 
5.6.1 Experimentation  
Materials 
Reagents (4-phenyl-2-butanone (PB), 2-propylamine (IPA), 1-methyl-3-phenylpropylamine (MPP) 
and acetone (ACE) and solvent (acetonitrile) were purchased from Sigma-Aldrich at the highest 
available purity (Buchs, Switzerland) and used without further purification. CLEA preparation of 
Codexis ATA-117 (TAm, EC 2.6.1.18) was kindly supplied by CLEA Technologies (Delft, 
Netherlands). The enzyme alcohol dehydrogenase (ADH, EC 1.1.1.1) from Saccharomyces 
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cerevisiae which came as lyophilized powder was purchased from Sigma-Aldrich (Buchs, 
Switzerland). The enzyme glucose dehydrogenase (GDH, EC 1.1.1.47) was kindly supplied by 
Codexis (Redwood city, CA) came as lyophilized powder. In all experiments the enzyme amount 
refers to either grams of lyophilized powderof mL of CLEA. All the different resins were kindly 
supplied by Sigma-Aldrich (Buchs, Switzerland).  
Methods 
Analytical methods  
Samples were measured on an Ultimate 3000 HPLC (Dionex, Sunnyvale, CA, USA), equipped with 
D89GHWHFWRU DQGDSKRWRGLRGH DUUD\GHWHFWRU7KH FRPSRXQGVZHUH VHSDUDWHGRQD/XQDȝP
C18(2) 100 Å (50 x 4.6 mm) column (Phenomenex, Torrance, CA, USA) at a flow rate of 2 mL/min 
using a multi-step gradient flow of aqueous 0.1% v/v trifluoruacetic acid and acetonitrile, with the 
following gradient of acetonitrile: 0 min (0%), 1 min (10%), 2.5 min (10%), 5.9 min (60%), 6 min 
(0%), 7  min (0%). The compounds were quantified at the following wavelengths: 4-phenyl-2-
butanone (254 nm, 5.7 minutes) and 1-methyl-3-phenylpropylamine (254 nm, 4.1 minutes).  
Inhibition studies of the substrate  
Initial rate experiments were performed with 1 M 2-propylamine while the concentration of 4-
phenyl-2-butanone was varied between 0 and 10 mM in 2 mL volume. Reactions were run at 30oC 
in 100 mM Tris buffer (pH 7) at 300 rpm. Reaction started with the addition of 0.20 mL of CLEA-
transaminase. Samples of 200 L were withdrawn after 72 hours and added to a centrifuge tube 
containing 800 L of 6 N HCL in order to stop the reaction (data not shown). The samples were 
analysed by HPLC. 
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Adsorption capacity of components 
50 mg of the resin was added to four 3 mL vials. Each vial contained 12 mM 4-phenyl-2-butanone 
or 42 mM 1-methyl-3-phenylpropylamine  or 2 M 2-propyl amine or 2 M acetone. The vials were 
agitated at 300 rpm at 30oC for 24 hours. A sample of the aqueous solution was withdrawn after 24 
hours to determine the concentration of the components in equilibrium by either HPLC or 
spectrophotometer (method explained in previous case study).  
Adsorption isotherm between resin and reactants 
50 mg of the resin was added to five 3 mL vials consisting of a range of reactant concentrations (0 
till solubility limit of of limiting substrate).  The experiment was performed for both 4-phenyl-2-
butanone and 1-methyl-3-phenylpropylamine. The vials were agitated at 300 rpm at 30oC for 24 
hours. A sample of the aqueous solution was withdrawn after 24 hours to determine the 
concentration of the reactants in equilibrium by HPLC. The concentration of the reactants in the 
resins was calculated by mass balance. 
Re-usability of resins 
The resin was packed in a stainless steel column (1 mL volume) with 60% (V/V) resin to test the 
performance of the resin. 10 mM of 1-methyl-3-phenylpropylamine was flowed through the column 
at a flow rate 0.5 mL/min for 2 hours. Samples were taken every 10 minutes for analysis by HPLC. 
Afterwards, 1-methyl-3-phenylpropylamine was extracted from the resin with acetonitrile flowed 
through the column at 0.05 mL/min for 6 hours. The column was then flushed with ethanol and 
water and was ready to be loaded again. This procedure was performed for repeated batches.  
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Optimal resin concentration 
Batch adsorption experiments were performed using 4 mL vials containing 3 mL of 175 mM  4-
phenyl-2-butanone, 500 mM 2-propylamine and 175 mM 1-methyl-3-phenylpropylamine, 175 mM 
acetone in 100 mM tris buffer with varying amount of resin. The vials were placed in a 
thermoshaker (Model 11, HLC Biotech, Bovenden, GerPDQ\ IRU  KRXUV DW  Û&ZLWK RUELWDO
agitation of 300 rpm. At the end of the equilibrium period, 500 L of sample was taken from the 
liquid phase to measure the concentration of the reagents by HPLC. 
Transamination of 4-phenyl-2-butanone (Reaction 1) 
Transamination of 4-phenyl-2-butanone was conducted at 2 mL scale with the following in the 
reaction media: 1 M 2-propylamine, 0.5 g/L pyridoxal-5-phosphate, 0.20 mL CLEA -Ȧ-
transaminase. 350 mM (50 g/L) of 4-phenyl-2-butanone and 20% (v/v) resin (AF 5). Reactions were 
run at 30oC and 100 mM Tris buffer (pH 7) in a 4 mL glass vial at 300 rpm. Upon completion of the 
reaction (72 hours), the resins were filtered off and the product was eluted with acetonitrile and 
analysed by HPLC. 
Nitrogen saturated with water was continuously swept over the reaction media at a flow rate of 90 
mL/min.  
Transamination of 4-phenyl-2-butanone (Reaction 2)  
The procedure was conducted as explained in reaction 1 with the addition of 1 g/L NAD+, 350 mM 
glucose, 20 g/L of crude ADH and 1 g/L of crude GDH in the reaction media. 
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5.6.2  Application of the proposed methodology 
Step 1: Characterize reaction 
$Q LQKLELWLRQ VWXG\ KDV EHHQ SHUIRUPHGRI WKHȦ-transaminase reaction in order to set targets of 
substrate and product concentration for the resin. From Table 5.5 effect of substrate concentration 
on the percent yield can be seen when the reaction is conducted by adding the substrate to a reaction 
media containing 10% (V/V) Clea-Tam and 1 M 2-propylamine. At very low concentration, the 
observed yield was compromised due to inhibition. Therefore, it would be desirable that the 
aqueous concentration of substrate and product in the reactor is less than 6 mM in order to achieve 
minimum yields of 70%.  
Table 5.5 Effect of substrate concentration on yield after 72 hours (10% V/V Clea-Tam, 1 M 2-
propylamine (pH 7), 2 mM PLP) 
[4-phenyl-2-butanone] 
mM 
Yield 
% 
1 96 
3 75.4 
5 72.1 
6 66.8 
The properties of the components were investigated using a physical property database (EPI). Table 
5.6 tabulates the properties of the reactants involved in the desired reaction scheme (Figure 5.9). 
The Log P value along with the aqueous solubility of the reactant expresses the hydrophobicity of 
these components. Based on these parameters it can be seen that the reactants MPP and PB are both 
hydrophobic while the others are hydrophilic. It would be desirable to select a porous resin which 
acts primarily on the hydrophobicity of the components. 
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Table 5.6 Physical properties of the reactants 
Component Molecular 
weight 
g/mol 
Water 
solubility 
[g/L] 
Log P 
PB 148.21 1.62 1.96 
IPA 57.09 1000 0.26 
MPP 149.24 12 2.12 
ACE 58.08 1000 -0.24 
Step 2: Screen resin 
Resins were selected from the Sigma Aldrich catalogue as listed in Table 5.7. Based on the 
experience from previous case study, resins with surface area greater than 1000 m2/g resin were 
selected for investigation.  
Table 5.7 Resin properties  
Adsorbent Type Matrix Surface 
Area 
[m2/g] 
Pore 
Diameter 
[Å] 
Moisture 
content 
[%] 
Sepabeads  SP850 SDB 1000 38 65.8 
Optipore  L493 SDB 1100 46 49.7 
Lewatit AF5 Carbon 1200 80 46.4 
Note: SDB – styrene divinyl benzene 
Capacity for MPP  
The capacity for MPP (mmol/gresin) was measured experimentally for each of the resins using data 
set 2. The capacity is tabulated in Table 5.8. As can be seen, the resins with the largest surface area, 
AF5, displayed the highest capacity for MPP among the tested resins. This result is consistent with 
the previous case study.  
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Selectivity of MPP  
The selectivity of MPP over the other compounds was calculated using data set 3 and presented in 
Table 5.8. From Table 5.8 it can be seen that all the resins were moderately selective for MPP with 
respect to PB. Resin AF5 was the least selective for co-substrate IPA. Similarly the resin did not 
have a strong affinity for acetone either. Therefore resin AF5 was selected for further investigation. 
Resin SP850 was not selected as it displayed resin capacity lower than AF5. 
Table 5.8 Capacity and selectivity of target molecule  
 
 
Adsorption Isotherms of PB and MPP  
These components revealed to be indeed displaying favourable adsorption isotherms as can be seen 
in Figure 5.10. It can also be noted that the resin showed similar partitioning for both substrate and 
product. The selectivity for the product with respect to the substrate was not significantly high and 
thus cannot be used for selectively removing the product to assist in shifting the reaction towards 
product synthesis. 
Adsorbent      Capacity Selectivity  
 [mol/kg] [g/g] [PB/MPP] [IPA/MPP] [ACE/MPP] 
SP850 1.47 0.22      0.65 0.56 0 
L493 1.46 0.22      1.13 0.42 0.14 
AF5 1.65 0.25      1.01 0.09 0.07 
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Figure 5.10 Adsorption isotherm of the limiting substrate and target product (open symbol is 4-
phenyl-2-butanone and filled symbol is 1-methyl-3-phenylpropylamine. Dotted line indicate 
solubility limit of substrate and dashed line indicated critical concentration of product). 
Step 3: Evaluate cost of introducing resin 
The performance of the resin (adsorption capacity) was experimentally measured for five batches 
using data set 5 as shown in Figure 5.11. The result provided evidence that no significant loss in the 
performance of the resin was observed even after five batches, thus indicating its resistance towards 
the different components and solvents, hence, in principle the resin can be used several times. 
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Figure 5.11 Recyclability and re-usability of the resin. (Solid line represents the average capacity of 
the resin) 
 
5.6.3 Synthesis of 1-methyl-3-phenylpropylamine: validation 
To evaluate the required amount of adsorbent, a reaction mixture was made to mimic 50% 
conversion i.e. 175 mM of 4-phenyl-2-butanone, 175 mM of 1-methyl-3-phenylpropylamine, 175 
mM of acetone and 500 mM 2-propylamine was incubated in a vial containing varying amount of 
resins. The corresponding concentration of 4-phenyl-2-butanone and 1-methyl-3-
phenylpropylamine in the aqueous phase was measured. The results of the corresponding 
concentrations are tabulated in Table 5.9.  
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Table 5.9 Equilibrium concentration of the reagents 
Substrate load 
(g/g) 
Resin load  
(v/v) 
4-phenyl-2-butanone  
(mmol/L) 
1-methyl-3-phenylpropylamine   
(mmol/L) 
0.80 10% 2.97 53.06 
0.60 15% 1.58 27.86 
0.40 20% 0.18 2.67 
0.30 30% 0.01 0.02 
0.20 50% Not detectable Not detectable 
0.10 70% Not detectable Not detectable 
From Table 5.9, it can be seen that with a resin loading of 0.40 g/g (40 gram substrate per 10 gram 
of resin) corresponding to 20% (v/v) was required to maintain concentrations of the substrate and 
SURGXFWZLWKLQWKHFULWLFDOFRQFHQWUDWLRQRIWKHȦ-transaminase reaction. A higher resin loading such 
as 30% (v/v) would result in the reaction being kinetically limited by substrate availability.  
Prior to selecting the reactor configuration, some experiments were carried out to measure any 
deviation of specific catalyst activity of the enzymes in the presence of resins. The results indicated 
that the resins were indeed inert and did not affect the catalysis (data not shown). 
Two modes of operation were carried out: single phase to act as a benchmark and bi-phasic system 
with the inclusion of resins suspended in the reactor. The single phase mode resulted in a nominal 
yield of 1 %. To overcome this limitation four strategies were suggested: strategy1) Addition of 
resin to reaction 1, strategy 2) Coupling of reaction 1 and reaction 2, strategy 3) Coupling the 
second strategy with water saturated nitrogen sweeping over the reaction media and strategy 4) 
Coupling the second strategy with reaction 2 to integrate the resin and cascade reaction in one pot. 
The results of these strategies are tabulated in Table 5.10. From Table 5.10 it can be clearly seen 
WKDW HPSOR\LQJ WKH GLIIHUHQW SURFHVV VWUDWHJLHV KDG D SRVLWLYH LPSDFW RQ WKH \LHOG RI WKH Ȧ-
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transaminase reaction. As expected, the product concentration increased significantly with strategy 
1 and even further with strategy 2, as compared to the benchmark reaction.  
Table 5.10 Process improvements with each strategy 
Scenario 1-methyl-3-
phenylpropylamine (mM) 
Yield  
(%) 
Single phase (benchmark)      3.68 ± 0.01 1.02 
Strategy 1 (reaction 1+ reaction 2) 37.27 ± 0.34 10.23 
Strategy 2 (reaction 1+ resin) 143.72 ± 2.41 40.21 
Strategy 3 (strategy 2 + N2 sweeping) 169.87 ± 2.34 44.67 
Strategy 4 (strategy 2 + reaction 2) 236.68 ± 3.96 69.61 
 
5.6.4 Discussion 
Each strategy added to the single phase reaction improved the product yield as compared to the 
benchmark. Even though the starting amine donor concentration was 3 folds greater, it did not help 
in significantly contributing to higher yields. With that in mind, a selective cascade enzyme, ADH, 
was added to the reaction media containing 1 M IPA. This greatly enhanced the yield contributing 
to a 10 fold higher yield. Unfortunately, the yield achieved did not manage to even reach 
equilibrium yields, which was calculated to be around 67%. The yield was calculated based on 
theoretical reaction equilibrium data acquired from other studies (Tufvesson et al., 2012). The result 
provided evidence that indeed the reaction was challenged with inhibition problem as equilibrium 
yields could not be achieved with an excess of amine donor and a selective cascade reaction. 
Bearing that in mind, porous resins were added to minimize the aqueous substrate and product 
concentration experienced by the enzyme. In strategy 2, an excess of amine donor coupled with the 
resins proved to be beneficial for the reaction. The yield achieved of around 40% was significantly 
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higher than the benchmark reaction. Higher yields could not be achieved because at the end of the 
reaction, the concentration of MPP in the aqueous phase was measured to be around 8 mM causing 
the enzyme to be inhibited. Attempt was made to improve the yield further by sweeping saturated 
nitrogen over the reaction media to remove formed acetone (strategy 3). This strategy proved to be 
unsuccessful as the yields did not improve significantly. Furthermore, it was observed that the 
volume of the reaction media reduced on account of nitrogen sweeping. It would be suggested to 
include a strategy to recycle the lost reaction media.   With strategy 4, around 70% yield could be 
attained. It was noticed that the activity of the enzyme ADH was quite poor for which 20 g/L of the 
enzyme was added. Higher concentration could not be added as it was precipitating in the reactor.  
The results of Table 5.10 points out that multiple strategies are required in order to achieve yields 
higher than equilibrium. The problem set forth from this case study indicates the necessity of 
evolving the enzyme ADH to improve the specific activity in order to minimize the enzyme 
loading.  It would be also desirable to increase the operability space of the transaminase enzyme in 
order to be more tolerant to higher substrate and product concentration. Increasing the phase ratio of 
resin would decrease total accumulated concentration of MPP in the reactor, though it would 
simultaneously reduce the available substrate concentration. Alternatively, the resin could be 
engineered to be equally selective for both PB and MPP.   
5.7 Conclusions 
A method to select resin to be used as an auxiliary phase has been developed. The methodology is 
exemplified with two case studies RI Ȧ-transaminase-catalysed reactions. The methodology 
systematically approaches the problem where the output of each step becomes an input for the 
following step. The screening is done based on the capacity for the target molecule, selectivity for 
the target molecule over the other components, adsorption isotherms of the different reactants to 
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measure the partitioning and finally the cost of the resin coupled with re-usability studies to identify 
a final candidate. Porous resins present to be an interesting alternative to overcome kinetic 
limitations which is evident from both the case studies. The resins were non-selective, making them 
suitable for the multi-purpose task of an integrated substrate supply and product removal. However, 
the requirement of yields higher than equilibrium restrictions imposes the need for coupling porous 
resins with a selective product removal technique, as it was shown in the second case study. The 
outcome of the above being that multiple strategies are required, in order to facilitate high 
productivity of the enzyme.  
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Chapter 6  
Model based approach  
for evaluating processes 
 
 
6.1 Introduction 
Process modelling presents a very powerful tool that can translate existing information and data to 
useful predictions for new conditions (Al-Haque et al., 2012; Vasic-Racki et al., 2003b). Process 
models are multi-objective functions that predict the behaviour of the real system to gain insight 
into the reaction kinetics and in turn be able to tune the reaction conditions in order to harness the 
full potential of biocatalysis (Brass et al., 1997; Sin et al., 2009). Such an example can be seen in 
WKHNLQHWLFUHVROXWLRQRIĮ-methylbenzylamine where the kinetic model guided the optimal ratio of 
enzyme and co-substrate concentration to provide the highest yield (Shin and Kim, 1998). While in 
other cases it can be used for optimizing the enzyme ratio for bi-enzymatic processes (Chen et al., 
2006; Van Hecke et al., 2009) or for evaluating in-situ product removal opportunities and different 
reactor configurations (Frykman et al., 2005; Sun et al., 1999; Takors, 2004). Consequently, the 
sensitivity of the kinetic parameters can be investigated to see what effect it has on the output of the 
process in order to guide catalyst improvements (Sayar et al., 2009). Furthermore kinetic models 
can be used to simulate different process scenarios for different reactor configurations to make 
“what-if” analysis. In that context analysis can be made whether it would be beneficial to run a 
reaction in a batch reactor or packed bed reactor or in a continuous stirred tank reactor. 
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Furthermore, mathematical modelling can be used to generate windows of operation to graphically 
visualize the operating space bounded by both process and system constraints (Chhatre et al., 2011; 
Law et al., 2008; Woodley and TitchenerHooker, 1996). In the case of integrated resin bioreactors it 
is important to formulate mathematical models in order to evaluate the process feasibility, e.g. 
analysing the required partition coefficients and alternative reactor configurations (internal or 
external) necessary to alleviate substrate and product inhibition. Consequently, the models can be 
used conceptually to assess the process feasibility and as well to guide the type of experiments that 
need to be carried out 
6.2 Modelling needs 
Mathematical modelling of bioprocesses is an important tool in both academia (Gernaey et al., 
2010; Glassey et al., 2011; Morales-Rodriguez et al., 2012) and industry (Brass et al., 1997; Fox 
and Clay, 2009; Jimenez-Gonzalez and Woodley, 2010) for evaluating a process. Methodologies 
can be seen for modelling reaction kinetics for both single (Al-Haque et al., 2012) and multi-
enzyme processes (Santacoloma et al., 2011) based on first principles, reactor modelling for various 
types of reactor (Fogler, 2005) and mass transfer models (Quijano et al., 2010) to describe the 
substrate transfer rate from resin to aqueous phase.  
To model a process, the different phenomena that take place in the process have to be included in 
the mathematical model. These phenomena can range from mode of substrate transport (diffusion), 
reaction (kinetic), separation (partitioning) and the type of reactor (flow reactor or batch reactor). 
The assumptions made have to be stated beforehand as it influences the type of model required for 
the process. For example, a reactor operating in a plug flow reactor has to include the flow term as 
compared to a batch reactor where no flow term is required. Similarly, introducing a resin into the 
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reactor requires partitioning terms to be included in the model. Table 6.1 lists the different types of 
mathematical models required to describe the different reactor types.  
Table 6.1 Mass balances for different reactor types 
Reactor type Type of model Example 
Stirred tank batch reactor Batch reactor dC/dt = r1 
Substrate feeding Semi-batch reactor d(CV)/dt = r1V  
Plug flow  Tubular reactor dC/dV = r1/ v0 
Continuous flow in and out CSTR  V = v0(C0 – C)/ r1 
Different constitutive models have to be included in the mass balance to describe the different 
phenomena taking place in the reactor. Table 6.2 lists the different type of models that are used in 
this thesis.  
Table 6.2 Types of models required to describe the process 
Phenomena Type of model Example 
Reaction Rate model r1 = k1C/(K2 + C) 
Partitioning between resin and reactants Adsorption model q = qmaxC*/(P + C*)  
Flux of substrate supply and product removal Mass transfer model Q = kLA(C – C*) 
The candidate models from Table 6.2 will then be inserted into the mass balance of the desired 
reactor (Table 6.1). The mass balance of a batch reactor, where only reaction is taking place, will 
have the structure of Equation 6.1. 
1 2
dC k C / (K C)
dt
                         [6.1] 
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The different models are combined to describe the process of interest in order to evaluate its 
feasibility and moreover to gain further process understanding. In this way one will be able to 
assess the bottlenecks of the process and thus to be able to propose solutions to overcome them.  
6.3 Case study: asymmetric synthesis of 1-phenylethylamine 
The process of interest is the synthesis of 1-phenylethylamine (PEA) and co-product acetone (ACE) 
from acetophenone (APH) and 2-SURS\ODPLQH ,3$ LQ WKH SUHVHQFH RI WKH Ȧ-transaminase (EC 
2.6.1.X) (transaminase, ATA - 040). From previous chapters it has been assessed that the reaction is 
limited by substrate and product inhibition and therefore it would be desirable to introduce an 
integrated approach of substrate feeding and product removal, using porous resins as an auxiliary 
phase in a batch reactor. There are three phenomena that take place in this process. First, the 
interaction of the different compounds with the enzyme (reaction) and second the interaction of the 
different compounds with the resin (partitioning) and third the rate of substrate supply and product 
removal (flux). Figure 6.1 displays the general scheme for the production of 1-phenylethylamine 
with porous resins as the auxiliary phase. 
 
Figure 6.1 Synthesis of 1-phenylethylamine (PEA) and co-product acetone (ACE) from the 
substrates acetophenone (APH) and 2-propylamine (IPA) in the presence of the enzyme 
transaminase in an integrated resin-batch reactor 
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The objective of the process model is to describe the dynamic process behaviour of the reactor and 
to gain further understanding of the process parameters and in turn identify the process bottlenecks. 
6.3.1 Model formulation 
Mole balance in aqueous phase 
Samples are measured only in the aqueous phase for simplicity and therefore the mole balance is 
made only in the aqueous phase.  
dCAPH/dt = -Qss/V – rPEA                      [6.2] 
dCPEA/dt = -QPR/V + rPEA                      [6.3] 
Kinetic model 
The kinetic model for this reaction includes surplus inhibition terms of acetophenone and 1-
phenylethylamine. The inhibition has been identified as competitive (data not shown). The kinetic 
model has been derived as follows (Equation 6.4 Ȝ   Ȗ   while the parameters have been 
reported in a previous study (Al-Haque et al., 2012):  
 
 
 
 
 
                                            [6.4] 
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Partitioning model 
The compounds APH and PEA are hydrophobic while the other two compounds IPA and ACE are 
hydrophilic. The selected resin acts on the hydrophobicity of the compounds to partition the 
substrate APH from the resin phase to the aqueous phase and the product formed, PEA, partitions 
from the aqueous phase to the resin phase. Adsorption models as shown in Equation 6.5 to 6.7 are 
generally considered to describe this phenomenon (Likozar et al., 2012). 
1. Sips 
max*
n
eq
n
eq
q C
q
P C
                                            [6.5] 
2. Langmuir 
max* eq
eq
q C
q
P C
                                                    [6.6] 
3. Freundlich 
max*
n
eqq q C                                                    [6.7] 
It is assumed that all points within the resin remain in local thermodynamic equilibrium and as a 
result the models shown in Equation 6.5 to 6.7 can be applied to this process (Pedersen et al., 1985). 
It would be therefore pertinent to discriminate the different models in order to assess which model 
describes the experimental data best.  
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Mass transfer model: 
The flux for APH from the resin to the aqueous phase can be formulated as Equation 6.8. 
QSS = kSS*A*mass*(CAPH, resin – PAPHCAPH, aqueous)                    [6.8] 
The flux for PEA removal from the aqueous phase to the resin phase can be formulated as Equation 
6.9:   
QPR = kPR*A*mass*(PPEACPEA, aqueous – CPEA, resin)                    [6.9] 
For both Equation 6.8 and 6.9, the value of the surface area, A, can be acquired from the supplier of 
the resin as shown in Table 6.3. The value of P can be calculated from the appropriate adsorption 
model.  
6.3.2 Experimentation 
Reagents and enzyme 
Reagents and solvents of the highest purity available were purchased from Sigma-Aldrich (Buchs, 
Switzerland) and used without further purLILFDWLRQ7KHXQSXULILHGHQ]\PHȦ-transaminase (ATA-
040) which came as lyophilized powder was kindly supplied by c-LEcta Gmbh (Leipzig, Germany). 
In all experiments enzyme amounts refer to grams of lyophilized powder. The resin Lewatit AF 5 
which is carbon based was kindly supplied by Sigma-Aldrich (Buchs, Switzerland). The properties 
of the resin are listed in Table 6.3.  
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Table 6.3 Properties of Lewatit AF 5 resin 
Matrix structure Carbon 
Ionic form Neutral 
Particle size (mm) 0.4 – 0.8 
Pore volume (cm3/g) 0.15 
Surface area (m2/g) 1200 
Density (g/L) 600 
Moisture (%) 46.4 
Analytical methods 
HPLC 
Samples were measured on an Ultimate 3000 HPLC (Dionex, Sunnyvale, CA, USA), equipped with 
a UV detector and a photodiode array detector using a method described elsewhere (See Chapter 4). 
GC 
Samples were measured online using an internal standard with an autosampler TriPlus, Thermo 
Scientific, Dreieich, Germany automatically from a flow cell in the product stream. See previous 
chapter for details on the method.  
Experimental methods 
Data set 1 for estimating kinetic model parameters  
This data set was not required for this case study as the kinetic model with estimated parameters has 
been acquired from a previous study (See Chapter 4).  
Data set 2 for estimating partition coefficients  
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This data set was acquired from Chapter 5. 
Data set 3 for estimating mass transfer coefficients.  
150 mg of the resin loaded with saturated concentration of 50 g/L of APH was released into a 3 mL 
vial containing water. The vials were agitated at 300 rpm at 30oC. Samples were withdrawn at time 
intervals of minutes 1, 5, 10, 30, 60 and 1440 to determine concentration of APH by HPLC. 
50 g/L of PEA was added into a 3 mL vial containing 150 mg of the resin. The vials were agitated 
at 300 rpm at 30oC. Samples were withdrawn at time intervals of minutes 1, 5, 10, 30 and 60 to 
determine concentration of PEA by HPLC. 
Data set 4 for validation  
Two sets of experiments were performed for this data set. Experiment 1) 100 mM of acetophenone 
was pre-adsorbed with 50% V/V resin. The resin was loaded in a column which was linked to a 
membrane reactor by an external loop. The membrane had a cut-off point of 10 kDa thus restricting 
the enzyme to leave the reactor. A reaction media containing 1 M 2-propylamine, 2 mM cofactor 
3/3DQGJ/Ȧ-transaminase (ATA-40, C-LEcta) was introduced into the reactor. A magnetic 
bar rotating at 300 rev/min was used to maintain a well-mixed reactor. The reaction started by 
turning on a pump with the flow rate adjusted to provide a residence time of 1 hour. APH and PEA 
content was determined via GC. Experiment 2) the conditions were identical to experiment 1 except 
300 mM of acetophenone was pre-adsorbed.  
6.3.3 Parameter estimation 
Estimating partition coefficients 
Data set 2 was used to estimate the parameters from the different adsorption models. The model 
prediction, as can be seen in Figure 6.2, was used further to compare the reliability of the model 
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prediction to the experimental value by calculating the goodness of fit R2. From Table 6.4, it can be 
seen that the Sips model describes the experimental data the best. This was unexpected as the model 
includes three parameters which were optimized as compared to Langmuir and Freundlich 
isotherms which consist of two parameters. The Langmuir and Freundlich isotherm correspond 
similarly with the measured data, as it may be observed from R2 values in Table 6.2. The results of 
the partitioning coefficient are in accordance with studies done in an organic solvent such as 
cyclohexanone (Shin and Kim, 1999b).  At pH 7, the partition coefficient of PEA and buffer was 
0.21 while for APH was 95.64. 
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Figure 6.2 Equilibrium data for the adsorption of 1-phenylethylamine and acetophenone on resin,  
(symbols represent measured data; solid lines represent model prediction using estimated 
parameters; dotted line (Sip), dash-dot line (Langmuir) and dash-dash line (Freundlich)). 
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Table 6.4 Estimated adsorption parameters for different models 
 
 
 
 
 
 
 
 
From the results of Table 6.4, it was decided to use the estimated parameters of the Sips isotherm in 
the process model based on the goodness of the fit. 
Estimating mass transfer coefficients 
Data set 3 was used to calculate the mass transfer coefficient values. The partition coefficients of 
the Langmuir model from Table 6.4 were used in the mass transfer models. The estimated 
parameters are shown in Table 6.5, from where it can be seen that the mass transfer coefficient for 
substrate supply was smaller than for product removal. This is in agreement with other studies using 
cyclohexanone as a solvent (Shin and Kim, 1999b) and moreover the substrate acetophenone is 
more hydrophobic than 1-phenylethylamine and thus is bound firmer to the resin. Furthermore it 
can be seen from Figure 6.3 that the concentration of 1-phenylethylamine in the resin increases like 
a first-order process until it reaches equilibrium conversion. It can be stated that the reaction is not 
Parameter 1-phenylethylamine acetophenone 
Sips isotherms   
qmax (mmol/g) 8.63 16.36 
P (mmoln/Ln) 3.45 38.57 
N 0.51 0.57 
R2 0.98 0.99 
Langmuir isotherm  
qmax (mmol/g) 5.31 6.41 
P (mmol/L) 1.02 31.42 
R2 0.95 0.97 
Freundlich isotherm  
qmax (mmol/g) 1.74 0.42 
N 0.32 0.57 
R2 0.97 0.99 
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limited by mass transfer rate of the substrate release and product uptake. However in cases where 
the reaction rate is faster than the substrate release rate from the resin, it would be required to 
improve the process by increasing the available surface area of resin or varying the flow rate 
through the resin column.  
Table 6.5 Estimated mass transfer co-efficient 
 
 
 
*Note: The agitation was fixed at 300 rpm 
The estimated parameters were used as input to the process model to provide predictions for 
different substrate loading.  The equations were solved using an ordinary differential equation 
solver of MatLab™ (ODE15s). Figure 6.3 illustrates the asymmetric synthesis of 1-
SKHQ\OHWK\ODPLQH XVLQJ Ȧ-transaminase in an auxiliary resin phase reactor. Two different 
experimental conditions were simulated with substrate loading of 100 mM and 300 mM. The solid 
and dashed line indicates the model predictions while the symbols, both round and square, are 
experimental measurements. It is evident that the model describes the data very well. Initially the 
substrate concentration in the aqueous phase rises, as substrate is released from the resin until it 
reaches a pseudo equilibrium. Biocatalytic consumption of the substrate causes more substrate to be 
released from the resin to compensate the displaced equilibrium. The concentration of the substrate 
in the aqueous phases is maintained beneath the inhibitory level. The product formed partitions 
back onto the resin. The concentration is always maintained low to alleviate product inhibition. In 
this way the reaction proceeds until equilibrium is reached.  
Parameter Value* 
[m/min] 
R2 
kSS 1.19E-5 0.97 
kPR 5.43E-4 0.99 
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Figure 6.3 Asymmetric synthesis of 1-phenylethylamine using resin as an auxiliary phase. Solid and 
dashed lines are model prediction. (Solid line) 1-phenylethylamine in resin, (solid-dash line) 1-
phenylethylamine in aqueous, (dashed line) acetophenone in aqueous. Square symbol is 
experimental measurements for condition A and round symbol is experimental measurements for 
condition B. Experimental conditions: (A) Enzyme = 3 g/L, IPA = 1000 mM, APH (resin) = 200 
mM, resin = 50% V/V (B) Enzyme = 3 g/L, IPA = 1000 mM, APH (resin) = 300 mM, resin = 50% 
V/V 
 
6.3.4 Simulations  
Phase ratio of the two phases 
Figure 6.4 shows the simulation results to predict the effect of the phase ratio between phases on the 
reaction rate. In this simulation, the amount of the substrate was fixed irrespective of the volume 
ratio. Therefore, initial concentration of the substrate in each phase is different with respect to the 
volume ratio. As the proportion of the solid phase increases, the conversion increases, suggesting 
that the reaction rate increases rapidly according to the increase in the proportion of solid phase. 
However, after a certain volume ratio (exceeding 30% V/V), the conversion decreases. This 
phenomenon occurs because of the decrease in the equilibrium concentration of acetophenone in the 
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aqueous phase, resulting in the reaction rate to be substrate limited. Such a phenonemna was also 
observed in the kinetic resolution of Į-methylbenzylamine in a bi-phasic mixture of cyclohexanone 
and phosphate buffer. With increasing phase ratio of cyclohexnone the aqueous concentration of Į-
methylbenzylamine decreased thus reducing the rate of reaction (Shin and Kim, 1997).  
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Figure 6.4 Asymmetric synthesis of 1-phenylethylamine using resin as an auxiliary phase at 
different volume ratio square symbols (10% V/V), diamond (30% V/V), plus (50% V/V), star (70% 
V/V) 
Partitioning of 1-phenylethylamine and acetophenone in the resin 
The influence of the partitioning coefficient plays a vital role in the case of substrate supply and 
product removal. Figure 6.5 illustrates the impact of varying the ratio of the partition coefficient. 
From Figure 6.5 it can be seen that in cases, where the partition coefficient of acetophenone is 
higher than the product 1-phenylethylamine, the reaction is substrate limited resulting in lower 
conversion. However, in cases where the partition coefficient equals each other than the maximum 
conversion that can be attained would be the equilibrium conversion. However, if the resin is more 
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selective for the product, then then resin can be used for driving the reaction towards product 
synthesis to achieve conversions that is not limited by equilibrium.   
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Figure 6.5 Asymmetric synthesis of 1-phenylethylamine using resin as an auxiliary phase at 
different distribution coefficient ratio. Plus symbol (PAPH/PPEA = 10), square symbol (PAPH/PPEA = 1) 
and diamond symbol (PAPH/PPEA = 1/10) 
For substrates and products that are moderately polar, it is difficult to find a suitable auxiliary phase 
that can selectively remove the target product (Straathof, 2003). An experimental methodology to 
identify a suitable resin has been demonstrated in Chapter 5. Selection based on the properties of 
the polymer such as the degree of crystallization and thermodynamic affinity has also been 
exploited (Parent et al., 2012). However, efforts need be placed in designing auxiliary phases that 
are compatible with this strategy. From Figure 6.5 it could be seen that the selective removal of the 
product is essential to achieve high yields. Efforts need to be placed at tailoring resins to effectively 
distinguish between substrates and products. Such an approach has advanced in the field of 
molecular imprinted polymers for selective extraction (Lasakova and Jandera, 2009; Masqué et al., 
2001). Molecular imprinting in polymers is a process in of polymerising functional and cross-linked 
monomers around a template molecule in order to generate specific recognition sites for specifically 
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rebinding the target molecule (Turiel and Martin-Esteban, 2010). Such a technology has advanced 
in different industrial sectors among which pharmaceutical is one (Lasakova and Jandera, 2009). 
However, low capacity and slow mass transfer are the bottlenecks that have yet to be overcome 
(Chen et al., 2011).    
6.4 Case study: Enantioselective synthesis of 2-octanol 
Enantiomerically pure (R)-2-octanol is produced from 2-octanone using the enzyme LbADH (EC 
1.1.1.2). The enzyme is co-factor dependent and thus the co-factor has to be recycled to make the 
process economically feasible. An enzyme coupled approach was selected based on the high 
selectivity and catalytic efficiency using the enzyme GDH (EC 1.1.1.47). Co-substrate glucose is 
used as a substrate for GDH. From previous chapters it has been assessed that the reaction is limited 
by substrate inhibition and therefore one proposal was to use a continuous stirred tank membrane-
reactor to overcome the kinetic limitation. Resin is not required in this case study as the reaction is 
not compromised by product inhibition. Therefore there is only one phenomena taking place in this 
process i.e. the reaction. The schematic of the reaction is shown in Figure 6.6: 
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Figure 6.6 Reaction system for the enantioselective reduction of 2-octanone 
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6.4.1 Model formulation 
Mass balance 
A CSTR model is used for the mass balance. 
C0 – C + r1V = 0 
Kinetic model 
The kinetic model to describe the reaction has already been described in section 4.6. The final 
modified Michaelis-Menten equation is as shown below in Equation 6.10 and 6.11. 
Forward direction:  
,
[ ] [ ]
[ ][ ] [ ] 1 [ ]1 [ ] 1
 § · § ·§ ·    ¨ ¸ ¨ ¸¨ ¸ © ¹© ¹ © ¹
LDH f f
NADPHON
MM NADPOL ON
PP i
ON NADPHr V
NADPOL ON K NADPHK ON
KK K
                [6.10] 
 
Reverse direction: 
,
[ ] [ ]
[ ] [ ]1 [ ] 1 [ ]
 § · § ·   ¨ ¸ ¨ ¸© ¹ © ¹
LDH r r
OL NADP
M MON NADPH
P P
OL NADPr V
ON NADPHK OL K NADP
K K
                 [6.11] 
A similar model was used for the GDH reaction.  
[ ] [ ]
[ ] [ ]
  GDH Glu NADPM M
Glu NADPr V
K Glu K NADP
                                                           [6.12] 
The model parameters have been estimated previously as presented in Section 4.6.  
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6.4.2 Simulations 
In the simulation of the synthesis of 2-octanol, cofactor NADPH degradation of 4.1 x 10-6 h-1 and 
enzyme deactivation of 1.92 x 10-5 h-1 was determined (data not shown).  
Effect of the concentrations of enzyme and co-factor NADP 
The kinetic model developed can be used in determining the optimal initial concentrations of the 
enzymes and co-factor. At a given 2-octanone concentration, the use of excess of enzymes or 
expensive cofactor should be avoided. The optimal concentrations of cofactor NADP and enzyme 
ratio of LbADH/GDH were evaluated to identify which combination can provide the highest 
conversion. Figure 6.7 shows the effect of varying the enzyme ratio and NADP on conversion at a 
fixed concentration of 2-octanone. The ratio of enzyme concentration displays a higher sensitivity 
to conversion than with NADP. At sufficient concentrations of NADP approximately above 0.025 
mM and enzyme ratio above 1, in the case of 60 mM of 2-octanone, the increase in the 
concentration of NADP nor enzyme ratio increases conversion.  
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Figure 6.7 Optimization of enzyme ratio and co-factor concentration as a function of conversion 
Reaction conditions: 60 mM 2-octanone and 675 mM glucose 
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Effect of reaction engineering 
The modelling of the reaction kinetics as a tool for reaction engineering plays an important role in 
assessing the feasibility of processes (Al-Haque et al., 2012). The modelling also facilitates 
identification of the most effective reactor mode (Vasic-Racki et al., 2003b). From the estimated 
parameters of Table 4.6, it was seen that the substrate surplus inhibition of 2-octanone was evident. 
In order to overcome this limitation it was envisaged that operating in a continuous stirred tank 
reactor (CSTR) would be beneficial. CSTR are a favourable reactor configuration in view of 
enzyme deactivation that is introduced by one of the substrates, since operating at high conversion 
in the steady state yields a constant low substrate concentration. Consequently, the rate of 
deactivation should be very small. However, a general limitation of using CSTR is that a full 
conversion cannot be achieved unless the residence time is extremely large or more than one CSTR 
is used in series to mimic a packed bed reactor. The results of the optimized reaction conditions 
from section 6.5.1 were used to simulate the reaction in CSTRs. Figure 6.8 illustrate the model 
simulations of conversion as a function of residence time. The simulation is evaluated for both a 
single CSTR and two CSTR in series. 
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Figure 6.8 Conversion as a function of residence time in continuously stirred tank reactors (CSTR). 
Black line is one CSTR and black line is two CSTR in series (dotted is first CSTR and dash-dot is 
second CSTR) 
From Figure 6.8 it can be seen that with a single CSTR the maximum conversion that can be 
reached is less than 90%. However, the time required was more than 24 hours. With the help of 
simulation it could be seen that adding another CSTR in series would enable reaching almost a 
100% conversion within 24 hours.   
The cascade of two membrane reactors in series can be proposed for the substrate inhibition 
problems. The system consists of two equally sized continuously operated enzyme membrane 
reactors with enforced flow where the retention of soluble enzyme in the reaction vessel is achieved 
by means of an ultrafiltration membrane (Yuryev et al., 2011). An advantage of this system is that 
the reactor operates under sterile conditions without diffusion limitations enabling continuous 
homogeneous biocatalysis with a very good exploitation of the biocatalyst.  
174
156 
 
6.5 Discussion 
Process modelling plays a key role in selecting the most effective process design. Process models 
can be used to simulate for different reaction conditions or to study the implications of different 
process designs. These kinds of simulations can reduce the number of experiments for optimizing 
reaction conditions and predict experimental results in ranges where experimental design is difficult 
or cumbersome. The process model can be broken down into sub problems, to reduce the 
complexity of the mathematical formulation and also to help design experiments more effectively. 
Each sub-problem can be solved individually to provide a greater insight into the process. The result 
of each core is added to the subsequent core to include the observed phenomenon in the process 
model. Such an approach can be used to identify the bottlenecks of of each step of the process and 
propose solutions to overcome it.  
The process modelling of the Ȧ-transaminase case study helped in analysing critical parameters 
such as mass transfer rate, solid-liquid volume ratio and partitioning coefficients. In this case study, 
there was no observed mass transfer limitation as the enzymatic reaction is relatively slower. 
Substrate and product inhibition could be mitigated using resins, however the partitioning 
coefficient of the resin was not effective enough to overcome the equilibrium constraint. Therefore 
more than one process strategy or more selective product removal technologies such as molecularly 
imprinted polymers or a sequential cascade reaction can be applied to displace the equilibrium 
towards the synthesis direction.   
The case of the bi-enzymatic synthesis of 2-octanol serves as an interesting case study, in which 
process modelling has helped in meeting the challenges to facilitate large scale production. In redox 
reactions, the cost of the co-factor is a typical barrier to implementing this kind of chemistry at large 
scale. Through process modelling, it was possible to optimise both the concentration of the co-
factor and the enzyme ratio in order to generate the highest conversion. An enzyme ratio of 1.5 
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[LbADH] per [GDH] in the presence of 0.05 mM of NADP can yield conversions of higher than 
90%. The results of this simulation were directly inputted to the process model in order to simulate 
strategies to overcome substrate inhibition. By means of simulation, it could be seen that using a 
CSTR would be beneficial for reactions which suffer from enzyme deactivation through one of its 
substrate (2-octanone). Furthermore, it was evaluated that to reach an almost 100% conversion two 
CSTRs have to be used in series. It would be therefore proposed to use two membrane reactors in 
series with soluble enzymes. In this way the overall productivity can be maximised. 
6.6 Conclusions 
Process modelling was an effective tool for analysis and gaining process knowledge for the two 
cases studies. In the first case study, the process model helped to evaluate the trade-offs between the 
thermodynamic partitioning and the three rate equations (substrate supply, product removal and rate 
of reaction). The predictions provided the necessary information required to optimize the process 
and set the required partitioning coefficients and phase ratio required for the process. The rate of 
supply and removal were not a limitation for this relatively slow reacting enzyme. The limitation for 
the process was the low partitioning of PEA over APH to the resin. Further efforts have to be made 
to design resins to display similar or higher partitioning for PEA with respect to APH. Process 
modelling in the second case study helped in optimizing the process in terms of co-factor 
concentration and enzyme ratio. Two membrane reactors in series were proposed in order to 
overcome the substrate inhibition problem and achieve almost a 100% conversion within 24 hours.  
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Chapter 7   
General discussion 
 
 
The main goal of this thesis has been to explore the possibilities of integrating resins in enzymatic 
processes. A systematic framework has been developed in characterizing the reaction, selecting a 
resin and evaluating the process as a means of justifying the integration of resin in enzymatic 
processes. Three case studies were used to illustrate the applicability of the methodology to fulfil 
different objectives. The case studies were selected not only for being industrially relevant but as 
well having certain challenges, through which process tools and strategies could be developed to 
overcome these challenges. Every aspect of the framework was tested: characterising the reaction 
by kinetic modelling, selecting the resin and evaluating the process using a model based approach.  
Biocatalysis in many cases presents as an excellent alternative to chemo catalysis, especially when 
the key concern is stereo- or regio- selectivity. Several challenges pertaining to low specific catalyst 
activity for some enzymes (transferases), in the presence of industrially relevant concentration and 
yield limited to equilibrium conversion, can discourage industries to consider this option. However 
several solutions can be suggested to overcome these challenges to harness the full potential of 
biocatalysis. Some solutions can only be met by protein engineering while others can be alleviated 
by reaction engineering options. In many cases, a combination of both solutions has to be 
implemented to tackle difficult synthesis. A decision tree, as presented in Chapter 1 (Figure 1.9), 
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can help to ease the selection of the appropriate process options, guide data collection and identify 
key parameters that have to be considered (e.g. phase toxicity, mass transfer, inhibition).  
Using a non-selective auxiliary phase is an interesting option to improve the viability of the 
enzymatic processes, which are limited by low catalyst productivity due to substrate and product 
inhibition. It is an integrated approach of substrate feeding and product removal. However, attempts 
to introduce any technology require some considerations to be taken into account. Several 
parameters, such as resin capacity, product selectivity, enzyme biocompatibility and cost 
effectiveness have to be considered. In some cases, using resin would be advantageous while in 
other cases organic solvent or ionic liquid could be the better option. The choice of the auxiliary 
phase has to be done on a case by case basis. For example, in the enantioselective microbial 
reduction of 3,4-methylene-dioxyphenylacetate to the corresponding (S)-alcohol using 
Zygosaccharomyces rouxii, Cp,crit was experimentally measured to be 2 g/L indicating the need for 
ISPR (Zmijewski et al., 1997). A water-immiscible organic solvent, hexane, provided a distribution 
coefficient of 1, thus was unsuitable for extraction. On the other hand, porous resin XAD-7 gave 
distribution of around 30 – 40 (Vicenzi et al., 1997) which resulted in many fold increased 
volumetric productivity of the process.  
In order to choose a process option, the reaction has to be at first characterized. The critical 
concentration and aqueous solubility of the different components have to be evaluated. Kinetic 
modelling, which takes into account inhibition and equilibrium relation, is an effective method for 
determining the operability space of the reaction. When trying to estimate the kinetic model 
parameters, it was realized that estimating them is not straight forward. In fact, the global minimum 
can be rarely attained for such complex models and thus often leading to identifiability issues of the 
parameters. Different strategies are required, including model decomposition and multiple 
parameter initializations and consequently both initial rate and progress curve data are required to 
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increase the probability of attaining a global minimum. In order to evaluate the reliability of all 
parameters in the model, different types of analysis have been suggested. In that manner, results are 
used to prioritize further analysis of significant parameters or to consider model simplifications of 
insignificant parameters, all with a statistical support, as illustrated in Chapter 4. The methodology 
developed was indeed found to be more robust and provided reliable predictions in comparison to 
other approaches. A parity plot comparing the different approaches can be seen in Figure 7.1.  
Figure 7.1 clearly illustrates the reliability of the current approach where the model predictions fall 
on the experimental data line. It can be seen that while using the other methodologies, the 
predictions deviate over time, as opposed to the developed approach which displays a better fit to 
describe the experiment. In the Chen methodology, the prediction fits quite well in the initial time 
period, but with increasing time the reversibility of the reaction, combined with the substrate and 
product inhibition, contributes to deviations from the prediction. 
 
Figure 7.1 Parity plot of different estimation methodologies.  
Proposed methodology (diamond), graphical approach (triangle), non-linear regression (square) and 
Chen and co-worker (circle). Reaction conditions: E0 = 1.8 g/L, CIPA=1000 mM , CAPH = 2 mM, 2 
mM PLP, 100 mM phosphate buffer (pH 7) 
Designing smart experiments is a key part of developing any kinetic model. Much of the effort is 
required for designing the experiments, performing the experiments as well as analysing the data. 
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Type of experiments (initial rate or time course), what to measure (which components) and how 
often to measure (every minute or every 30 minutes) are important considerations for data 
collection. Consequently, it would be suggested to decompose the complex enzymatic kinetic model 
to initial rate model, to minimise the number of parameters to be estimated simultaneously and 
moreover to be able to design experiments tailored for the model. In this way the number of 
experiments required can be optimized. Table 7.1 depicts the number of experiments that were 
required for estimating the kinetic model parameters of case study 1.  
Table 7.1 Different methodologies to estimate kinetic model parameters for equilibrium reactions 
a(Gyamerah and Willetts, 1997) 
b(Shin and Kim, 1998) 
c The minimum number of data points corresponds to the number of parameters 
d(Cheng et al., 2012) 
e(Al-Haque et al., 2012) 
Initial rate models are not sufficient in large scale processes where high conversion of the substrate 
is desired. An initial reaction rate model cannot be used to accurately predict neither the overall 
reaction rate nor the equilibrium of the reaction. It could be seen that for the third case study, the 
model prediction towards the end of the reaction was deviated from the experimental data (Figure 
4.11). It would therefore be suggested to use a dynamic model which can preferably describe the 
Type of 
experiment Methodology 
Number of 
experiments Limitations  
Initial rates 
Graphical plotting High (130)a 
Applicable only for reactions that follow 
simple Michaelis-Menten kinetics. High 
estimation errors 
Non-linear regression High (125)b Low accuracy when parameters are correlated 
Progress curves Non-linear regression Low (20)c Reliability is dependent on the need for good initial guess of parameters  
Initial rates and 
progress curves 
Chen and co-workers Intermediate (43)d Unreliable for equilibrium reactions including regions of negligible inhibitory region 
Proposed approach Intermediate (52)e 
The prediction of KEQ is subjected to greater 
uncertainty as compared to obtaining it by 
experimentation 
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rate of reaction as a function of all relevant components at all relevant concentrations, taking into 
account the effect of the equilibrium relation in the equation. 
Using porous resin based on the chemistry for binding the substrate and product is a non-selective 
route. Therefore, for equilibrium limited reactions such as transaminase, more than one strategy is 
required to drive difficult reactions, such as transaminase catalysed reaction, to completion. 
Selecting the appropriate option has to be done in a systematic manner. Adding an excess of the 
substrate and simultaneous removal of co-product by enzymatic or physical means have to be 
evaluated on a case by case basis. A key parameter being the reaction equilibrium, KEQ, can in 
many instances provide the headspace of the process flow sheet. Figure 7.2 shows the relationship 
between KEQ and maximum allowed co-product concentration to achieve 90% yield when using an 
initial concentration of 1M ketone and a 10-fold excess of amine donor for the synthesis of a chiral 
amine.  
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Figure 7.2 Concentration of allowed co-product to reach 90% yield when using an initial 
concentration of 0.5 M ketone and a tenfold excess of amine donor for the synthesis of chiral amine 
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As it can be seen in Figure 7.2, at KEQ values of 0.01, the allowed co-product concentration will 
need to be <10 mM. This information can be then used by process engineers to evaluate alternative 
processes for shifting the equilibrium. 
Selecting resins for the transaminase case studies is quite challenging because of the similarity in 
the properties between the substrates and products. It was observed that the capacity of the resin and 
the selectivity for the product had an inverse relationship. Figure 7.3 illustrates the tendency of all 
the resins that were investigated for the transaminase case studies.  
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Figure 7.3 Selectivity of product and phase ratio as a function of resin capacity 
As it can be seen in Figure 7.3, a trade-off has to be made between capacity and selectivity, which 
can be crucial from an economic point of view. Low resin capacity points towards the need for 
higher resin loading. The phase ratio in turn determines the equilibrium concentration of the 
substrate in the reactor and the type of reactor that can be used (stirred tank reactor or packed bed 
reactor). In the first case study, it was evident that the selectivity for the product was lower than for 
the substrate, leading to the requirement of a resin loading of 40% (V/V) in a packed bed reactor. 
On the other hand, for the second case study 20% (V/V) of resin loading was sufficient to maintain 
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a substrate and product concentration below the critical concentration. A stirred tank reactor would 
be suggested for such a case. A further key finding was that the resin had a relatively strong affinity 
for the enzyme studied in this thesis. A membrane separated reactor or immobilized enzymes would 
be suggested for Ȧ-transaminase reactions. Alternatively, whole cell catalysis can be opted, which 
would not penetrate into the micro pores of the resin.  
Process modelling of biocatalytic processes was the third aspect that was incorporated in the 
framework. Extremely valuable information can be acquired by means of modelling. In the case of 
integrated resin-enzyme processes, the rate of substrate supply and product removal can be a 
bottleneck of the system. However, what was realized from the evaluation is that the reaction was 
not mass transfer limited. The rate of reaction for this enzyme is much lower than the rate of 
substrate supply, and therefore for such systems using resins would not pose as a problem. 
Alternatively, if the enzyme was 10 times faster, the reaction would be mass transfer limited. For 
such cases, it is possible to increase the surface area by using resins with smaller pores, otherwise 
organic solvents would be a better choice. In the second case study of 2-octanol production, the 
reaction was challenged with substrate inhibition. In such cases, a classic reaction engineering 
approach can be applied, in which using a continuous stirred tank reactor (CSTR) would overcome 
the substrate inhibition problem. A CSTR operates at low substrate concentration, so the rate of 
enzyme deactivation on account of substrate inhibition would be minimised. Process modelling can 
allow investigating such scenarios without the need of practically doing the experiments. The 
results should be validated experimentally to confirm the simulations. Modelling should be a tool 
applied at all scales of the process to help decision making easier and also to facilitate the transition 
from lab scale to pilot scale experiments.  
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Chapter 8  
Conclusions 
 
 
8.1 Conclusions of the framework 
The main topic of interest of this thesis is the integration of porous resins in enzymatic processes. It 
is indeed an interesting option which however has been limited to only single substrate and single 
product systems (reduction, oxidation and microbial degradation). The concept has thus been 
expanded to multi-component systems in this thesis, in order to create a generic platform for using 
this technology in enzymatic processes. The first decision of selecting the appropriate process 
option among a pool of process options can be quite challenging. Furthermore, if porous resins are 
an option, then how can one choose the porous resin and moreover how to integrate into a process? 
With that context, a systematic framework has been developed in this thesis in order to address such 
issues of when, why and how to integrate resins in bioprocesses.  
The framework provides guidance for the process development in a systematic way. The main 
problem is broken into five steps where the solution of each step provides an input to the 
subsequent step. The key parameters of a process can be identified by going through those steps and 
the suggested tools of each step can effectively guide data collection. Three tools have been 
developed for this framework: i) A robust methodology for kinetic model parameter estimation, ii) 
A systematic approach for selecting resins and iii) Process evaluation using a model based 
approach. For the first tool, the methodology developed can assist in estimating kinetic model 
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parameters which can predict initial rate and progress curve data sets. The methodology is 
approached in a systematic and step-wise manner such that the parameters are reconciled at every 
step to minimize the estimation errors. Apart from the robustness of the methodology, the number 
of experiments required was optimized to be much lower than other approaches. The second tool of 
resin screening provides a heuristic approach to select resins for multi-component systems. The 
different criteria for selecting resins for this approach have been stated and proved to be adequate. 
With the third tool of process modelling it was possible to identify important parameters such as 
phase ratio, mass transfer coefficients for the integrated resin-enzyme approach and reactor 
configuration (internal or external) and type (batch or flow reactor). The framework has been 
validated with three case studies in this thesis. Although this framework has only been applied to 
two types of enzymatic classes (transferase and ketoreductase), it is possible to apply this 
framework for the evaluation and implementation of other biocatalytic reactions, which have 
similar characteristics as the studied cases. 
8.2 Conclusions of case study 1: asymmetric synthesis of  
1-phenylethylamine 
This case deals with the synthesis of optically pure chiral 1-phylethylamine using the enzyme Ȧ-
transaminase (TAm). The enzyme requires co-factor pyridoxial phosphate (PLP) which is 
regenerated within the reaction.  The overall reaction scheme for this case is: 
+ NH2 + O
O NH2
TAm
PLP
acetophenone 2-propylamine (S)-1-phenylethylamine acetone
  
8.2.1 Reaction characterization 
The key reaction characteristics obtained for this case are the following: 
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First, the reaction is challenged with an unfavourable thermodynamic equilibrium towards the 
synthetic direction and has been estimated to be 0.03.  
Second, the reaction is further challenged with both substrate and product inhibition limiting the 
productivity of the catalyst. Substrate concentration (APH) above 10 mM results in more than 50% 
loss in initial activity. Similarly, production concentration (PEA) above 30 mM inhibits the enzyme.  
Third, the substrate APH has an aqueous solubility of 40 mM. Supplying substrate beyond the 
saturation point denatures the enzyme.   
The reaction therefore presents an interesting case where the inclusion of a non-selective porous 
resin will help to achieve the high substrate loading required to be an economic process and 
simultaneously alleviate substrate and product concentration below the inhibitory concentration to 
improve the productivity of the catalyst. 
8.2.2 Resin screening 
The different components of the reaction were investigated to reveal that the components 
acetophenone and 1-phenylethylamine were moderately hydrophobic (Log P § 1.50 while 2-
propylamine and acetone were hydrophilic (Log P < 0). 
Porous resins found from the Sigma Aldrich catalogue with differing surface areas, pore diameter 
and matrix types were selected for screening. Lewatit AF5 displayed the highest resin capacity (2.3 
mmol/g) and moreover was minimal selective for co-substrate 2-propylamine and co-product 
acetone (S < 0.5). Furthermore, the resin was stable with no loss in performance after 5 batches.  
30% phase ratio was required in order to maintain substrate and product concentration within limits. 
The resin showed affinity for the enzyme as well (20% protein content was adsorbed) and thus the 
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resin had to be compartmentalized in an external column separated with an ultrafiltration membrane 
for the process.  
An experiment performed with 50 g/L ( 0.4 M) APH with the integration of the porous resins, 
resulted in yields comparable to equilibrium yields (26%) as opposed to the control experiment (no 
resins), where less than 2% yield was achieved.  
8.2.3 Process evaluation 
Three different models were tested to investigate which model best describes the adsorption 
isotherms of acetophenone and 1-phenylethylamine. Sips isotherm model presented the best fit of 
the experimental data (R2 §. The distribution coefficient for PEA and APH was estimated to be 
1.02 and 34.41 respectively. This is in agreement with other studies using cyclohexanone as a 
solvent (Shin and Kim, 1999b) and moreover the substrate acetophenone is more hydrophobic than 
1-phenylethylamine and thus is bound more firmly to the resin.  
The mass transfer coefficient for substrate supply was smaller than for product removal. This is in 
accordance with the distribution coefficient previously estimated. However, the reaction was not 
mass transfer limited as the rate of product formation steeped exponentially upwards.  
The load ratio was investigated further and based on simulations it could be seen that 30% (V/V) 
was the optimal setting for this process. Similarly, the distribution coefficients were varied in 
simulations to predict the output. The very low distribution of PEA was indeed not adequate to 
reach equilibrium yields. Distribution coefficient for PEA is required to be similar to APH to reach 
equilibrium yields or higher to attain conversion beyond that. 
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8.3 Conclusions of case study 2: asymmetric synthesis of 1-methyl-3-
phenylpropylamine 
This case deals with the synthesis of optically pure chiral 1-methyl-3-phenylpropylamine, a product 
produced by Cambrex. The reaction was done using enzyme Ȧ-transaminase (TAm) immobilized 
by CLEA.  The overall reaction scheme for this case is: 
NH2 O OH
NAD+ NADH
Z-transaminase
 Alcohol dehydrogenase
Glucose dehydrogenase
Reaction 1
Reaction 2
CH3
O
CH3
NH2
O
OH
OH
OHHOH2C
OH
OH
OH
OH
OH
OH
OH
O
 
8.3.1 Reaction characterization 
The reaction characteristics obtained for this case are the following: 
First, the reaction is challenged with an unfavourable thermodynamic equilibrium towards the 
synthetic direction and was found from literature to be 0.59.  
Second, the reaction achieved less than 70% conversion with a starting substrate concentration of 6 
mM on account of inhibition (equilibrium yield should be around 99%).  
Third, the substrate 4-phenyl-2-butanone has an aqueous solubility of 12 mM. Supplying substrate 
beyond the saturation point denatures the protein of the enzyme.   
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The reaction therefore presents an interesting case where the inclusion of a non-selective porous 
resin will help to achieve the high substrate loading, required to be an economic process and 
simultaneously help to keep aqueous substrate and product concentration below 6 mM.  
8.3.2 Resin screening 
Similar to the previous case study, the key substrate and product were moderately hydrophobic 
(Log P > 1) while the other components were hydrophilic (Log P < 1).  
Three different resins were selected having surface area greater than 1000 m2/g, of which resin 
Lewatit AF5 proved to have the best capacity (1.65 mmol/g). The resin showed moderate selectivity 
for the key substrate and product (S §ZKLOHlow for the other components (S < 0.1). 
A reaction mixture of 50% conversion was simulated to test different phase ratio which would 
correspond the final aqueous substrate and product concentration in the reactor to be less than 6 
mM. 20% phase ratio was determined to be optimal to keep substrate concentration to be 0.18 mM 
and product 1.67 mM.    
8.3.3 Process evaluation 
Integration of porous resins in the enzymatic process resulted in yields of around 40%. Higher 
yields could not be achieved because at the end of the reaction the concentration of 1-methyl-3-
phenylpropylamine in the aqueous phase was measured to be around 8 mM causing the enzyme to 
be inhibited. Two strategies were attempted to improve the yield further, by removing acetone in-
situ: sweeping saturated nitrogen over the reaction media and adding a selective enzyme (reaction 
2) in sequence with reaction 1. The strategies proved to be successful to improve the yields to 
around 70%. However, it was observed that the volume of the reaction media reduced on account of 
nitrogen sweeping while the activity of the cascade enzyme was quite poor for which reason 20 g/L 
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of the enzyme was added. Higher concentration could not be added as it was precipitating in the 
reactor. 
From the results it points out that multiple strategies are required in order to achieve yields higher 
than equilibrium. The problem set forth from this case study indicates the necessity of evolving the 
cascade enzyme to improve the specific activity in order to minimize the enzyme loading. On the 
other hand, efforts could be placed in engineering the resins to be more selective for the key product 
and thus help in shifting the equilibrium as well. 
8.4 Conclusions of case study 3: enantioselective synthesis of 2-
octanol 
Optically pure 2-octanol is synthesized from 2-octanone using the enzyme LbADH (EC 1.1.1.2). 
The enzyme is co-factor dependent and thus the co-factor has to be recycled. An enzyme coupled 
approach was selected based on the high selectivity and catalytic efficiency using the enzyme GDH 
(EC 1.1.1.47). Co-substrate glucose is used as a substrate for the GDH enzyme. An overview of the 
reaction scheme is shown as follows: 
O OH
O OH
OH
OH
OH
HOH2C O O
OH
OH
OH
HOH2C
OH
OH
OH
OH
OH
OH
O
+ NADP++ NADPH + H+
LbADH
GDH
2-octanone (R)-2-octanonol
D-glucose GDL gluconic acid
H2O
 
8.4.1 Reaction characterization 
The key reaction characteristics of this reaction have been identified as follows: 
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First, the substrate 2-octanone was inhibiting the enzyme. Concentrations above 10 mM strongly 
reduced the initial activity of the enzyme. 
Second, the reaction was favourable in the synthetic direction, which was realized with a higher 
Vmax value in the forward direction than the reverse direction.  
Finally the aqueous solubility of 2-octanone was poor (5 mM), for which a co-solvent (ionic liquid) 
was added to the reaction to increase the solubility to 60 mM.  
8.4.2 Process evaluation 
Effective utilization of the co-factor is a major drawback for these kinds of redox reactions. The co-
factor concentration and enzyme ratio were optimized by using process modelling. The co-factor 
concentration could be reduced to 0.025 mM while maintaining enzymes ratio of 1:1.5.  
By means of process modelling, it was revealed that substrate inhibition was a limitation to this 
process, thus using non-selective resins would not be suggested. Alternatively, continuous stirred 
tank reactors which work in low concentration of substrate were suggested. Coupling two CSTR’s 
suggested the possibility of attaining almost a 100% conversion within 24 hours. 
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Chapter 9  
Future work 
 
 
Biocatalysis is now frequently considered as an option in the synthesis of complex molecules. Some 
of the major limitations that were once considered such as inhibition, sparingly water soluble 
substrates can be solved by introducing resins as an auxiliary phases as has been discussed in this 
thesis. Majority of the research has been conducted in whole cell catalysis where the reaction will 
not be mass transfer limited. However, soluble enzyme benefits of fast kinetics. It would be 
interesting to investigate the influence of bead size, geometry and type of resin on the reaction.  
From the screening of resins it was found that a single resin could not be identified to be called the 
‘super’ resin. It would be desirable that research efforts are placed in tailoring resins to fit the 
process requirements. This concept is being developed with solvent design and it would be also 
interesting to expand it towards designing a resin which can be applied not only based on 
hydrophobicity and ionization but also based on the chemistry. Screening kits for selecting resins 
could be devised.  
Furthermore with the increased interest of using resins as an auxiliary phase, it would be very 
beneficial to create a standardized database. Generally the supplier of the resin can only provide 
specific details regarding the resin such as functional properties and physical properties. If a 
database could be made available with the type of resin, target molecule, partition coefficient for all 
reactants and capacity for substrate then it would help facilitate the efficient selection of resin.  
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Resins alone are not the only auxiliary phase that is used for processes. It would also be interesting 
to investigate organic solvent and ionic liquids as auxiliary phases. A clear limitation of liquid 
phase auxiliary phase is the compatibility issue. Even though the number of ‘green’ solvents is not 
so many but it still is a challenge in identifying a solvent which does not negatively impact the 
enzyme. Solvent selection methodology directed towards biocatalysis would be an important tool to 
develop.  
With the development of different auxiliary phases, it would be interesting to investigate 
multiphasic system. A cascade of reactions could be carried out with the substrates immobilized in 
different auxiliary phases loaded in a packed bed reactor. This would give rise to interesting reactor 
designs and process options.  
An ideology by protein engineers are that inhibition of an enzyme can be solved by altering the 
protein structure of the enzyme. This may be true within the next five years. However, the 
thermodynamic equilibrium is independent of the enzyme and depends on the reaction. In-situ 
product removal would prove to be a powerful tool for biocatalytic reactions. It would help to 
integrate the process, increase product concentration and thus make downstream processing easier. 
It could be envisaged to devise micro scaled reactors to test different configuration of in-situ 
product removal. In this way one would be able to assess the different options without spending 
expensive resources such as chemical and enzymes.  
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Appendix 1 
Reaction mechanisms 
 
 
Monosubstrate enzyme kinetics 
This appendix compiles the reaction rate expressions for some of the enzyme mechanisms that are 
used in this thesis. Specific definitions used are elaborated to make it easier for the reader to follow 
the text.  
For a simple single component system where the substrate S is catalysed by enzyme E, the reaction 
mechansim can be illustrated as shown in Equation A.1 
E S ES E P o U                        [A.1] 
It is assumed  that the first step of the reaction is reversible and fast enough to reach equilibrium to 
form a complex ES. The second step in the reaction is asumed to be slower than the first treaction 
and considered to follow a first-order reaction which forms the product P. These two assumptions 
gave rise to the so called ”michaelis-menten rate” equation as shown in Equation A.2 (Michaelis 
and Menten, 1913). 
 
m S
M S
V Cr
K C
                                                                    [A.2] 
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Particular derivations of the reaction rate expressions are obtained when the enzyme isinfluenced by 
substrate (s) and product (s) (e.g. enzyme inhibition). In this thesis only linear inhibitions have been 
encountered. However, there are other types of non-linear inhibitions that can take place which have 
to be treated differently (Cornish-Bowden, 2004).  
Linear inhibition 
Competitive inhibiton: This form of inhibition occurs when the inhibitory compound, I, compete 
with substrate A for the same active site of the enzyme. Figure A.1 illustrates the reaction sequence.  
 
Figure A.0.1 Mechansim that produces competitive inhibition 
In order to account for this inhibition, the rate expression of Equation A.2 is modified to Equation 
A.3 to include the inhibition term which affects only the Michaelis-Menten constant. 
c
m S
I
M S
ic
V Cr
C
K 1 C
K
 § · ¨ ¸© ¹                         [A.3] 
Non-competitive inhibition: This form of inhibition occurs when the inhibitory compound, I, bind 
reversibly with the acttive site of the enzyme and the enzyme complex. Figure A.2 illustrates the 
reaction sequence.  
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Figure A.0.2 Mechansim that produces non-competitive inhibition 
This type of inhibition is quite rare and is generally used only in text books. To incorporate this 
effect on the kinetic model (Equation A.2) is modified to Equation A.4. 
NC NC
1 2
m S
I I
M S
NC NC
V Cr
C C
K 1 C 1
K K
 § · § ·  ¨ ¸ ¨ ¸¨ ¸ ¨ ¸© ¹ © ¹                        [A.4] 
Un-competitive inhibition: This form of inhibition occurs when the inhibitory compound binds with 
the enzyme-substrate complex to reduce the net rate of reaction. Figure A.3 illustrates the reaction 
sequence.  
 
Figure A.0.3 Mechanism that produces un-competitive inhibition 
In order to account for this inhibition, the rate expression of Equation A.2 is modified to Equation 
A.5 to include the inhibition term which affects only the Vm constant. 
U
U
Im S
M S I
CV Cr 1
K C K
§ · ¨ ¸¨ ¸ © ¹                          [A.5] 
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Bisubstrate enzyme kinetics 
In this thesis, two models have been used: 1) Ping pong bi bi model and 2) the modified Michaelis-
Menten model.  
The first model has been derived on the basis that the reaction follows the sequence ash shown in 
Figure A.4 
   A                         P       B                          Q
E   EA      E'P      E'      E'B      EQ      EU U  
Figure A.0.4 Ping Pong Bi Bi mechanism 
For this kind of reaction sequence, the kinetic model can be derived from steady-state kinetics using 
methods such as King-Altman or Wong-Hanes which are well explained in the literature (Cornish-
Bowden, 2004;Leskovac, 2003). 
The kinetic model to describe this reaction is shown in Equation A.6. 
P Qf r
m m A B
EQ
f Q f P
r B r A m M m M
m M A m M B P Q
EQ EQ
f Q f r A
r m M m m M
m A B A P P Q B QA Q
i EQ EQ i
C C
V V C C
K
r
V K V KV K C V K C C C ...
K K
V K V V KV C C C C C C C C
K K K K
§ ·¨ ¸¨ ¸© ¹ 
   
  
                                                      [A.6] 
For the second model, the equation has been derived based on the reaction following the sequence 
shown in Figure A.5 which is called the compulsory-order ternary-complex mechanism.  
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   A          B                          P        Q
E      EA      EAB EPQ      EQ      EU  
Figure A.0.5 Compulsory-order ternary-complex mechanism 
The kinetic model to describe this mechanism has been derived simlarly as the previous one as 
shown in Equation A.7.  
rf
m P Qm A B
A B Q P
i M i M
A Q Q
QA M B M P A B M A P
A A B P Q Q A B A P Q
i i M M i i i M i M i
A
M B Q P Q B P QA B P
A B Q P Q A B P B P Q
i M i M i i M i i M i
V C CV C C
K K K Kr CC K C K C C C K C C1 ...
K K K K K K K K K K K
K C C C C C C CC C C
K K K K K K K K K K K

 
      
  
                                      [A.7] 
To simplify the model, experiments can be designed at times very close to zero at which point the 
influence of product can be assumed to be negligible. The model is then called the initial rate model 
or modified Michaelis-Menten equation as shown in Equation A.8 
  
f
m A B
A B
M B M A
V C Cr
K C K C
                                             [A.8] 
Nomenclature 
R Rate (mM/min) 
Vm Velocity parameter (mM/min) 
KM Michaelis-Menten constant (mM) 
KI Inhibition constant (mM) 
A, B, P, Q, S Components of the reaction (mM) 
E Enzyme (mM) 
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KIc Competetive inhibition constant (mM) 
KNC1 and KNC2 Non-competetive inhibition constant (mM) 
KIu Uncompetetive inhibition constant (mM) 
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ABSTRACT: Biocatalytic transamination is being established
as key tool for the production of chiral amine pharmaceu-
ticals and precursors due to its excellent enantioselectivity as
well as green credentials. Recent examples demonstrate the
potential for developing economically competitive processes
using a combination of modern biotechnological tools for
improving the biocatalyst alongside using process engineer-
ing and integrated separation techniques for improving
productivities. However, many challenges remain in order
for the technology to be more widely applicable, such as
technologies for obtaining high yields and productivities
when the equilibrium of the desired reaction is unfavorable.
This review summarizes both the process challenges and the
strategies used to overcome them, and endeavors to describe
these and explain their applicability based on physiochem-
ical principles. This article also points to the interaction
between the solutions and the need for a process develop-
ment strategy based on fundamental principles.
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Introduction
Chiral amines are key building blocks for many new
pharmaceuticals (NCEs and APIs). Chiral amines can be
produced both by chemical and biocatalytic synthesis
(Breuer et al., 2004). However, despite the great effort that
has been put into developing efﬁcient routes for chemical
synthesis, this still remains a challenge (Nugent and
El-Shazly, 2010). As an alternative, transaminases (EC
2.6.1.X; also known as aminotransferases) have received
much attention as suitable catalysts for producing these
amines either by direct asymmetric synthesis from pro-
chiral ketones or by kinetic resolution of racemic amines.
Transaminases catalyze the transfer of an amine (–NH2)
group from an amine donor, usually an amino acid or a
simple amine such as 2-propyl amine, to a pro-chiral
acceptor ketone, yielding a chiral amine as well as a co-
product ketone or alpha-keto acid (Fig. 1). Transaminases
require the cofactor pyridoxal phosphate (PLP) to act as a
shuttle to transfer the amine group (Eliot and Kirsch, 2004).
This cofactor is fully regenerated within the same two
substrate reaction on the same enzyme, and hence does not
pose the cofactor regeneration problems encountered in
oxidation/reduction reactions (Hwang et al., 2005; Pannuri
et al., 2003). Generally speaking, transaminases are suitable
catalysts due to their high stereoselectivity, and ability to
operate under environmentally mild reaction conditions.
Transaminases and their function have been known for
quite some time (Christen and Metzler, 1985) and the
technology is already used in industry to produce selected
chiral amines (Pannuri et al., 2003). Even so, in spite of the
many attractive features of transaminase catalyzed reactions,
there are still a number of challenges that need to be dealt
with in order to make transaminase processes feasible for the
production of a wider range of amines.
In the reaction step, two general strategies are used to
obtain the target chiral amine; either direct asymmetric
synthesis or kinetic resolution of a racemic amine. The latter
alternative is the commonly used option in industry today
although it is hampered by a 50% theoretical yield, unless a
racemization step is included to enable a dynamic kinetic
resolution (DKR). Nonetheless, using this strategy high
enantiomeric excess (ee) values are easily attainable.
However, in this report, the focus will be on direct
asymmetric synthesis, since this is the state-of-the art of the
Correspondence to: P. Tufvesson
Contract grant sponsor: European 6th Framework Programme
Contract grant number: EIB.08.016
Contract grant sponsor: European Union 7th Framework Programme
Contract grant number: 245144
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technology and for the future the preferred reaction
conﬁguration, although more challenging than the resolu-
tion strategy.
Many of the problems encountered with transaminases
are common to other biocatalytic processes and conse-
quently many parallels can be drawn to other biocatalytic
reactions for the production of chiral molecules (e.g.,
chiral alcohols). A number of reviews have been
published describing the general features of transaminases,
for instance by Taylor et al. (1998) and Stewart (2001),
whereas Hwang et al. (2005) describes the different
subgroups of transaminases and their substrate speciﬁcities
related to the 3D structure, as well as protein engineering
efforts to tailor the speciﬁcities. In a review by Koszelewski
et al. (2010c) the recent developments in the ﬁeld are
described, with a focus on the different sources of v-
transaminases available.
The current review takes a process perspective and the
focus is on the considerations for developing industrial
transamination processes at large scale, summarizing the
challenges and strategies to meet a number of proposed
success criteria for an efﬁcient and economic process. The
article also reviews the different proposed solutions and
analyzes these from a feasibility point of view supported by
calculations and examples. We also suggest engineering
tools to model and assess the process to move this
technology towards a rational approach for developing
large-scale processes.
Process Overview
The biocatalytic transaminase catalyzed production scheme
consists of four major steps (Fig. 2); fermentation,
biocatalyst formulation, reaction, and product recovery.
Unless the biocatalyst is purchased from an external supplier
(in which case the ﬁrst two steps can be disregarded), the
desired enzyme activity is expressed in a host microorganism
to high product titer and thereafter prepared in a suitable
form (biocatalyst formulation) for the reaction step (Fig. 3).
To avoid unnecessary costs the biocatalyst is used in the
crudest possible form; either as whole cells or cell-free
extract (crude enzyme). Immobilization of the cells or
enzymes can furthermore be used to facilitate recovery and
improve the stability, thereby extending the use of the
catalyst to multiple batches.
After the reaction is complete the biocatalyst is removed
(biocatalyst separation) and the product is separated and
puriﬁed. In each step of the process there are a number of
factors that will determine the ﬁnal economic viability of the
process and the optimization of each step is essential in
order to achieve a viable process.
There is little quantitative data published on the
economics of biocatalytic processes and how the different
performance metrics affect the cost of the total process.
However, some of the metrics commonly used to bench-
mark the process (Bommarius et al., 2001; Straathof et al.,
2002; Tufvesson et al., 2010) are summarized in Table I. In a
previous article (Tufvesson et al., 2011) we have described
the requirements for biocatalyst productivities for ﬁne and
pharmaceutical processes.
Many parameters work together to determine the success
of an industrial biocatalytic process and clearly the limits in
Table I are not absolute and should therefore be seen as
general recommendations. Deﬁnitive requirements can only
be determined on a case-by-case basis taking into account
the added value of the process, competing technologies, and
so on.
One of the most important factors is the added cost of the
biocatalyst, which is why it is essential to maximize the
biocatalyst productivity (g product/g biocatalyst). In addi-
tion, the product concentration is a key parameter as it
determines the equipment cost and ease of downstream
Figure 1. Overview of the biocatalytic transamination reaction.
Figure 2. Overview of the biocatalytic transamination process.
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separation and recovery. In order to compare how the state-
of-the art transaminase technology relates to the above
stated requirements, a summary of published reaction
conditions and process metrics has been compiled in
Tables II and III.
As can be seen from Figure 4, most studies are far from
meeting the required industrial process requirements, with
three notable exceptions; the work by Truppo et al. and the
work by Savile et al., both reports from 2010 and the work by
Martin et al. (2007). Even though none of these studies fulﬁll
all of the guidelines in Table I, Martin et al. (2007) shows a
very high catalyst productivity, especially considering that
the catalyst is a whole cell. Savile et al. (2010) on the other
hand demonstrate that the process can be run at substrate
loadings signiﬁcantly above the recommended minimum
concentration. Ways for improving the reaction perfor-
mance have included both biocatalyst improvements (e.g.,
by protein engineering or immobilization) and process
improvements (e.g., by in situ product removal).
In the following sections of this article the main process
challenges in biocatalytic transamination will be presented
and solutions (and/or suggestions) for process improvement
will be discussed.
Process Challenges and Strategies
In order to meet the success criteria put forward above, a
thorough knowledge of the reaction system is required
relating both to the reaction thermodynamics, the physical
characteristics of the reaction components and the
possibilities and limitations of the given biocatalyst.
There are many challenges inherent to transaminase
processes that need to be dealt with and numerous reports
have been published that address one or more of these
challenges. Frequently the suggested solutions, or technol-
ogies, solve more than one problem, for instance the use of
an auxiliary phase may solve issues related to substrate and
product inhibition as well as low water solubility, but on the
other hand the solution might pose other problems such as
lower biocatalyst stability. An overview of transaminase
process challenges have been put together in Table IV, along
with the suggested technologies or strategies used to
Figure 3. Detailed process design for the ﬁrst three steps in the biocatalytic transamination process. S1—main feeding stream (amine donor, amine acceptor, PLP),
S2—substrate for co-product removal, S3—co-factor regeneration.
Table I. Success factors for the economic feasibility of a biocatalytic
process (Tufvesson et al., 2010).
Fermentation
Cell titer 50–100 g CDW/L (if intra cell.)
Protein titer 1–10 g/L
Biocatalyst formulation
Retention of activity High
Stabilization Improve catalyst productivity >5 times
Reaction
Product concentration >50 g/L
Catalyst productivity 10–35 g product/g whole cell (DCW)
100–250 g product/g free enzyme (crude)
50–100 g product/g immob. enzyme
Stereoselectivity >98% ee
Yield >90%
Tufvesson et al.: Chiral Amines Using Transaminases 1481
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overcome these, as well as the further implications of using a
speciﬁc technology.
Thermodynamic Limitations
A critical issue that needs to be addressed in a biocatalytic
transamination reaction is the thermodynamic equilibrium
of the reaction system since knowledge about the thermo-
dynamics of the reaction will determine which process
solutions are feasible on an industrial scale.
The transamination reaction is reversible and the
maximum achievable conversion is thus determined by
the initial concentrations and the thermodynamic equili-
brium constant (K) of the reaction. K in turn is determined
by the change in Gibbs free energy for the reaction, which is
given by the difference in DG between the products and the
reactants. For the amine transfer from an amino acid to an
alpha keto acid to form another amino acid, the change in
Gibbs free energy is small and thus the equilibrium constant
is around one (Taylor et al., 1998). However, for the transfer
of an amine group from an amino acid to acetophenone, a
commonly investigated ketone, the equilibrium is strongly
in the favor of the amino acid (amine donor). Kim and Shin
Figure 4. State of the art in transaminase reaction for chiral amines synthesis
plotted AS Biocatalyst productivity versus product concentration. ^: Cell-free
catalyst; &: cascades (cell-free); D: cascades (whole cell); *: whole cell; gray
markers: synthesis of chiral amines; white markers: synthesis of amino acids. (A)
Sitagliptin, Savile et al. (2010); (B) a-MBA, Truppo et al. (2010); (C) b-(2-thienyl)-D-
alanine, Meiwes et al. (1997); (D) LHPA, Lo et al. (2005); (E) 2-aminobutyric acid, Li et al.
(2002).
Table IV. Bottleneck analysis.
Challenges
Major limitations
Process
related
Biocatalyst
related
Low
thermodynamic
equilibrium
Low
substrate
solubility
Substrate
and product
degradation Inhibition Stability Activity
Separation of
biocatalyst
Solutions
Chemistry related
Stronger amine donor U Cost and availability of the donor
Excess amine donor U Inhibition and stability of
enzyme; Not applicable for low
Keq; donor cost; downstream
separation
Process related
Solvent (co-solvent/2-phase) U Enzyme stability; downstream
separation; VOC
Separation of (co-)product
by (a) distillation
U Co-distillation of water and/or
other components
(b) Extraction
(solvent, membrane, resin)
U U U U Selectivity between substrates
and products
Controlled supply of substrate
(fed-batch)
U U Capacity
Degradation of
co-product (cascade)
U Compatibility; Added cost of
biocatalysts; co-factor recycling
Biocatalyst related
Whole cell U Side-reactions; separation; GMO
regulations
Immobilization U U Deactivation; development cost;
higher biocatalyst cost
Enzyme development U U Development time and cost
Analysis of challenges in biocatalytic transamination and implications for how suggested solutions inﬂuence which technologies that are suitable/
compatible.
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(1998) report a K of about 103 (for the synthesis of a-
methylbenzylamine) based on parameter estimation when
performing a kinetic study. Still there are indications from
other studies that it may be evenmore unfavorable than this,
since transamination of acetophenone with 10 equivalents
L-alanine was completed at 3% conversion, as opposed to
the theoretical equilibrium conversion of 9% (Truppo et al.,
2009a).When using 2-propyl amine instead of amino acid as
the donor, the equilibrium becomes more favorable
(Truppo et al., 2009a) but still the equilibrium lies strongly
in favor of the reactants. Although Shin and Kim (1999)
have compared the effect of different amine donors on the
yield, they do not show that equilibrium has been reached.
To our knowledge no other reports determining the
equilibrium constants using different donors have been
published. Even so, the relative amine donating potential of
many compounds can be qualitatively extrapolated from
literature, for instance the donor potential of a-MBA is
order of magnitudes higher than for 2-propylamine, which
in turn has much higher potential than alanine. It is clear
that the availability of an even stronger amine donor could
be very beneﬁcial.
By knowing the reaction Gibbs free energy (DG), one can
determine the process strategy needed to meet the
requirements in terms of yield and product concentration.
Different strategies inherently bring about different cost
structures and therefore one can identify the reactions that
are likely to be able to be scaled-up and applied in industry.
Therefore knowledge of the reaction equilibrium constant
and/or Gibbs free energy allows a more intelligent process
design. Jankowski et al. (2008) have developed a group
contribution method for estimating Gibbs free energies for
biochemical reactions in aqueous solutions at pH 7 and
258C, having a standard error of 2 kcal/mol. This
methodology was recently applied by Seo et al. (2011) in
the comparison of the transamination potential of different
amine donors, where 1-aminoindan was estimated to be
thermodynamically favorable for the transamination of
acetophenone. Considering the uncertainty in the group
contribution method it was within the standard error, that
an experimental yield of only 37% was obtained using four
equivalents of amine donor, indicating a thermodynamically
unfavorable reaction (Seo et al., 2011).
In order to overcome the thermodynamic limitations in
transaminase reactions there are several solutions that have
been shown to (at least) partly overcome these: addition of
excess of amine donor, application of ISPR (in situ removal
of product or co-product), auto-degradation of the product,
use of enzymatic cascades or whole-cell catalysis.
Addition of Excess Amine Donor
The easiest option for shifting the equilibrium towards a
high yield of the product would in principle be to use an
excess of the amine donor. This strategy was applied by
Savile et al. (2010) for the production of Sitagliptin at high
substrate concentrations using approximately 10-fold excess
of 2-propylamine. However, the use of this strategy is
limited to those cases when the equilibrium is only slightly
unfavorable. In fact, from the Savile article it can be
extrapolated, that the K in this case is close to unity.
The reason for the limitation to this strategy is that if the
substrate concentration is to be kept at a high level (>50 g/
L), there will be an upper limitation of how large an excess of
amine donor can be used, with stoichiometric equivalents in
the range of 1–50 times approaching the limits of amine
donor solubility. Figure 5 plots the necessary excess of amine
donor required to achieve a yield of 90% at varying value of
K. As can be seen from Figure 5, to achieve a yield of 90% an
excess of 100-fold is required if theK value is 101. Similarly,
if K the value is 103, an excess of 10,000-fold would be
required, which for obvious reasons is unrealistic.
As a consequence of this, for transaminations where K is
lower than 102 adding an excess of amine donor will not be
sufﬁcient to reach the process metrics and thus additional
strategies are required.
Removal of Product or Co-Product
A second method to shift the equilibrium position in favor
of the desired product is to remove the product or co-
product from the media during the reaction itself, that is, in
situ product removal (ISPR). Again, the equilibrium
constant of the reaction determines how low a concentration
of product or co-product is required to achieve the target
Figure 5. The equilibrium constant (K) determines the excess of amine donor
required to reach a thermodynamic equilibrium of 90% (solid line). The broken lines are
visual support for an excess of 10 and 50, which can be considered process
boundaries.
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yields. Figure 6 shows the relationship between K and
co-product concentration to achieve 90% yield when using
an initial concentration of 1M ketone and a 10-fold excess of
amine donor for the synthesis of a chiral amine. As can be
seen in Figure 6, at K values <103 the required co-product
concentration will need to be <1mM. This is important to
keep in mind when considering which methods can be used
to shift the equilibrium.
The best strategy for ISPR will depend on the properties of
the product amine as well as the other components in the
reaction mixture. In general, a strategy will be favorable
when it produces a big driving force for separating the
product from the other components. The physico-chemical
properties that are most commonly exploited for ISPR are
volatility, solubility, charge, hydrophobicity, and molecular
size (Lye and Woodley, 1999).
ISPR strategies are particularly relevant when considering
transamination reactions, as they enable a shift of the
reaction equilibrium position as well as reducing product
inhibition (as will be discussed later). There are many
examples to illustrate the use of ISPR strategies in
connection with transaminase catalyzed reactions. A
summary of the different approaches for ISPR, including
the improvement achieved and main drawbacks, can be
found in Table V.
Liquid–liquid extraction is a common strategy for the
downstream recovery that allows the recovery of a large
range of different amines. Extraction under either acidic or
basic conditions allows control of the amine product if
Figure 6. Concentration of co-product required to reach 90% yield when using
an initial concentration of 1mol/L ketone and a tenfold excess of amine donor for the
synthesis of chiral amine.
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protonated, and thus provides an efﬁcient tool for
separating the amine from other components in the product
stream (in particular the remaining substrate ketone). For
example, such an approach was applied in the post-reaction
recovery of (R)-4-phenylbutan-2-amine by Koszelewski
et al. (2008b). Integrating the extractive recovery with the
reaction step would allow a shift of the equilibrium by
extracting the product into the second phase, that is, in situ
extraction. ISPR by employing adsorbing resins for
extracting the product has also been suggested (Woodley
et al., 2008). This strategy was shown by Truppo et al. (2010)
to be an efﬁcient method to also overcome product
inhibition and shifting equilibrium in the production of
both (R)- and (S)-methyl benzylamine. At substrate
concentrations of 50 g/L (0.4M), 200 g of ion-exchange
resin was used for product adsorption, resulting in
improved reaction rates and yields. This strategy further
allowed the product to be easily recovered by ﬁltration and
washing of the resin. However, the added cost of using large
amounts of resin needs to be considered. Multiple re-uses of
the resin will be necessary for a reasonable cost contribution.
There are limitations with all separation strategies. A
common limiting factor is related to the selectivity of the
separation and the relative concentrations of the reaction
components, including the solvent. For instance, an
observed problem when using either solvent or resin
extraction is that the ketones or amines have similar
distribution behavior and therefore will co-extract into the
solvent or resin unless another driving force is in place such
as ionization. This is well illustrated in the report by Truppo
et al. (2010) employing the use of resins to extract the
product. The amine donor 2-propyl amine was seen to
compete with the product (MBA) for binding to the resin.
The similarity between the pKa value of the product and the
amine donor (9.54 and 10.73, respectively) also excludes
using ionization for separation, since at pH 7 more than
99% of both compounds are protonated. This problem was,
however, alleviated in the report by changing the amine
donor to alanine and implementing a cascade enzymatic
system to degrade the pyruvate (as will be described
below).
Evaporation of a volatile product (or co-product) may
also be an option for shifting the equilibrium towards the
product. This has been suggested as an option if 2-
propanamine or 2-butanamine is used as the amine donor
yielding acetone or butanone, respectively, as the co-
substrate (Yun et al., 2004). For volatile amines, distillation
could also be a possible route for product recovery in kinetic
synthesis (see Table VI). For example (R)-sec-butylamine
(boiling point 638C) was recovered by distillation of the
product mixture under basic conditions (Hanson et al.,
2008). Also Savile et al. (2010) report a slight improvement
in yield by sweeping the reactor with nitrogen gas to remove
the formed acetone.
The selectivity problem is, however, also very problematic
when using the evaporation strategy. Assuming ideal
conditions, an estimate of the vapor composition can
quickly be estimated based on Raoult’s law (see Eq. 1,
Table VI).
xvapi ¼
pi
xliP
pixli
(1)
x
vap
i molar fraction of compound i in vapor; p

i vapor
pressure of pure compound; xli molar fraction of compound
i in liquid phase.
As an example, if 10mM acetone is being removed from a
water solution the relative amount of water (Cwater 55M)
evaporated will be over 500 times that of acetone. Hence, in a
thermodynamically unfavorable system, the concentration
of acetone will need to be reduced signiﬁcantly beyond this
point as shown previously, making the problem more
difﬁcult. Similarly, the volatility of any co-solvent and the
donor amine need to be considered when using this
approach.
Auto-Degradation of Co-Product
A very convenient, but not widely applicable approach is the
use of a self-degrading co-product or products.
Fotheringham and coworkers (Ager et al., 2001; Li et al.,
2002) found that when using ornithine or lysine as amine
donor, the formed amino-keto acid is cyclized sponta-
neously thus favoring the reaction in the direction of the
amine (Ager et al., 2001; Li et al., 2002; Lo et al., 2005).
Truppo et al. (2010) used a similar approach where the
product cyclized, thereby shifting the equilibrium of the
reaction.
Enzymatic Cascade Reactions
A much explored approach to obtain a high yield of the
desired product is to couple the transamination reaction to
other enzymatic steps (Fig. 3) that convert the co-product
(e.g., pyruvate or acetone) into a non-reactive species or
back to the original substrate. A multitude of different
coupling reactions have been proposed and reported. These
are summarized in Table VII and are reviewed beneath.
Table VI. Vapor pressure values of pure compounds at 258C.
Compound Pvap (mbar)
Acetophenone 0.53
a-methylbenzylamine 0.72
Alanine Non volatile
Pyruvic acid 1.7
Acetone 309
2-propyl amine 773a
Acetaldehyde 1202
2-butyl amine 237a
2-butanone 121
Water 30.7
aAt reaction conditions (pH 7) the vapor pressure of amines are
negligible due to protonation of the amine.
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One early strategy, employed by Chao et al. (1999), was
the combined use of phosphoenolpyruvate carboxykinase
(EC 4.1.1.32; PcK) and pyruvate kinase (EC 2.7.1.40) to
convert the formed oxaloacetate to pyruvate in a two-step
reaction. A simpler strategy was reported by Fotheringham
and co-workers (1999, 2001) in a process for making amino
acids, where the transamination was coupled to acetolactate
synthase (EC 2.2.1.6), which converted the formed pyruvate
by-product to the non reactive acetoin. Signiﬁcant yield and
purity advantages over the process using the transaminase
alone were reported, with an eight to tenfold increase in the
ratio of product to the major impurity. Another common
strategy to eliminate the pyruvate is through the addition
of lactate dehydrogenase (LDH, EC 1.1.1.27), converting
pyruvate to lactic acid while simultaneously oxidizing
NADH to NADþ (Ho¨hne et al., 2008; Hwang et al., 2009;
Shin and Kim, 1999; Truppo et al., 2009a). Although the
system has been shown to work effectively, the main
drawback is the requirement of the co-factor NADH, which
needs to be re-generated.When using cell-free transaminase,
this can be achieved by adding glucose dehydrogenase
(GDH, EC 1.1.99.10) or formate dehydrogenase (FDH, EC
1.2.1.2) together with glucose or formate. The same effect
could also be achieved by using a whole-cell system as most
organisms already have a system for pyruvate metabolism
and NADH regeneration. In a report by Ho¨hne et al. (2008)
it was shown that the equilibrium can instead be shifted by
the use of pyruvate decarboxylase (PDC, EC 4.1.1.1). The
major argument for using this (in contrast to LDH) is that
cofactor recycling is eliminated, and the reaction is
practically irreversible as the products are very volatile
(acetaldehyde and CO2), and would be evaporated for the
desired shift of equilibrium (Ho¨hne et al., 2008). Truppo
et al. (2009b) developed a novel system for the resolution of
racemic amines using a transaminase coupled with an amino
acid oxidase (AAO, EC 1.4.3.2). In contrast to previously
reported approaches that use a stoichiometric amount of
amine acceptor, the system described here employs a
catalytic amount of amine acceptor (pyruvate) that is
continuously recycled in situ by an AAO and molecular
oxygen. Pyruvate can also be reconverted into L-alanine with
L-alanine dehydrogenase (EC 1.4.1.5) coupled with FDH for
NADH regeneration, which therefore in principle only
consumes stoichiometric amounts of ammonium formate
(Koszelewski et al., 2008b).
Regardless of the cascade system, the interactions and
compatibility of each of the enzymes and their associated
reagents need to be considered. For instance, the introduc-
tion of high concentrations of formate (for use with FDH) is
likely to affect the activity and stability of the other enzymes.
The interactions can be formalized in an interaction matrix
table (Santacoloma et al., 2011). Characteristics related to
the catalyst constrains, process modeling, and cascade or
network interactions, reactor selection, monitoring and
control are also described by Santacoloma et al. (2011).
Whole-Cell Biocatalysis
Despite the fact that the multi-enzyme cascade approach has
the potential to be very successful (e.g., Koszelewski et al.,
2008a; 2009; Truppo et al., 2010), the economical burden of
using multiple enzymes is signiﬁcant (Tufvesson et al.,
2010). In particular the combination with the addition of
co-factor (NAD(P)H) will increase the process cost, even
when using low concentrations (Berenguer-Murcia and
Fernandez-Lafuente, 2010). A suitable strategy to overcome
this limitation is using a whole cell as the biocatalyst. Whole-
cell strategies (Fig. 3) have become a very promising ﬁeld
especially for bioconversions which usually require a
cofactor addition and/or regeneration (Leo´n et al., 1998).
The wild-type microorganism containing the desired
transaminase may be used, but the more common approach
is to clone the desired transaminase into a host vector. For
example the use of recombinant E. coli (Ingram et al., 2007;
Koszelewski et al., 2009) or Pichia pastoris (Bea et al., 2010)
expressing v-transaminase, optionally following a similar
approach as seen for cascades, creating so called cassettes
over-expressing the production of the enzymes involved in
the degradation or recycling of the co-product. Nevertheless,
the number of available v-transaminases with a known gene
sequence is still rather limited (Clay et al., 2010; Koszelewski
et al., 2010b).
In Tables II and III examples of the use of whole-cell
systems are given. Reported yields are usually in the range of
Table VII. Enzymatic cascades for shifting the equilibrium.
Enzymes Co-reactantsa Co-products Refs.
Oxaloacetate degradation PcK, PK a-KG, ATP Pyruvate, CO2 Chao et al. (1999)
Pyruvate degradation ALS Alanine CO2, acetoine Fotheringham et al. (1999)
PDC Alanine CO2, acetaldehyde Ho¨hne et al. (2008)
PDC, ADH, FDH Alanine, NADH, Formate CO2, ethanol Not reported
LDH, GDH Alanine, Glucose, NADH Lactic acid, gluconic acid Shin and Kim (1999)
LDH, FDH Alanine, Formate, NHþ4 , NADH Lactic acid, CO2 Koszelewski et al. (2008b)
Co-product degradation (Y)ADH, GDH 2-PA/BA, glucose, NADH 2-propyl/butyl alcohol, gluconic acid Not reported
(Y)ADH, FDH 2-PA/BA, formate, NADH 2-propyl/butyl alcohol, CO2 Cassimjee et al. (2010)
Alanine recycling AADH, GDH Alanine, NHþ4 , NADPH Pyruvate (low), H2O Truppo et al. (2009a,b)
ALS, acetolactate synthase; PDC, pyruvate decarboxylase; ADH, alcohol dehydrogenase; FDH, formate dehydrogenase; GDH, glucose dehydrogenase; 2-
PA/BA, 2-propyl amine or 2-butyl amine; PcK, phosphoenolpyruvate carboxykinase; PK, pyruvate kinase.
aReactants that are required for the reaction additionally to the amine acceptor (ketone).
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80–99% with comparable enantioselectivity and similar
reaction rates to enzyme cascades.
Several authors (Cassimjee et al., 2010; Fotheringham
et al., 1999; Koszelewski et al., 2010b; Panke et al., 1999; Yun
and Kim, 2008) have shown that chromosomal integration
of genes under a suitable regulatory system to an E. coli or
P. pastoris mutant is a very useful route for constructing a
whole-cell biocatalyst that is able to synthesize chiral amines
to high speciﬁc activities and that can maintain activity for
extended periods under reaction conditions in the presence
of an organic phase. However, the adequate expression level
of each protein still remains a challenge (Kratzer et al.,
2010). Other typical drawbacks found in whole-cell
biocatalysis, such as uncontrolled side reaction (and
consequently unwanted side products) and slower reaction
rates (due to trans-membrane diffusion problems and
higher metabolic burden), are also encountered in the
transaminase reaction using whole cell. Consequently the
lower cost of using whole cells has to be weighed against
these drawbacks to ﬁnd the most suitable catalyst form
(Woodley, 2006).
Biocatalyst Limitations
Transaminases can be found with activity for a broad range
of substrate ketones as has been recently reviewed by Kroutil
et al. (Koszelewski et al., 2010c), although S-selective
enzymes are more common. However, even if an enzyme
with the desired speciﬁcity and selectivity can be found, the
activity and stability must be high enough to allow a
biocatalyst productivity that results in a feasible cost
contribution from the biocatalyst (Tufvesson et al., 2010).
Improvement of the biocatalyst is very often required for
industrial application. For instance, poor stability of the
enzyme could require it to be replenished throughout the
course of reaction to maintain a sufﬁcient rate. However, if
the enzyme stability is improved to a point where it
maintains a rate for a longer period of time the loading can
be reduced signiﬁcantly.
The cost of the biocatalyst is dependent on variables, such
as expression level, efﬁciency of the fermentation protocol,
enzyme speciﬁc activity and the form of the biocatalyst (e.g.,
whole cell, cell-free extract (crude enzyme), puriﬁed or
immobilized enzyme). With an optimized production
protocol the biocatalyst does not need to be excessively
expensive, although the development of an optimized
process takes time and requires many different skills
(e.g., cloning, fermentation, puriﬁcation/immobilization).
Excluding development costs, a likely cost for an efﬁciently
produced in house biocatalyst used for pharmaceutical
production is calculated to be around 10–35s/kg for whole
cells (dry cell weight), 100–250s/kg crude enzyme (cell-
free extract) and 50–100s/kg for an immobilized
preparation (Tufvesson et al., 2011). This in turn puts
requirements on the productivity of the biocatalyst in
terms of product produced per amount of biocatalyst for
an economical process.
A common problem is substrate and product inhibition
of the enzyme. For instance, in the transamination of MBA
from acetophenone, both substrates and products are
known to inhibit the enzyme activity severely already at
millimolar concentrations (Truppo et al., 2009a). This could
be managed by multiphasic reactions, for example, using an
auxiliary solvent or a resin, but it is also conceivable that this
could be overcome by modiﬁcations to the enzyme itself.
Improvement of the Biocatalyst
Several recent examples illustrate very well the advances in
biocatalyst improvement, such as the development of a
process for the anti-diabetic drug Sitagliptin by Savile et al.
(2010), and the work by Martin et al. (2007). The state-of-
the-art methodology to develop the enzymes to ﬁt process
requirements is based both on random changes to the
protein, combined with the addition of a selective pressure
to ﬁnd the improved mutants (Turner, 2009) and an
understanding of the relationship between protein structure
and its properties (Frushicheva et al., 2010). Approaches
such as saturation mutagenesis (Reetz and Carballeira,
2007), and the use of multivariate statistical techniques, for
example, ProSAR (Fox et al., 2007) has evolved into an
extremely powerful tool to develop highly efﬁcient tailor
made catalyst with less effort than ever before. For instance
Martin et al. (2007) managed to improve the activity of a
transaminase by a factor of almost 300, while at the same
time improving the stability of the enzyme toward the
process conditions, yielding amuchmore economic process.
Other examples are given in reports by Rothman et al.
(2004) and Yun et al. (2005) who managed to overcome
product inhibition by directed evolution, Cho et al. (2008)
redesigned the substrate speciﬁcity of an v-transaminase for
the kinetic resolution of aliphatic chiral amines.
To obtain a biocatalyst with the desired properties it is
important to screen under the preferred reaction process
conditions. However, it is generally difﬁcult to screen for all
the desired properties simultaneously (Burton et al., 2002),
why a gradual adaptation might be beneﬁcial (Tracewell and
Arnold, 2009). Also, due to the high costs associated with the
techniques for biocatalyst improvement improvements
in the biocatalyst should go together with process
improvements.
Separation and Recycling of Biocatalyst
When the reaction is ﬁnished all detectable enzyme needs to
be completely removed or eliminated to ensure product
purity and also to avoid problems with emulsions being
formed in the downstream processing. Fast and easy
separation of the biocatalyst from the reaction medium
can also be a key factor for enzymatic resolution reactions
where the reaction has to be stopped at a given conversion to
achieve an adequate ee of the product. In particular, when
using whole cells and high concentration of organic
compounds or mixing (resulting in cell lysis), the separation
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can be problematic due to formation of emulsions or
foaming. A simple method is to denature the enzyme to an
insoluble precipitate by acidiﬁcation, ﬁltration is then
sufﬁcient to remove the majority of the enzyme precipitate
(Savile et al., 2010). For high value products, discarding
the enzyme after reaction can be economically feasible.
However, in cases when the biocatalyst cost needs to be
reduced recycling of the biocatalyst could be necessary.
Immobilization. Immobilization of enzymes can provide
several advantages compared to free enzymes, including:
easy recovery and reuse of enzyme, improved operational
and storage stability of the enzyme, the possibility for
continuous operation in packed bed reactors, and mini-
mizing protein contamination in the product (Sheldon,
2007). Well-known problems of immobilization are loss in
activity due to introduction of mass transfer limitation and
by loss of active enzyme. A less discussed issue is that the
required preparation step increases the cost of the enzyme.
However, the cost contribution of the immobilized enzyme
in the applied process has the potential to be lower than for
free enzyme, since the immobilized enzyme can be reused
for many reaction cycles.
Immobilization of whole cell v-transaminase by entrap-
ment in calcium alginate beads has been applied for the
kinetic resolution of chiral amines in a packed bed reactor
(Shin et al., 2001b). Entrapment of whole cells in calcium
alginate beads was found to cause diffusion limitations and
changes in substrate and product inhibition (Shin et al.,
2001b). It was also reported that also both Vmax and KM
changed when cells were immobilized in calcium alginate
beads (Martin et al., 2007).
Immobilization of free v-transaminases has been
achieved both by covalent linkage to different solid support
materials (Yi et al., 2007) and by entrapment in sol–gel
matrices (Koszelewski et al., 2010a; Lee et al., 2006) with
reported immobilization yields of20–50% protein and less
than 20% activity. v-transaminase immobilized on chitosan
beads was reported to retain 77% activity after ﬁve reaction
cycles, but was also susceptible to severe substrate and
product inhibition (Yi et al., 2007). Immobilization of v-
transaminase in sol–gel matrices resulted in improved
enzyme activity at higher pH and temperatures compared to
free enzyme (Koszelewski et al., 2010a). Easy separation of
product from sol–gel immobilized (R)-selective v-transa-
minase allowed a two-step deracemization, consisting of
kinetic resolution with the (R)-selective immobilized v-
transaminase and asymmetric synthesis with an (S)-selective
v-transaminase, to be carried out with a product yield of
89% (Koszelewski et al., 2010a).
When scaling up a reaction using immobilized biocatalyst
the resistance of the particles to mechanical forces needs to
be considered as this can limit their applicability. The use of
a packed bed reactor would alleviate this problem but could
be limited by the pressure drop over the bed or mass transfer
(Lilly and Woodley, 1994).
Solubility Limitations and Use of Solvents
For the success of most biocatalytic routes, it is also critical
to be able to supply substrates at a concentration above 50–
100 g/L (Pollard and Woodley, 2007). A common char-
acteristic inherent to aqueous biocatalytic processes is the
low solubility of many substrates in water. Operating the
process at too low a substrate concentration would lead to a
low volumetric productivity and thereby high costs for
equipment and downstream processing for product
recovery. A list of some of the compounds used for
transamination reactions is shown in Table VIII. From the
table it is evident that for compounds such as acetophenone
and homophenylalanine, a feeding strategy has to be
employed to supply the substrate at a high concentration
(Kim et al., 2007a). When a biocatalytic route is limited by
substrate availability, whether due to low aqueous solubility,
slow dissolution rate, or inhibition/toxicity, the controlled
addition (feeding) of the substrate into the reaction medium
is a common solution (D’Anjou and Daugulis, 2001; Doig
et al., 2002; Lynch et al., 1997). This strategy can also help to
minimize imine dimer formation (Savile et al., 2010,
supplementary information).
Table VIII. Physical properties of different compounds at 258C.a
Compound LogP
Aqueous solubility, Saq Critical conc. for cell, C
aq
crit
g/L mol/L g/L mol/L
Acetophenone 1.58 6.1 0.05 2.1 0.02
a-methylbenzylamine 1.49b 42 0.45 9.5 0.08
Alanine 2.99 165 1.9 26.4 0.30
Pyruvic acid 1.24b Fully miscible 11.4 109 1.24
Acetone 0.24 Fully miscible 17.2 100.1 1.72
2-propanamine 0.26 Fully miscible 16.9 100.5 1.70
Butanone 0.29 223 3.1 32 0.44
Butylamine 0.97 Fully miscible 1.53 105 1.44
Homophenylalanine 1.20 5a 0.03 1.9 0.01
2-oxo-4-phenylbutanoic acid 0.96b 21.3a 0.12 6.1 0.03
aData from EPI Suite—Estimation Software (http://www.epa.gov/oppt/exposure/pubs/episuitedl.htm).
bEstimated data using atom/fragment contribution method.
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The substrate itself can be added beyond its solubility,
thereby forming a second phase. However, this can cause
toxicity and stability problems depending on the properties
of the compound. The molecular toxicity, or the critical
concentration (Ccrit), is deﬁned as the concentration at
which the catalytic activity is lost (Osborne et al., 2010) or
reduced by half (Vermue et al., 1993). Compounds with an
aqueous solubility between 0.0003 and 1M usually require
an auxiliary phase for the purpose of in situ substrate
addition (Straathof, 2003). As seen in Table VIII, this range
includes for instance a-methylbenzyl amine, acetophenone,
homophenylalanine and 2-oxo-4-phenylbutanoic acid
which are known to have low solubility or inhibitory effects
toward the catalytic activity (Kim and Shin, 1998; Lo et al.,
2005).
To increase productivity, either a water miscible co-
solvent (e.g., THF, iso-propanol, DMSO) that increases the
solubility of the substrate in the aqueous phase can be added,
or a water immiscible solvent (e.g., toluene, heptane, ethyl-
acetate) can be added to act as a reservoir for the substrate.
For instance Koszelewski et al. (2008b) investigated the
effect of different water miscible solvents on the amination
of 4-phenyl-2-butanone. It was seen that the addition of
15% DMSO gave the best activity for the enzyme. On the
other hand, addition of solvents will decrease the stability of
the biocatalyst and might also cause downstream problems,
since the solvent needs to be separated from the product.
DMSO for instance is known to be problematic to remove
completely. Furthermore, water miscible solvent added up
to 25% of volume generally only increases the solubility to a
limited extent thereby limiting the usefulness of this
approach.
An example of a 2-phase system was reported by Shin and
Kim (1997), who used cyclohexanone in the resolution of
MBA, which increased the reaction rate ninefold and
allowed the resolution of 500mMMBA with an ee of>95%
at 51% conversion (Shin and Kim, 1997). A reported
drawback was decreased stability of the enzyme due to the
aqueous/organic interface. This problem was alleviated
in another report by Shin and co-workers, using a reactor
with the two liquid phases separated by a membrane (Shin
et al., 2001a). Membrane extraction was also used in
connection with a packed-bed reactor where whole cells
were immobilized in calcium alginate beads (Shin et al.,
2001b).
Many different solvents can be used for this purpose,
although for industrial applications it is important that the
solvents are generally regarded as safe (GRAS), which limits
the number of available solvents. Also, the environmental
impact of using solvents should be considered as solvent
(volatile organic compound) emissions are one of the main
contributors to the environmental impact of pharmaceutical
processes (Jime´nez-Gonza`lez et al., 2004). Further, the costs
and efforts associated with wastewater treatment of side
streams containing organic solvents are often complex and
closely related with the solubility and toxicity of the solvents
used (Leo´n et al., 1998).
Conclusions
Biocatalytic transamination is on the verge of taking-off as a
tool for the production of chiral amines. Figure 4 points to
the fact that the state-of-the art in transaminase processes
has been insufﬁcient for successful industrial application
until very recently. The work by Truppo, Martin, Savile and
respective co-workers could indeed indicate a breakthrough
for transaminase technology. It is interesting to note that the
ﬁrst achieved process feasibility by reaction methods such as
the use of enzymatic cascades and ISPR (Truppo et al.,
2010), while the two others achieved improved process
feasibility by protein engineering techniques to improve
product catalyst productivity as well as tolerance to higher
concentrations of the substrate (Martin et al., 2007; Savile
et al., 2010). Further, the recent work on novel cascade
reactions by Ho¨hne et al. (2008) and by Koszelewski et al.
(2008b) are signiﬁcant contributions to the ﬁeld that may in
the future enable the asymmetric synthesis of products made
by thermodynamically challenging reactions.
However, there is a need for the development of platform
technologies to facilitate implementation and shortening of
development times and uncertainties. Such technologies
would include a broader availability of affordable transa-
minases, cascade systems or optimized whole-cell systems,
preferably in an immobilized form. Also, protocols and kits
for selecting the most appropriate separation procedure
(e.g., resin selection for ISPR) could also simplify the
development procedure. Further, the scientiﬁc community
needs to be aware of the economic constraints present in
industry to address the issues of biocatalyst productivity
(g product/g biocatalyst), process intensity (g/L) and space
time yield (g/L h). There is often a trade-off between the cost
of the catalyst improvement and the beneﬁts that can arise
from such efforts. In an ideal situation, process and
biocatalyst improvements should go side-by-side, in order
to diminish the risk of improvement of one of the process
metrics at the expense of another.
A rational process selection methodology, where the
process set-up is given by the intrinsic properties of the
system, for example, reaction thermodynamics, substrate
solubility, enzyme kinetics (e.g., inhibition), would be
desirable and would simplify and improve biocatalytic
process design. However, as can be seen above, the choices
made are highly interdependent and knowledge gaps still
make such an approach out of reach. Even so, guidelines and
rules of thumb are desirable to identify if a process is feasible
allowing better choices to be made. For instance, knowledge
of the thermodynamic properties of the reaction is crucial
information in the early process development determining
which process solutions are feasible. Still fundamental
knowledge about the technologies to achieve high yields in
thermodynamically unfavorable systems is lacking.
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Effective estimation of parameters in biocatalytic reaction kinetic expressions are very
important when building process models to enable evaluation of process technology
options and alternative biocatalysts. The kinetic models used to describe enzyme-catalyzed
reactions generally include several parameters, which are strongly correlated with each
other. State-of-the-art methodologies such as nonlinear regression (using progress curves)
or graphical analysis (using initial rate data, for example, the Lineweaver-Burke plot,
Hanes plot or Dixon plot) often incorporate errors in the estimates and rarely lead to
globally optimized parameter values. In this article, a robust methodology to estimate pa-
rameters for biocatalytic reaction kinetic expressions is proposed. The methodology deter-
mines the parameters in a systematic manner by exploiting the best features of several of
the current approaches. The parameter estimation problem is decomposed into ﬁve hier-
archical steps, where the solution of each of the steps becomes the input for the subse-
quent step to achieve the ﬁnal model with the corresponding regressed parameters. The
model is further used for validating its performance and determining the correlation of the
parameters. The ﬁnal model with the ﬁtted parameters is able to describe both initial rate
and dynamic experiments. Application of the methodology is illustrated with a case study
using the x-transaminase catalyzed synthesis of 1-phenylethylamine from acetophenone
and 2-propylamine. VC 2012 American Institute of Chemical Engineers Biotechnol. Prog.,
28: 1186–1196, 2012
Keywords: biocatalysis, parameter estimation, kinetic modeling, omega-transaminases
Introduction
Biocatalysis is continuing to attract a growing interest in
the chemical and pharmaceutical industries and is now
becoming a key component in the toolbox of industrial pro-
cess chemists.1 Often the green credentials and effective
utilization of the raw materials are cited as the most impor-
tant positive features of biocatalysis. However, in order for
the process to be economically feasible (as well as green),
high catalyst productivity (mass of product per mass of cat-
alyst) is required.2 To achieve this, as for any chemical pro-
cess, detailed knowledge of the reaction kinetics is essential
for effective implementation and operation of the process
technology. Furthermore, the kinetic parameters provide an
insight into the biocatalytic reaction mechanisms (such as
inhibition).3 Often, the ratio of E0K
f
cat/K
A
M is used to
describe the biocatalyst performance.4 However, for more
complex biocatalytic reactions it is important to include
also the inhibition parameters of the substrate(s) and prod-
uct(s) to accurately quantify the catalyst effectiveness and
to provide guidance for biocatalyst improvement.5 The ki-
netic parameters can also be used in a process model to
describe the dynamic behavior of the reaction and in this
way be used to evaluate opportunities for process integra-
tion (e.g., in situ product removal),6 process control and
operational optimization.7 Furthermore, the reaction equi-
librium can be derived from the kinetic parameters, which
is essential in selecting suitable process operating
strategies.8
Biocatalytic reactions are frequently considered to obey
mixed order (between 0 and 1) kinetics similar to the Lang-
muir-Hinshelwood model denoted as the Michaelis and
Menten kinetics.9 The principles of the Michaelis and
Menten kinetics have been further expanded to describe mul-
tisubstrate reactions with complex reaction behavior. For
example, a generic equilibrium controlled bisubstrate reac-
tion can be formulated as Eq. 1:
Aþ B$ Pþ Q (1)
The kinetic model (full) for Eq. 1 which follows a ping pong
bi-bi mechanism in which substrate (A) is bound ﬁrst, while
the coproduct (P) is released before the second substrate (B)
Correspondence concerning this article should be addressed to J. M.
Woodley at jw@kt.dtu.dk.
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and the ﬁnal product (Q) leaves the enzyme last,10 can be
formulated as Eq. 211:
rQ ¼ rA
¼
E0K
f
catK
r
cat

c½A½B  k ½P½QKEQ

1þ ½I
KI
Si

KrcatK
B
Mc½A þ KrcatKAMc½B þ
KfcatK
Q
M
KEQ
k½P þ K
f
catK
P
M
KEQ
k½Q
þ Krcatc½A½B þ
KfcatK
Q
M
KAi KEQ
ck½A½P þ K
f
cat
KEQ
k½P½Q
þ K
r
catK
A
M
KQi
ck½B½Q ð2Þ
The dynamic equation consists of nine parameters including
terms such as the catalytic turnover of the reaction
(Kfcat,K
r
cat), Michaelis parameters (K
A
M, K
B
M, K
P
M, K
Q
M), inhibi-
tion parameters (KAi ,K
Q
i ) that are derived from the core
mechanism, uncompetitive substrate inhibition parameter
(KISi) due to formation of nonproductive complexes and the
binary reaction direction indicator (k and c) thus forming a
complex model.
The chemical equilibrium can be represented with a con-
stitutive equation using the Haldane relationship. The rela-
tionship is shown in Eq. 3:
KEQ ¼

Kfcat
Krcat
2
 K
P
MK
Q
M
KAMK
B
M
¼

Kfcat
Krcat

 K
Q
MK
P
i
KBMK
A
i
¼

Kfcat
Krcat

 K
P
MK
Q
i
KAMK
B
i
¼ K
P
i K
Q
i
KAi K
B
i
(3)
Although enzymes have evolved to operate very effectively
at low concentrations of substrates in a natural environment,
for industrial applications, high concentrations of substrates
are required to ensure that capital and subsequent down-
stream processing costs are manageable. For this reason, the
effects of higher concentrations of substrate (and product) on
the enzyme kinetics are critically important. In fact, under
industrial conditions it is normally the case that the enzyme
is inhibited by the substrate and the product or even other
components present in the reaction medium. These excess in-
hibition effects are introduced into the kinetic expression
through an inhibition relationship

1þ ½I
KI
Si

factored into
Eq. 2 either in the velocity term or the Michaelis constant
term or both, depending upon whether the reaction exhibits
uncompetitive, competitive or noncompetitive inhibition,
respectively.12 For example, a reaction exhibiting uncompeti-
tive inhibition with compound I, would result in the inhibi-
tion relationship factored into the numerator as shown in Eq.
2. When attempting to estimate the parameters in Eq. 2, it is
often recognized that the parameters may be strongly corre-
lated, thereby compromising the uniqueness of the parameter
values.13 This means that the physical meaning of the pa-
rameters is lost and that many different sets of parameter
values can fulﬁl the requirements of the given equations. For
instance, different initial guesses for the parameters will
result in completely different values of the parameters. There
is, therefore, a need to address the problem of determining
the kinetic parameters for biocatalytic reactions in a system-
atic and efﬁcient manner.
To reduce the number of parameters to be estimated
simultaneously, it is therefore suggested to decompose the
full model to the initial rate model by designing experiments
where samples are taken at the initial period of the experi-
ment. During this initial time, it can be assumed that the
inﬂuence of product and reversibility of the reaction is negli-
gible. Therefore, the terms related to product accumulation
and the equilibrium relationships can be omitted. For equilib-
rium controlled reactions, in the absence of products, Eq. 2
can be decomposed into Eqs. 4a and 4b by considering c ¼
1 and k ¼ 0 to get equation for rA and considering k ¼ 0
and c ¼ 1 to get equation for rQ:
Forward direction (Eq. 4a):
rQ ¼ rA ¼ E0K
f
cat½A½B
KAM½B þ KBM½A þ ½A½B

1þ ½I
KISi

(4a)
Reverse direction (Eq. 4b):
rA¼ rQ¼ E0K
r
cat½P½Q
KPM½Q þ KQM½P þ ½P½Q

1þ ½I
KISi

(4b)
where Eq. 4a represents the consumption of substrate A for
the forward direction, while Eq. 4b represents the consump-
tion of substrate Q when running the reaction in the reverse
direction. The most commonly used methodologies to esti-
mate the parameters for enzymatic reactions are the graphi-
cal plotting (GP) method and nonlinear regression (NLR)
method. The former requires a linearization of the kinetic
expression at different initial rate conditions to obtain linear
plots from which the kinetic parameters can be determined.
Some of the commonly used plots are the Lineweaver-Burke,
Hanes and Dixon plots.14 Although simple to use, these
methods introduce inaccuracy in the parameter estimation as
the errors increase signiﬁcantly at low concentrations of the
substrate.15,16 Furthermore, where there is signiﬁcant inhibi-
tion of the substrates, the plots are no longer linear and
therefore assumptions of linear regions are not valid.
The NLR method, on the other hand, relies on minimizing
the margin of error between the model outputs or model pre-
dictions and the corresponding experimentally measured val-
ues. Often, this procedure is carried out using an
optimization routine such as the least squares method. This
is clearly an improvement on the GP method since no model
linearization is required, although usually mathematical soft-
ware with curve ﬁtting or an optimization toolbox is needed.
The major advantage of the NLR method is that it can be
applied for both initial rate data (as the GP method) and a
set of reaction progress curves. However, a difﬁculty in
using the NLR method is the necessity of good initial
guesses for the kinetic parameters. A local minimum of the
objective function is frequently found if the initial guesses
are poor and the kinetic model is complex.17
An alternative approach developed by Chen et al.18 pro-
posed a methodology, which simpliﬁes the kinetic expression
into regions of negligible and non-negligible inhibition.
However, the assumption of including a region of negligible
inhibition is rather subjective, leading to an inherent weak-
ness in this approach. For reaction systems with severe inhi-
bition, using data from the low concentration range (where
inhibition is assumed to be negligible) is likely to result in
erroneous estimations and may result in overestimation of
the Michaelis parameters. Furthermore, the method was vali-
dated for an irreversible biocatalytic reaction with the
assumption that the coproduct was completely removed in
situ. On the other hand, many industrially relevant
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biocatalytic reactions (e.g., reactions catalyzed by transami-
nases, transketolases, and transaldolases) are equilibrium
controlled reactions involving two substrates being converted
into two corresponding products for which the optimization
of the parameters have to be treated differently.
In this article, a systematic methodology to estimate the
kinetic parameters of enzymatic systems which exhibit
substrate/product inhibition is presented. The methodology
incorporates the advantages of each of the different
approaches, thus enabling estimation of the parameters with
the highest reliability. Likewise, the methodology avoids the
assumptions made by Chen et al.18 to construct a negligible
inhibition region. An experimental framework is presented to
provide guidelines for the type of experiments required to ac-
quire the kinetic parameters according to the model selected.
The outcome of the new approach will provide a platform
for good practice for estimating kinetic parameters of bioca-
talytic reactions. In this article, the methodology is exempli-
ﬁed stepwise using the x-transaminase catalysed reaction
between acetophenone and 2-propylamine for the asymmetric
synthesis of (S)-1-phenylethylamine as a demonstration.
Proposed Methodology for Kinetic Parameter
Estimation
To deal with the problems discussed above, a robust sys-
tematic methodology for kinetic parameter estimation has
been developed. This is built upon the previously docu-
mented methodology of Chen et al.18 The parameter estima-
tion problem is decomposed into ﬁve hierarchical steps
where the solution of each of the steps becomes the input
for the subsequent step. The available data is broken down
into six subsets to match the different steps of the estima-
tion. Figure 1 illustrates the proposed methodology.
Description of the methodology
In step 1, data set 1 contains the results of experiments
where the initial rate of reaction is measured as a function of
enzyme concentration. Often, the rate of reaction increases
linearly with enzyme concentration until a saturation limit is
reached where mass-transfer limitations begin to inﬂuence
the overall reaction rate. Subsequent addition of enzyme will
Figure 1. Proposed methodology for kinetic parameter estimation.
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increase the overall rate of reaction in a nonlinear manner.
The objective is therefore to determine this linear region to
guide the experiments such that all subsequent experiments
for parameter estimation must be carried out with enzyme
concentrations within the enzyme linear region as the nonlin-
ear effect of the enzyme concentration is not considered in
this study.
In step 2 the kinetic model (full model) (Eq. 2) is decom-
posed into two initial rate models for the forward and
reverse reactions (Eqs. 4a and 4b) to represent the initial pe-
riod of the experiment. In this way, the numbers of parame-
ters to be estimated simultaneously are reduced. Data
collected from initial rate experiments (data sets 2 and 3) at
different substrate concentrations in both directions are used
to regress the parameters (Kfcat, K
r
cat, K
A
M, K
B
M, K
P
M, K
Q
M, K
I
Si)
in the decomposed models (Eqs. 4a and 4b). The objective
function (Eqs. 5a and 5b) for both forward and reverse reac-
tions which is calculated as the sum of the squares of the
deviations between model prediction and experimental result
(least squares) is minimized for both the forward and reverse
reaction subject to that parameter values are greater than 0
(y[ 0, where y represents a vector of parameters).
J1ðhÞ ¼ 1=2
XN
j¼1
rAexp;j  rA;jðhÞ
 2
(5a)
J2ðhÞ ¼ 1=2
XN
j¼1
rQexp;j  rQ;jðhÞ
 2
(5b)
A common challenge in kinetic parameter estimation for bio-
catalytic reactions is the high degree of correlation between
parameters, which often results in a local minimum in the
objective function. Therefore, it is required to solve the opti-
mization problem for different initial parameter values to
increase the probability of ﬁnding a global minimum in the
objective function. The optimization is solved within a given
range to obtain the local minimum for each evaluated set.
The ﬁnal estimated parameters correspond to the minimal of
the local optimization. These parameters can be considered
to the global optimal solution.
In step 3 the additional core inhibition parameters (KAi and
KQi ) from the full kinetic model (Eq. 2) are regressed using
data set 4 (dynamic experiments where the product accumu-
lation and substrate depletion is followed over time) keeping
all the other parameters ﬁxed at the values obtained in step
2. Similar to step 2, the optimization problem is solved sev-
eral times with different initial values. Equation 2 represents
the reaction rate which is used to formulate the mass balan-
ces for each of the reactants in the process. Consequently,
the process model is expressed as a set of ordinary differen-
tial equations (ODEs), which must be solved to obtain the
prediction for the substrate and product concentrations as a
function of time. The expressions for product formation and
substrate consumption have the same form only differing in
a plus sign for product formation and minus sign for sub-
strate consumption. The objective function (Eq. 6) is formu-
lated by the least squares method as the sum of squared
error between the model prediction and experimental data of
the different compound concentrations yn. Furthermore, the
optimization is subjected to the constraint that parameter val-
ues are greater than 0 (y [ 0, y now represents the addi-
tional parameters).
JðhÞ ¼ 1=2
XN
j¼1
½ynj;exp  ½ynj;modelðhÞ
 2
(6)
where, n represents the number of different compounds pres-
ent in the reaction
In step 4 the parameters that have been estimated in steps
2 and 3 are used as initial estimates and using the full data
set (sets 2, 3, 4, and 5), they are regressed to obtain the
ﬁnal model (Eq. 2). The ﬁnal model with the regressed pa-
rameters is able to describe the initial rate data sets as well
as the progress curve data sets. The knowledge of the equi-
librium constant if available can be included into the full
model to reduce the search space for the estimation. The
value of the equilibrium constant (KEQ) may be obtained
experimentally19,20 or by using group contribution meth-
ods.21 However, this data is generally not available for
enzymes exhibiting slow reaction rates because performing
equilibrium experiments would require a lot of enzymes
which is relatively expensive. KEQ can then be calculated
using the estimated parameters by following Eq. 3. Two pa-
rameters (KBi and K
P
i ) which are not included in the full
model (Eq. 2) are calculated using the relationship shown
in Eq. 3, the estimated parameters and the value of
the KEQ.
Once the ﬁnal model with the corresponding parameters is
obtained, it is veriﬁed with new data and analyzed before
making it ready for different applications. In step 5a, veriﬁ-
cation of performance is made through data set 6 (progress
curves and initial rate data with different initial conditions).
In step 5b, the objective is to understand the correlation
between parameters, thereby identifying the relationship
between the parameters. A linear approximation of the co-
variance matrix of parameter estimators, COV(y), was used
to estimate the correlation matrix. The covariance matrix of
the estimated parameters was formulated in Eq. 722:
Cov hð Þ ¼ min J hð Þ
N  P

d y½ 
dh
T
1
r2

d y½ 
dh
" #1
(7)
where min J(y) corresponds to the minimum value obtained
from the objective function (Eq. 6), N is the number of data
points and P is the number of estimated parameters, and
d y½ 
dh

corresponds to the Jacobian matrix which is also the
local sensitivity of model variable y to parameters y.
The importance of the covariance matrix is to calculate
both the conﬁdence intervals of the parameters and the cor-
relation matrix of the estimated values.
The conﬁdence interval of parameters is determined with
a conﬁdence level of (1  a) corresponding to the 95th
percentile of the t-distribution value calculated at the a/2
percentile with N  p degrees of freedom, as described in
Eq. 8.
h1a ¼ h
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
diagðCovðhÞ
p
Þ  t

N  p; a
2

(8)
In Eq. 8, the diag(Cov(y)) takes into account only the diago-
nal values of the covariance matrix of parameters (see Eq. 7)
for this calculation.
The linear relationship between the parameters is analyzed
with the correlation matrix COR(yi, yj) as shown in Eq. 9,
thus23:
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Cor hi; hj
  ¼ Cov hi; hj
 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Cov hi; hið ÞCov hj; hj
 q (9)
Here, correlation coefﬁcients are calculated: a negative
coefﬁcient between two parameters indicates that as one pa-
rameter value increases, the other decreases; while a posi-
tive coefﬁcient indicates that both parameter values
increase or decrease simultaneously. A value of zero
denotes a lack of correlation. Even though it is preferable
that correlation between parameters does not exist, this is
usually not the case since the parameters in multisubstrate
enzymatic reactions are generally correlated with each
other. At the end of step 5, the model is ready for use in
different applications.
Type of experiments
The experiments required to collect the six data sets can
be summarized in Table 1 as follows:
Case Study: Kinetic Modeling of x-Transamination
for the Synthesis of 1-phenylethylamine
To illustrate the application of the systematic methodology
for kinetic model parameter estimation, the synthesis of 1-
phenylethylamine (PEA, also know as a-methylbenzene
amine) and coproduct acetone (ACE) from acetophenone
(APH) and 2-propylamine (IPA) in the presence of the x-
transaminase (EC 2.6.1.X) (TAm, ATA - 040) has been stud-
ied. In the synthesis of optically pure chiral amines using
TAm, the reaction is catalyzed by the transfer of an amine
(ANH2) group from an amine donor, to a pro-chiral acceptor
ketone, yielding a chiral amine as well as a coproduct ke-
tone11 (see Figure 2). The enzyme requires pyridoxal phos-
phate (PLP) as a cofactor to act as a shuttle to transfer the
amine moiety between the molecules.24
Experimental section
Reagents and Enzyme. Commercial-grade reagents and
solvents were purchased from Sigma-Aldrich (Buchs, Swit-
zerland) and used without further puriﬁcation. The unpuriﬁed
enzyme x-transaminase (ATA-040) which came as lyophi-
lized powder was kindly supplied by c-LEcta Gmbh (Leip-
zig, Germany). In all experiments enzyme amount refer to
gram of lyophilized powder.
Type of Experiments. Unless otherwise mentioned, all
reactions were carried out in 4 mL vials with an operating
volume of 3 mL. The experiments were performed in a ther-
moshaker (Model 11, HLC Biotech, Bovenden, Germany) at
30C with orbital agitation of 400 rpm. The pH was main-
tained at 7 by addition of 100 mM of potassium phosphate
buffer (pH 7). The concentration of cofactor PLP in the vial
was 2 mM. Samples of 200 lL were taken at the speciﬁed
time intervals and added to a centrifuge tube containing 800
lL of 1 N HCL to stop the reaction. The samples were cen-
trifuged for 5 mins at 14,100 rpm (MiniSpin plus, Eppendorf
AG, Germany) and analyzed by HPLC with a ﬁnal dilution
of 50-fold. The experiments required to collect the six data
sets are summarized in Table 2 as follows:
Table 1. Collected Data Sets for the Proposed Methodology
Initial
Rate*
Initial
Rate†
Progress
Curve‡
Variables Enzyme
concentration
Substrate
concentration
Substrate
or product
concentration
over time
Data set 1 
Data sets 2 and 3 
Data sets 4 and 5 
Data set 6§  
* Initial rate of reaction is measured for varying enzyme concentration
at a ﬁxed substrate concentration. † Initial rate of reaction is measured
for varying substrate concentration for forward and reverse direction at a
ﬁxed enzyme concentration. ‡ Concentration of substrates and products
are measured as a function of time (until it approaches equilibrium) at a
ﬁxed enzyme concentration. § Independent data set which is not used for
parameter estimation.
Figure 2. Transamination catalysed by x-transaminase illustrating the synthesis of 1-phenylethylamine (PEA) and co-product acetone
(ACE) from the substrates acetophenone (APH) and 2-propylamine (IPA) in the presence of the enzyme TAm.
Table 2. Data Collection for the Application of the Proposed Methodology
Data Set
Variable
Sampling Time (min)Enzyme (g/L) IPA (mM) APH (mM) MBA (mM) ACE (mM)
1 0–10 1,000 5 – – 1, 3, 5
2 1.8 100, 300, 500 1–10 – – 1, 3, 5
3 1.8 – – 1–30 50, 100, 500 1, 3, 5
4 1.8 1,000 1.8 0.8 – Intervals of 30 min until equilibrium
5 1.8 1,000 1.7 0.5 – Intervals of 30 min until equilibrium
6a 3.6 – – 5 1,000 Intervals of 30 min until equilibrium
6b 1.8 – – 1–30 1,000 1, 3, 5
Parity plot 1.8 1,000 2 – – Intervals of 30 min until equilibrium
g represents the grams of lyophilized powder of the enzyme
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Analytical. Samples were measured ex situ on an Ultimate
3000 HPLC (Dionex, Sunnyvale, CA), equipped with a UV
detector and a photodiode array detector. The compounds
were separated on a Luna 3 lm C18(2) 100 A˚ (50 	 4.6
mm) column (Phenomenex, Torrance, CA) at a ﬂowrate of 2
mL/min using a multistep gradient ﬂow of aqueous 0.1% v/v
triﬂuoroacetic acid and acetonitrile, with the following per-
centage of acetonitrile: 0 min (0%), 1 min (10%), 2.5 min
(10%), 5.9 min (60%), 6 min (0%), 7 min (0%). The com-
pounds were quantiﬁed at the following wavelengths: aceto-
phenone (280 nm) and 1-phenylethylamine (210 nm), with
retention times of 5 and 2.1 mins, respectively.
Reaction kinetic modeling
The x-transaminase-catalyzed reaction is known to follow
the so-called ‘‘ping-pong bi-bi’’ mechanism.25,26 The reaction
is heavily inﬂuenced by (competitive) inhibition of the sub-
strate acetophenone (APH) and product 1-phenylethylamine
(PEA), as well as having unfavorable reaction equilibrium.
Consequently, there is a strong motivation to go forward
with the formulation and analysis of a kinetic model to pre-
dict reaction behavior under different process conditions.
The kinetic model to describe the reaction mechanism is
derived based on the King–Altman method11,27,28 as shown
in Figure 3. Alternatively, kinetic models from the scientiﬁc
literature if available can also be used.
As can be seen in Figure 3, the mechanism includes the
formation of four nonproductive complexes E-PLP-APH, E-
PMP-IPA, E-PMP-PEA, and E-PLP-ACE, which are charac-
terized by a substrate inhibition constant KAPHSi and K
IPA
Si in
the forward direction and KPEASi and K
ACE
Si in the reverse
direction. The derived rate equation is as follows (Eq. 10)11
(k ¼ c ¼ 1):
Figure 3. King-Altman representation of the x-transaminase
reaction mechanism.
r½PEA ¼ r½APH ¼
½E0KfcatKrcat

k½IPA½APH  c ½ACE½PEAKEQ

KrcatK
APH
M k½IPA

1þ c½PEA
KPEASi
þ ½IPA
KIPASi

þ KrcatKIPAM ½APHk

1þ ½APH
KAPHSi
þ c ½ACE
KACESi

þ Kfcat
KPEAM ½ACE
KEQ
c

1þ ½APH
KAPHSi
þ k ½ACE
KACESi

þ Kfcat
KACEM ½PEA
KEQ
c

1þ ½PEA
KPEASi
þ k ½IPA
KIPASi

þ Krcatk½IPA½APH þ Kfcat
KPEAM kc½IPA½ACE
KEQKIPAi
þ Kfcat c
½ACE½PEA
KEQ
þ Krcat
KIPAM kc½APH½PEA
KPEAi
(10)
The constitutive equation of the chemical equilibrium is for-
mulated using the Haldane relationship in Eq. 11:
KEQ ¼

Kfcat
Krcat

KPEAM K
ACE
M
KAPHM K
IPA
M
¼

Kfcat
Krcat

KACEM K
PEA
i
KIPAM K
APH
i
¼

Kfcat
Krcat

KPEAM K
ACE
i
KAPHM K
IPA
i
¼ K
PEA
i K
ACE
i
KAPHi K
IPA
i
ð11Þ
Equation 10 is further decomposed into Eqs. 12a and 12b by
considering the initial period of the experiment. In this case
study, the time interval for initial rate was considered to be
the ﬁrst 5 mins of reaction time. During this time period, it
was assumed that the concentration of product was
extremely small and thus the terms related to product and
equilibrium in Eq. 7 could be neglected. In this way, the rate
equation in the absence of products for both forward,
r[APH], (c ¼ 1, k ¼ 0) and reverse direction, r[PEA], (c ¼
0, k ¼ 1) was decomposed into Eqs. 12a and 12b.
Forward direction (Eq. 12a):
r½PEA ¼ r½APH ¼ ½E0K
f
catð½APH½IPAÞ
KAPHM ½IPA

1þ ½IPA
KIPA
Si

þ KIPA½APH

1þ ½APH
KAPH
Si

þ ½IPA½APH
(12a)
Reverse direction (Eq. 12b):
r½APH ¼ r½PEA ¼ ½E0K
r
catð½PEA½ACEÞ
KPEAM ½ACE

1þ ½ACE
KACE
Si

þ KACEM ½PEA

1þ ½PEA
KPEA
Si

þ ½PEA ½ACE
(12b)
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Unlike the methodology of Chen et al.,18 the simpliﬁed
model used here takes into account substrate inhibition for
all components involved in the reaction removing the risk of
assuming a negligible inhibition region.
Application of the proposed methodology
Step 1: Determine Linear Region for Increasing Enzyme
Concentration. Plotting the initial rate of reaction vs. the
concentration of the enzyme from data set 1 (see Figure 4),
shows that the rate of reaction loses its linearity after an
enzyme concentration of around 5 g/L. Further addition of
the enzyme increases the rate of reaction but not in a linear
manner with respect to enzyme concentration and therefore
also the model predictions were limited to rates of reactions
carried out with enzyme concentration of up to 5 g/L.
Step 2: Perform Nonlinear Curve Fitting for Decomposed
Model. The kinetic model (Eq. 10) was decomposed into
two initial rate models as shown in Eqs. 12a and 12b. The
objective function was formulated as shown in Eqs. 5a and
5b. The objective function was evaluated for different initial
parameter values within the range of 0–1,000. The new esti-
mated parameters are selected as established in the method-
ology and listed in Table 3 along with the 95% conﬁdence
interval (CI) calculated for each of the estimated parameters.
The optimization was solved in Matlab
VR
(The Mathworks,
Natick, MA) using the built-in least square function with a
tolerance of 1.0E-06. Figure 5 displays the performance of
the model predictions with the estimated parameters
compared to the experimental data (data sets 2 and 3). From
Table 3 it could be seen that the parameters, KIPASi and K
ACE
Si ,
which lies in the denominator of the fraction in Eq. 7, were
extremely large compared to the operating concentration of
the reactants. The signiﬁcance of these terms could thus be
considered negligible and were omitted from the kinetic
model (Eq. 10). It can be noted that a very good ﬁt of the
experimental data has been achieved.
Step 3: Perform Nonlinear Regression for Full Model. The
previously determined parameters (Kfcat, K
r
cat, K
APH
M , K
IPA
M ,
KPEAM , K
ACE
M , K
APH
Si , K
PEA
Si ) were ﬁxed and the additional pa-
rameters (KIPAi and K
PEA
i ) were regressed with data set 4
using the full kinetic model (Eq. 10). The objective function
was formulated as shown in Eq. 6. The full dynamic process
model represented by the set of ODEs was solved in
MatlabVR (The Mathworks, Natick, MA) using the ODE45
solver which was based on the Runge-Kutta algorithm for
solving ODEs. Additionally, integration accuracy was set to
1.0E-06 to maintain accuracy in the application of the solver.
Table 4 gives the parameter values obtained by minimiza-
tion of Eq. 6. Using initial rate experiments is not advised in
this step as it does not include the effect of the reaction
equilibrium and may compromise the value of core inhibi-
tion parameters. In a report by Shin and Kim,29 initial rate
data was used to estimate the kinetic parameters for x-trans-
aminase (from the source Bacillus thuringiensis JS64) cata-
lyzed resolution of 1-phenylethylamine. However, when the
estimated parameters were analyzed, it was evident that the
predictions were erroneous. This could be conﬁrmed from
the signiﬁcantly deviated predictions of the equilibrium con-
stant when compared to literature.19
Table 3. Estimated Parameter Values from Step 2 Using the
Proposed Approach
Parameters
Estimated
Values 95% CI
Rate constants (min1)
Kfcat 0.0025 7E-5
Krcat 0.023 4E-4
Michaelis constants (mM)
KAPHM 1.50 0.10
KIPAM 89.77 10.93
KACEM 240.62 9.41
KPEAM 2.41 0.14
Substrate inhibition constants (mM)
KAPHSi 1.23 0.16
KPEASi 6.01 0.21
KIPASi 7.2E4 7E5
KACESi 1.1E4 1E4
Figure 5. Experimental data (symbol) and model prediction
(solid line) using estimated parameters from step 2.
Reaction conditions: (a) Forward direction: E0 is 1.8 g/L, con-
centration of IPA is ﬁxed at 500 mM &, 300 mM * and 100
mM ~, 2 mM PLP, 100 mM phosphate buffer. (b) Reverse
direction: E0 is 1.8 g/L, concentration of ACE is ﬁxed at 500
mM &, 100 mM * and 50 mM ~, 2 mM PLP, 100 mM
phosphate buffer.
Figure 4. Enzyme linear region.
Reaction condition: 1000 mM IPA, 5 mM APH, 2 mM PLP,
100 mM phosphate buffer.
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Step 4: Perform Nonlinear Regression for Full Model for
Recalibrating all Parameters. The ﬁnal model and ﬁtted
parameters were obtained by regressing all the parameters
from steps 2 and 3 using data sets 2, 3, 4, and 5. In this case
study, the knowledge of the equilibrium constant was
acquired from literature.19 The remaining parameters (KAPHi
and KACEi ) which were not included in the model (Eq. 10)
were then additionally calculated using Eq. 11.
The ﬁnal estimates of the parameters are listed in Table 4
and Figure 6 illustrates the model predictions using the esti-
mated parameters. From Figure 6 it can be seen that the
model predictions ﬁtted very well the experimental data for
the progress curve and the initial rate data sets. From Table
4, it can be seen that the parameter value Kfcat which is the
catalytic turnover of the reaction in the forward direction is
much smaller than the parameter value Krcat which is the cat-
alytic turnover of the reaction in the reverse direction. This
was not surprising as this parameter describes the rate of cat-
alyst turnover and from experimental observations the
reverse reaction is more favourable which is reﬂected by the
difference in the Kfcat and K
r
cat values. This is also consistent
with a study reported by Shin and Kim.29 The Michaelis
constant of the cosubstrates (KIPAM and K
ACE
M ) is higher than
the corresponding reactants, which reﬂects the need to add
an excess of the cosubstrate in the reaction media to drive
the reaction forward, which is consistent with other studies
reported on transaminases.30 Further it can be seen from the
substrate inhibition constant of APH, KAPHSi and PEA, K
PEA
Si
that inhibition contributes signiﬁcantly to the reduction of
the rate of reaction which implies the need for a feeding
strategy to alleviate the substrate inhibition problem. The
core inhibition constant for IPA and ACE (KIPAi and K
ACE
i )
are extremely high which was expected as they did not pose
any inhibitory affect towards the rate of reaction. However
the value of the core inhibition constant of PEA, KPEAi was
signiﬁcantly low which also is consistent with studies
reported by other researchers. This conﬁrms, what is experi-
mentally observed, that the rate of reaction is signiﬁcantly
reduced with the build up of the product PEA when running
the reaction in the forward direction.29,31 The relatively low
value of the core inhibition constant indicates the necessity
of an effective in situ product removal technique to run the
reaction to achieve high levels of conversion.
Step 5a: Model Validation. To further conﬁrm the valid-
ity of the methodology, the estimated parameters used in the
model were checked against new data (data set 6) of pro-
gress curve and initial rate experiments, carried out using
different initial conditions as shown in Figure 7.
Figure 7 shows the comparison of model predictions and
experimental data for a different set of reaction conditions.
As can be seen, the agreement between the simulated data
(solid line) and experimental data (symbols) is very good.
Step 5b: Model Analysis. In this study, the standard devi-
ation of measurements r was assumed to be 5% of the aver-
age measured concentration during the batch. The standard
deviation of measurements was assumed to be identical at
each time instant. The correlation matrix for the case
described here is shown in Figure 8. As expected (for these
type of systems), parameters are signiﬁcantly correlated. It
can be especially seen in the parameters KIPAM and K
APH
M dis-
played strong correlation of around 0.99, which is reﬂecting
the high conﬁdence interval of the estimated parameters. The
true kinetic parameter values are strongly inﬂuenced by the
initial values used in the parameter estimation step. That is,
Figure 6. Model predictions using the estimated parameters of the model (solid line) and experimental data (symbols).
Reaction conditions: (a) E0 ¼ 1.8 g/L, CIPA ¼ 1000 mM, CAPH ¼ 1.70 mM, CPEA ¼ 0.50 mM, 2 mM PLP, 100 mM phosphate buffer (b) E0 ¼ 1.8
g/L, CIPA is ﬁxed at 500 mM & and CAPH is varied from 1 to 10 mM, 2 mM PLP and buffer 100 mM. CACE is ﬁxed at 100 mM (triangle) and
CPEA is varied from 1 to 30 mM, 2 mM PLP, and buffer 100 mM.
Table 4. Estimated Parameters Values from Steps 3 and 4 Using the
Proposed Approach
Parameters
Estimated
Values 95% CI
Estimated
Values 95% CI
Step 3 Step 4
Rate constants (min1)
Kfcat 0.0025 7E-5 0.0078 7E-5
Krcat 0.023 4E-4 0.013 0.007
Michaelis constants (mM)
KAPHM 1.50 0.10 1.85 4.78
KIPAM 89.77 10.93 101.28 38.23
KACEM 240.62 9.41 148.99 2.91
KPEAM 2.41 0.14 0.12 0.01
Substrate inhibition constants (mM)
KAPHSi 1.23 0.16 4.15 3E-4
KPEASi 6.01 0.21 10.38 3E-4
Core inhibition constants (mM)
KAPHM – – 0.09 –
KIPAM 4,281 0.03 4,281 0.63
KACEM 1.55 0.01 0.11 0.01
KPEAM – – 1E5 –
Equilibrium constant
KEQ – 0.033
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the reason why the proposed methodology reduces the possi-
bility of accumulating errors in the parameter estimation and
at the same time provides accurate estimates.
Discussion
The methodology presented in this article builds on previ-
ously established methods, to provide reliable estimation of
kinetic model parameters. In the current approach, model
decomposition along with NLR of both initial rate data and
progress curves has been incorporated in the methodology.
Although, NLR is a quicker method which utilizes all the in-
formation from the experiments, it rarely results in a global
optimum because of the existence of the strong correlation
between the parameters which results in erroneous predic-
tions. Thus a step-wise estimation is used in the current
approach, which assists in increasing the probability of ﬁnd-
ing the global optimum. The Chen methodology uses the
advantages of NLR, as can be seen in Figure 9, however, the
early assumption of a negligible inhibition region results in
the Michaelis and rate parameters to be overestimated
because of the use of data points at a very low concentration
to estimate Km and Kcat. The methodology developed for the
approach reported in this article builds on the NLR method
as well as the Chen et al. method with a more systematic
and robust approach. The ﬁnal model with the ﬁtted parame-
ters is able to describe both type of experiments (initial rate
and dynamic experiments). The methodology is approached
in a systematic and step-wise manner such that the parame-
ters are reconciled at every step to minimize the estimation
errors. Figure 9 illustrates the robustness of this technique.
The model predictions of the concentration of PEA with the
different methodologies are illustrated with a new set of
experiments.
In Figure 9, a parity plot of the different methodology is
shown. The ﬁgure clearly illustrates the reliability of the cur-
rent approach where the model predictions fall on the experi-
mental data line. It can be seen that while using the other
methodologies, the predictions deviate over time as opposed
to the current approach which displays a better ﬁt to describe
the experiment. In the Chen methodology, the predictions ﬁt
quite well in the initial time period, but with increasing
time, the reversibility of the reaction combined with the sub-
strate and product inhibition contribute to deviations from
the prediction.
Apart from the robustness of the technique, it is valuable
to examine the number of experiments required. Table 5
Figure 8. Correlation matrix of the estimated parameters.
Negative coefﬁcient between two parameters indicates that as
one parameter value increases, the other decreases. Positive
coefﬁcient indicates that both parameter values increase and
decrease simultaneously. Zero denotes a lack of correlation.
Figure 9. Parity plot of different estimation methodologies.
Proposed methodology (diamond), graphical approach (trian-
gle), NLR (square) and Chen et al. (circle). Reaction condi-
tions: E0 ¼ 1.8 g/L, CIPA ¼ 1000 mM, CAPH ¼ 2 mM, 2 mM
PLP, 100 mM phosphate buffer.
Figure 7. Model predictions using the estimated parameters of the model (solid line) and experimental data (symbols).
Reaction conditions: (a) E0 ¼ 3.6 g/L, CAPH ¼ 0 mM, CPEA ¼ 5 mM, CACE ¼ 1000 mM, 2 mM PLP, 100 mM phosphate buffer. (b) E0 ¼ 1.8 g/L,
concentration of ACE is ﬁxed at 1000 mM, 2 mM PLP, 100 mM phosphate buffer.
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tabulates the type of experiment, number of experiments and
limitations of the studied methodologies.
A global sensitivity analysis using the Morris method33
was performed on the estimated parameters involved in the
reaction model shown in Eq. 10. The Morris method esti-
mates the effect of the model parameters by calculating for
each parameter the elementary effect of varying the other pa-
rameter. This analysis is not part of the methodology devel-
oped here, but, it was performed to gain further understanding
of the signiﬁcance of the parameters in the model output. The
algorithm for performing the analysis was implemented in
MatlabVR (The Mathworks, Natick, MA). From the Morris
screening, it was identiﬁed that most of the parameters con-
tributed signiﬁcantly in the model. This phenomenon was
expected, since it could be seen from the correlation matrix
(Figure 8), that some of the parameters were strongly corre-
lated with each other. However, three parameters Kcatr , K
APH
M ,
and KIPAM did not signiﬁcantly inﬂuence the model output.
Therefore, with this knowledge, if the model was to be recali-
brated with a new set of experimental data, these three pa-
rameters can be ﬁxed and only the remaining seven need be
re-estimated. In this way, the parameter space can be reduced.
The sensitivity analysis also forms the basis for the type of
experiments that need to be made. Speciﬁcally in this TAm
case study, it was found that the progress curve provided
more information (dynamic behavior). Initial rate experiments
are laborious and in addition provide less information (1 data
point per experiment). More information can be gathered if
the intended initial rate experiments were continued over a
longer time interval (until steady state). The sensitivity analy-
sis can provide information about which time intervals it
would be desirable to take measurements and further the ini-
tial conditions (reactant concentrations) required for the
experiments. In this case study, if the model were to be recali-
brated, further experiments (progress curves) could be con-
ducted with varying concentrations of the acetophenone and
ﬁxed concentrations of 2-propylamine without the need for
adding 1-phenylethylamine to the initial reaction mixture.
Conclusion
A method to estimate the kinetic parameters of (ping-pong
bi-bi mechanism) biocatalytic reactions suffering from sub-
strate and product inhibition has been developed. The meth-
odology is exempliﬁed with the case study of an x-
transaminase-catalyzed reaction which displays severe sub-
strate and product inhibition. The methodology takes into
account the advantages of previously developed methodolo-
gies and aims to avoid assumptions which lead to erroneous
estimates. The methodology decomposes the kinetic model
into initial rate models to reduce the number of parameters
involved. The optimization is solved for different initial val-
ues of the catalytic turnover, Michaelis parameters and sub-
strate inhibition parameters to increase the probability that
the ﬁnal regressed parameters correspond to global optimal
solution. The parameters are then ﬁxed and the remaining
core inhibition parameters are determined by NLR using pro-
gress curves on the full model. Finally, all the parameters
are reconciled (re-estimated) using all the data sets (initial
rate and progress curve) to obtain the ﬁnal kinetic model
with the corresponding ﬁtted parameters. The ﬁnal model
with the regressed parameters is able to describe initial rate
and progress curve data sets. The methodology is highly reli-
able which is further validated by comparing predicted val-
ues of product concentration with different sets of
experimental results. In the proposed approach the number
of experiments required is considerably less than the linear
plotting method and more robust and reliable.
We believe that the proposed method will signiﬁcantly
simplify and improve the estimation of kinetic parameters
for challenging reactions such as x-transaminases, which can
be used in reaction models to evaluate the implications of
improved enzymes and processes.
Acknowledgments
The authors N.A.H. and P.A.S. kindly acknowledges Techni-
cal University of Denmark. N.A.H. and P.T. acknowledges pro-
ject AMBIOCAS ﬁnanced through the European Union
Seventh Framework Programme (Grant Agreement no.
245144) for the ﬁnancial support. W.N. acknowledges support
from BIOTRAINS Marie Curie ITN, ﬁnanced by the European
Union through the 7th Framework people Programme (Grant
agreement no.: 238531). P.T. wishes to acknowledge the ﬁnan-
cial support from the ERA-IB project ‘‘Eng Biocat‘‘ (Registra-
tion Number: EIB.08.016).
Notation
[A] ¼ concentration of substrate A, mM
[B] ¼ concentration of substrate B, mM
[P] ¼ concentration of product P, mM
[Q] ¼ concentration of product Q, mM
[E0] ¼ concentration of enzyme, g/L
[I] ¼ concentration of inhibitory compound, mM
Table 5. Different Methodologies to Estimate Kinetic Parameters for Equilibrium Reactions
Type of
experiment Methodology
Number of
experiments Limitations
Initial rates Graphical plotting High* Applicable only for reactions that follows simple Michaelis-Menten kinetics.
High estimation errors
Nonlinear regression High† Low accuracy when parameters are correlated
Progress curves Nonlinear regression Low‡ Reliability is dependent on the need for good initial guess of parameters due
presence of local minima
Initial rates and
progress curves
Chen and coworkers Intermediate§ Unreliable for equilibrium reactions including regions of negligible inhibitory
region
Proposed approach Intermediate# A robust method though it is dependent on the knowledge of the equilibrium
constant which is used for ﬁnal parameter calibration
*Gyamerah and Willetts used 130 experiments to determine the parameters for a transketolase reaction.32 † Shin and Kim used 125 experiments to
determine the parameters for an x-transaminase reaction.29 ‡ The minimum number of data points corresponds to the number of parameters. § Chen et al.
used 43 experiments to determine the parameters for a transketolase reaction.18 #52 experiments were used to determine the parameters for the x-trans-
aminase reaction.
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Kcat ¼ rate of catalyst turnover, 1/min
KM ¼ Michaelis constants, mM
Ki ¼ core inhibition constants, mM
KSi ¼ substrate inhibition constants, mM
KEQ ¼ chemical equilibrium constant
c, k ¼ reaction direction indicator
y ¼ model variable
r ¼ standard deviation
a ¼ signiﬁcance level
COV ¼ covariance
y ¼ parameter
J ¼ Jacobian matrix
N ¼ number of data points
p ¼ number of parameters to be estimated
TAm ¼ x–transaminase
PLP ¼ pyridoxal-50-phosphate
[APH] ¼ concentration of acetophenone, mM
[IPA] ¼ concentration of 2-propylamine, mM
[PEA] ¼ concentration of 1-phenylethylamine, mM
[ACE] ¼ concentration of acetone, mM
Superscripts
f ¼ forward
r ¼ reverse
A ¼ compound A
B ¼ compound B
P ¼ compound P
Q ¼ compound Q
I ¼ inhibitory compound
APH ¼ compound acetophenone
IPA ¼ compound 2-propylamine
PEA ¼ compound 1-phenylethylamine
ACE ¼ compound acetone
Subscripts
n ¼ number of compounds in reaction
i, j ¼ index
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